id	sid	tid	token	lemma	pos
dpc-3412	1	1	dermatology	dermatology	NOUN
dpc-3412	1	2	:	:	PUNCT
dpc-3412	1	3	practical	practical	ADJ
dpc-3412	1	4	and	and	CCONJ
dpc-3412	1	5	conceptual	conceptual	ADJ
dpc-3412	1	6	original	original	ADJ
dpc-3412	1	7	article	article	NOUN
dpc-3412	1	8	|	|	ADV
dpc-3412	1	9	dermatol	dermatol	ADJ
dpc-3412	1	10	pract	pract	NOUN
dpc-3412	1	11	concept	concept	NOUN
dpc-3412	1	12	.	.	PUNCT
dpc-3412	2	1	2024;14(1):e2024041	2024;14(1):e2024041	NUM
dpc-3412	2	2	1	1	NUM
dpc-3412	2	3	the	the	DET
dpc-3412	2	4	causal	causal	PROPN
dpc-3412	2	5	association	association	NOUN
dpc-3412	2	6	between	between	ADP
dpc-3412	2	7	medication	medication	NOUN
dpc-3412	2	8	intake	intake	NOUN
dpc-3412	2	9	and	and	CCONJ
dpc-3412	2	10	increased	increase	VERB
dpc-3412	2	11	risk	risk	NOUN
dpc-3412	2	12	of	of	ADP
dpc-3412	2	13	psoriasis	psoriasis	NOUN
dpc-3412	2	14	zhichen	zhichen	X
dpc-3412	2	15	li1	li1	NOUN
dpc-3412	2	16	,	,	PUNCT
dpc-3412	2	17	haobin	haobin	PROPN
dpc-3412	2	18	zhou2	zhou2	PROPN
dpc-3412	2	19	,	,	PUNCT
dpc-3412	2	20	chuxian	chuxian	PROPN
dpc-3412	2	21	hu3	hu3	PROPN
dpc-3412	2	22	,	,	PUNCT
dpc-3412	2	23	zechao	zechao	ADJ
dpc-3412	2	24	lu4	lu4	PROPN
dpc-3412	2	25	,	,	PUNCT
dpc-3412	2	26	zechu	zechu	PROPN
dpc-3412	2	27	lu1	lu1	PROPN
dpc-3412	2	28	,	,	PUNCT
dpc-3412	2	29	huayao	huayao	ADJ
dpc-3412	2	30	zhang5	zhang5	NOUN
dpc-3412	2	31	1	1	NUM
dpc-3412	2	32	the	the	DET
dpc-3412	2	33	second	second	ADJ
dpc-3412	2	34	clinical	clinical	ADJ
dpc-3412	2	35	college	college	NOUN
dpc-3412	2	36	of	of	ADP
dpc-3412	2	37	guangzhou	guangzhou	PROPN
dpc-3412	2	38	medical	medical	PROPN
dpc-3412	2	39	university	university	PROPN
dpc-3412	2	40	,	,	PUNCT
dpc-3412	2	41	guangzhou	guangzhou	PROPN
dpc-3412	2	42	,	,	PUNCT
dpc-3412	2	43	guangdong	guangdong	PROPN
dpc-3412	2	44	,	,	PUNCT
dpc-3412	2	45	china	china	PROPN
dpc-3412	2	46	2	2	NUM
dpc-3412	2	47	the	the	DET
dpc-3412	2	48	first	first	ADJ
dpc-3412	2	49	clinical	clinical	ADJ
dpc-3412	2	50	college	college	PROPN
dpc-3412	2	51	of	of	ADP
dpc-3412	2	52	guangzhou	guangzhou	PROPN
dpc-3412	2	53	medical	medical	PROPN
dpc-3412	2	54	university	university	PROPN
dpc-3412	2	55	,	,	PUNCT
dpc-3412	2	56	guangzhou	guangzhou	PROPN
dpc-3412	2	57	,	,	PUNCT
dpc-3412	2	58	guangdong	guangdong	PROPN
dpc-3412	2	59	,	,	PUNCT
dpc-3412	2	60	china	china	PROPN
dpc-3412	2	61	3	3	NUM
dpc-3412	2	62	the	the	DET
dpc-3412	2	63	sixth	sixth	ADJ
dpc-3412	2	64	clinical	clinical	ADJ
dpc-3412	2	65	medical	medical	ADJ
dpc-3412	2	66	school	school	NOUN
dpc-3412	2	67	of	of	ADP
dpc-3412	2	68	guangzhou	guangzhou	PROPN
dpc-3412	2	69	medical	medical	PROPN
dpc-3412	2	70	university	university	PROPN
dpc-3412	2	71	,	,	PUNCT
dpc-3412	2	72	guangzhou	guangzhou	PROPN
dpc-3412	2	73	,	,	PUNCT
dpc-3412	2	74	guangdong	guangdong	PROPN
dpc-3412	2	75	,	,	PUNCT
dpc-3412	2	76	china	china	PROPN
dpc-3412	2	77	4	4	NUM
dpc-3412	2	78	department	department	PROPN
dpc-3412	2	79	of	of	ADP
dpc-3412	2	80	urology	urology	NOUN
dpc-3412	2	81	,	,	PUNCT
dpc-3412	2	82	the	the	DET
dpc-3412	2	83	eighth	eighth	ADJ
dpc-3412	2	84	affiliated	affiliated	ADJ
dpc-3412	2	85	hospital	hospital	NOUN
dpc-3412	2	86	,	,	PUNCT
dpc-3412	2	87	sun	sun	PROPN
dpc-3412	2	88	yat	yat	PROPN
dpc-3412	2	89	-	-	PUNCT
dpc-3412	2	90	sen	sen	PROPN
dpc-3412	2	91	university	university	PROPN
dpc-3412	2	92	,	,	PUNCT
dpc-3412	2	93	shenzhen	shenzhen	PROPN
dpc-3412	2	94	,	,	PUNCT
dpc-3412	2	95	guangdong	guangdong	PROPN
dpc-3412	2	96	,	,	PUNCT
dpc-3412	2	97	china	china	PROPN
dpc-3412	2	98	5	5	NUM
dpc-3412	2	99	department	department	NOUN
dpc-3412	2	100	of	of	ADP
dpc-3412	2	101	breast	breast	NOUN
dpc-3412	2	102	surgery	surgery	NOUN
dpc-3412	2	103	,	,	PUNCT
dpc-3412	2	104	shaoguan	shaoguan	PROPN
dpc-3412	2	105	maternal	maternal	ADJ
dpc-3412	2	106	and	and	CCONJ
dpc-3412	2	107	child	child	NOUN
dpc-3412	2	108	health	health	NOUN
dpc-3412	2	109	hospital	hospital	NOUN
dpc-3412	2	110	,	,	PUNCT
dpc-3412	2	111	shaoguan	shaoguan	PROPN
dpc-3412	2	112	,	,	PUNCT
dpc-3412	2	113	guangdong	guangdong	PROPN
dpc-3412	2	114	,	,	PUNCT
dpc-3412	2	115	china	china	PROPN
dpc-3412	2	116	key	key	ADJ
dpc-3412	2	117	words	word	NOUN
dpc-3412	2	118	:	:	PUNCT
dpc-3412	2	119	psoriasis	psoriasis	NOUN
dpc-3412	2	120	,	,	PUNCT
dpc-3412	2	121	medicine	medicine	NOUN
dpc-3412	2	122	intake	intake	NOUN
dpc-3412	2	123	,	,	PUNCT
dpc-3412	2	124	mendelian	mendelian	ADJ
dpc-3412	2	125	randomization	randomization	NOUN
dpc-3412	2	126	,	,	PUNCT
dpc-3412	2	127	risk	risk	NOUN
dpc-3412	2	128	factors	factor	NOUN
dpc-3412	2	129	citation	citation	NOUN
dpc-3412	2	130	:	:	PUNCT
dpc-3412	3	1	li	li	PROPN
dpc-3412	3	2	z	z	PROPN
dpc-3412	3	3	,	,	PUNCT
dpc-3412	3	4	zhou	zhou	PROPN
dpc-3412	3	5	h	h	PROPN
dpc-3412	3	6	,	,	PUNCT
dpc-3412	3	7	hu	hu	PROPN
dpc-3412	3	8	c	c	X
dpc-3412	3	9	,	,	PUNCT
dpc-3412	3	10	lu	lu	PROPN
dpc-3412	3	11	z	z	PROPN
dpc-3412	3	12	,	,	PUNCT
dpc-3412	3	13	lu	lu	PROPN
dpc-3412	3	14	z	z	PROPN
dpc-3412	3	15	,	,	PUNCT
dpc-3412	3	16	zhang	zhang	PROPN
dpc-3412	3	17	h.	h.	PROPN
dpc-3412	3	18	the	the	DET
dpc-3412	3	19	causal	causal	PROPN
dpc-3412	3	20	association	association	NOUN
dpc-3412	3	21	between	between	ADP
dpc-3412	3	22	medication	medication	NOUN
dpc-3412	3	23	intake	intake	NOUN
dpc-3412	3	24	and	and	CCONJ
dpc-3412	3	25	increased	increase	VERB
dpc-3412	3	26	risk	risk	NOUN
dpc-3412	3	27	of	of	ADP
dpc-3412	3	28	psoriasis	psoriasis	NOUN
dpc-3412	3	29	.	.	PUNCT
dpc-3412	4	1	dermatol	dermatol	NOUN
dpc-3412	4	2	pract	pract	PROPN
dpc-3412	4	3	concept	concept	NOUN
dpc-3412	4	4	.	.	PUNCT
dpc-3412	5	1	2024;14(1):e2024041	2024;14(1):e2024041	X
dpc-3412	5	2	.	.	PUNCT
dpc-3412	5	3	doi	doi	NOUN
dpc-3412	5	4	:	:	PUNCT
dpc-3412	5	5	https://doi.org/10.5826/dpc.1401a41	https://doi.org/10.5826/dpc.1401a41	VERB
dpc-3412	5	6	accepted	accept	VERB
dpc-3412	5	7	:	:	PUNCT
dpc-3412	5	8	august	august	PROPN
dpc-3412	5	9	29	29	NUM
dpc-3412	5	10	,	,	PUNCT
dpc-3412	5	11	2023	2023	NUM
dpc-3412	5	12	;	;	PUNCT
dpc-3412	5	13	published	publish	VERB
dpc-3412	5	14	:	:	PUNCT
dpc-3412	5	15	january	january	PROPN
dpc-3412	5	16	2024	2024	NUM
dpc-3412	6	1	copyright	copyright	NOUN
dpc-3412	6	2	:	:	PUNCT
dpc-3412	6	3	©	©	PROPN
dpc-3412	6	4	2024	2024	NUM
dpc-3412	6	5	li	li	PROPN
dpc-3412	6	6	et	et	PROPN
dpc-3412	6	7	al	al	PROPN
dpc-3412	6	8	.	.	PUNCT
dpc-3412	7	1	this	this	PRON
dpc-3412	7	2	is	be	AUX
dpc-3412	7	3	an	an	DET
dpc-3412	7	4	open	open	ADJ
dpc-3412	7	5	-	-	PUNCT
dpc-3412	7	6	access	access	NOUN
dpc-3412	7	7	article	article	NOUN
dpc-3412	7	8	distributed	distribute	VERB
dpc-3412	7	9	under	under	ADP
dpc-3412	7	10	the	the	DET
dpc-3412	7	11	terms	term	NOUN
dpc-3412	7	12	of	of	ADP
dpc-3412	7	13	the	the	DET
dpc-3412	7	14	creative	creative	ADJ
dpc-3412	7	15	commons	common	NOUN
dpc-3412	7	16	attribution	attribution	NOUN
dpc-3412	7	17	-	-	PUNCT
dpc-3412	7	18	noncommercial	noncommercial	ADJ
dpc-3412	7	19	license	license	NOUN
dpc-3412	7	20	(	(	PUNCT
dpc-3412	7	21	by	by	ADP
dpc-3412	7	22	-	-	PUNCT
dpc-3412	7	23	nc-4.0	nc-4.0	NOUN
dpc-3412	7	24	)	)	PUNCT
dpc-3412	7	25	,	,	PUNCT
dpc-3412	7	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3412	7	27	,	,	PUNCT
dpc-3412	7	28	which	which	PRON
dpc-3412	7	29	permits	permit	VERB
dpc-3412	7	30	unrestricted	unrestricted	ADJ
dpc-3412	7	31	noncommercial	noncommercial	ADJ
dpc-3412	7	32	use	use	NOUN
dpc-3412	7	33	,	,	PUNCT
dpc-3412	7	34	distribution	distribution	NOUN
dpc-3412	7	35	,	,	PUNCT
dpc-3412	7	36	and	and	CCONJ
dpc-3412	7	37	reproduction	reproduction	NOUN
dpc-3412	7	38	in	in	ADP
dpc-3412	7	39	any	any	DET
dpc-3412	7	40	medium	medium	NOUN
dpc-3412	7	41	,	,	PUNCT
dpc-3412	7	42	provided	provide	VERB
dpc-3412	7	43	the	the	DET
dpc-3412	7	44	original	original	ADJ
dpc-3412	7	45	authors	author	NOUN
dpc-3412	7	46	and	and	CCONJ
dpc-3412	7	47	source	source	NOUN
dpc-3412	7	48	are	be	AUX
dpc-3412	7	49	credited	credit	VERB
dpc-3412	7	50	.	.	PUNCT
dpc-3412	8	1	funding	funding	NOUN
dpc-3412	8	2	:	:	PUNCT
dpc-3412	8	3	none	none	NOUN
dpc-3412	8	4	.	.	PUNCT
dpc-3412	9	1	competing	compete	VERB
dpc-3412	9	2	interests	interest	NOUN
dpc-3412	9	3	:	:	PUNCT
dpc-3412	9	4	none	none	NOUN
dpc-3412	9	5	.	.	PUNCT
dpc-3412	10	1	authorship	authorship	NOUN
dpc-3412	10	2	:	:	PUNCT
dpc-3412	10	3	zhichen	zhichen	X
dpc-3412	11	1	li	li	PROPN
dpc-3412	11	2	and	and	CCONJ
dpc-3412	11	3	haobin	haobin	PROPN
dpc-3412	11	4	zhou	zhou	PROPN
dpc-3412	11	5	contributed	contribute	VERB
dpc-3412	11	6	equally	equally	ADV
dpc-3412	11	7	to	to	ADP
dpc-3412	11	8	this	this	DET
dpc-3412	11	9	work	work	NOUN
dpc-3412	11	10	.	.	PUNCT
dpc-3412	12	1	corresponding	correspond	VERB
dpc-3412	12	2	author	author	NOUN
dpc-3412	12	3	:	:	PUNCT
dpc-3412	12	4	huayao	huayao	PROPN
dpc-3412	12	5	zhang	zhang	PROPN
dpc-3412	12	6	,	,	PUNCT
dpc-3412	12	7	department	department	PROPN
dpc-3412	12	8	of	of	ADP
dpc-3412	12	9	breast	breast	NOUN
dpc-3412	12	10	surgery	surgery	NOUN
dpc-3412	12	11	,	,	PUNCT
dpc-3412	12	12	shaoguan	shaoguan	PROPN
dpc-3412	12	13	maternal	maternal	ADJ
dpc-3412	12	14	and	and	CCONJ
dpc-3412	12	15	child	child	NOUN
dpc-3412	12	16	health	health	NOUN
dpc-3412	12	17	hospital	hospital	NOUN
dpc-3412	12	18	,	,	PUNCT
dpc-3412	12	19	no.1	no.1	NUM
dpc-3412	12	20	,	,	PUNCT
dpc-3412	12	21	yucai	yucai	NOUN
dpc-3412	12	22	road	road	NOUN
dpc-3412	12	23	,	,	PUNCT
dpc-3412	12	24	shaoguan	shaoguan	PROPN
dpc-3412	12	25	,	,	PUNCT
dpc-3412	12	26	guangdong	guangdong	PROPN
dpc-3412	12	27	,	,	PUNCT
dpc-3412	12	28	512026	512026	NUM
dpc-3412	12	29	,	,	PUNCT
dpc-3412	12	30	china	china	PROPN
dpc-3412	12	31	.	.	PUNCT
dpc-3412	13	1	e	e	X
dpc-3412	13	2	-	-	NOUN
dpc-3412	13	3	mail	mail	NOUN
dpc-3412	13	4	:	:	PUNCT
dpc-3412	13	5	hyzhang1988@163.com	hyzhang1988@163.com	X
dpc-3412	13	6	introduction	introduction	NOUN
dpc-3412	13	7	:	:	PUNCT
dpc-3412	13	8	psoriasis	psoriasis	NOUN
dpc-3412	13	9	is	be	AUX
dpc-3412	13	10	a	a	DET
dpc-3412	13	11	chronic	chronic	NOUN
dpc-3412	13	12	,	,	PUNCT
dpc-3412	13	13	inflammatory	inflammatory	ADJ
dpc-3412	13	14	,	,	PUNCT
dpc-3412	13	15	and	and	CCONJ
dpc-3412	13	16	papulo	papulo	NOUN
dpc-3412	13	17	-	-	PUNCT
dpc-3412	13	18	squamous	squamous	ADJ
dpc-3412	13	19	skin	skin	NOUN
dpc-3412	13	20	disorder	disorder	NOUN
dpc-3412	13	21	without	without	ADP
dpc-3412	13	22	a	a	DET
dpc-3412	13	23	radical	radical	ADJ
dpc-3412	13	24	cure	cure	NOUN
dpc-3412	13	25	.	.	PUNCT
dpc-3412	14	1	although	although	SCONJ
dpc-3412	14	2	previous	previous	ADJ
dpc-3412	14	3	observational	observational	ADJ
dpc-3412	14	4	analyses	analysis	NOUN
dpc-3412	14	5	have	have	AUX
dpc-3412	14	6	discovered	discover	VERB
dpc-3412	14	7	a	a	DET
dpc-3412	14	8	relationship	relationship	NOUN
dpc-3412	14	9	between	between	ADP
dpc-3412	14	10	medication	medication	NOUN
dpc-3412	14	11	intake	intake	NOUN
dpc-3412	14	12	and	and	CCONJ
dpc-3412	14	13	increased	increase	VERB
dpc-3412	14	14	risk	risk	NOUN
dpc-3412	14	15	of	of	ADP
dpc-3412	14	16	psoriasis	psoriasis	NOUN
dpc-3412	14	17	,	,	PUNCT
dpc-3412	14	18	they	they	PRON
dpc-3412	14	19	are	be	AUX
dpc-3412	14	20	susceptible	susceptible	ADJ
dpc-3412	14	21	to	to	ADP
dpc-3412	14	22	confounders	confounder	NOUN
dpc-3412	14	23	.	.	PUNCT
dpc-3412	15	1	objectives	objective	NOUN
dpc-3412	15	2	:	:	PUNCT
dpc-3412	15	3	we	we	PRON
dpc-3412	15	4	intend	intend	VERB
dpc-3412	15	5	to	to	PART
dpc-3412	15	6	ascertain	ascertain	VERB
dpc-3412	15	7	if	if	SCONJ
dpc-3412	15	8	there	there	PRON
dpc-3412	15	9	is	be	VERB
dpc-3412	15	10	a	a	DET
dpc-3412	15	11	causal	causal	ADJ
dpc-3412	15	12	association	association	NOUN
dpc-3412	15	13	between	between	ADP
dpc-3412	15	14	specific	specific	ADJ
dpc-3412	15	15	medication	medication	NOUN
dpc-3412	15	16	intake	intake	NOUN
dpc-3412	15	17	and	and	CCONJ
dpc-3412	15	18	increased	increase	VERB
dpc-3412	15	19	risk	risk	NOUN
dpc-3412	15	20	of	of	ADP
dpc-3412	15	21	psoriasis	psoriasis	NOUN
dpc-3412	15	22	by	by	ADP
dpc-3412	15	23	utilizing	utilize	VERB
dpc-3412	15	24	the	the	DET
dpc-3412	15	25	mendelian	mendelian	ADJ
dpc-3412	15	26	randomization	randomization	NOUN
dpc-3412	15	27	(	(	PUNCT
dpc-3412	15	28	mr	mr	PROPN
dpc-3412	15	29	)	)	PUNCT
dpc-3412	15	30	method	method	NOUN
dpc-3412	15	31	.	.	PUNCT
dpc-3412	16	1	methods	method	NOUN
dpc-3412	16	2	:	:	PUNCT
dpc-3412	17	1	we	we	PRON
dpc-3412	17	2	obtained	obtain	VERB
dpc-3412	17	3	the	the	DET
dpc-3412	17	4	genome	genome	NOUN
dpc-3412	17	5	-	-	PUNCT
dpc-3412	17	6	wide	wide	ADJ
dpc-3412	17	7	association	association	NOUN
dpc-3412	17	8	study	study	NOUN
dpc-3412	17	9	(	(	PUNCT
dpc-3412	17	10	gwas	gwas	PROPN
dpc-3412	17	11	)	)	PUNCT
dpc-3412	17	12	data	datum	NOUN
dpc-3412	17	13	for	for	ADP
dpc-3412	17	14	medication	medication	NOUN
dpc-3412	17	15	intake	intake	NOUN
dpc-3412	17	16	(	(	PUNCT
dpc-3412	17	17	23	23	NUM
dpc-3412	17	18	types	type	NOUN
dpc-3412	17	19	,	,	PUNCT
dpc-3412	17	20	n	n	NOUN
dpc-3412	17	21	=	=	SYM
dpc-3412	17	22	1809	1809	NUM
dpc-3412	17	23	)	)	PUNCT
dpc-3412	17	24	from	from	ADP
dpc-3412	17	25	uk	uk	PROPN
dpc-3412	17	26	biobank	biobank	NOUN
dpc-3412	17	27	samples	sample	NOUN
dpc-3412	17	28	.	.	PUNCT
dpc-3412	18	1	and	and	CCONJ
dpc-3412	18	2	we	we	PRON
dpc-3412	18	3	sourced	source	VERB
dpc-3412	18	4	the	the	DET
dpc-3412	18	5	gwas	gwas	PROPN
dpc-3412	18	6	data	datum	NOUN
dpc-3412	18	7	for	for	ADP
dpc-3412	18	8	psoriasis	psoriasis	NOUN
dpc-3412	18	9	from	from	ADP
dpc-3412	18	10	the	the	DET
dpc-3412	18	11	8th	8th	ADJ
dpc-3412	18	12	release	release	NOUN
dpc-3412	18	13	of	of	ADP
dpc-3412	18	14	the	the	DET
dpc-3412	18	15	finngen	finngen	PROPN
dpc-3412	18	16	database	database	NOUN
dpc-3412	18	17	,	,	PUNCT
dpc-3412	18	18	which	which	PRON
dpc-3412	18	19	included	include	VERB
dpc-3412	18	20	8,075	8,075	NUM
dpc-3412	18	21	psoriasis	psoriasis	NOUN
dpc-3412	18	22	cases	case	NOUN
dpc-3412	18	23	and	and	CCONJ
dpc-3412	18	24	330,975	330,975	NUM
dpc-3412	18	25	healthy	healthy	ADJ
dpc-3412	18	26	control	control	NOUN
dpc-3412	18	27	cases	case	NOUN
dpc-3412	18	28	.	.	PUNCT
dpc-3412	19	1	then	then	ADV
dpc-3412	19	2	a	a	DET
dpc-3412	19	3	two	two	NUM
dpc-3412	19	4	-	-	PUNCT
dpc-3412	19	5	sample	sample	NOUN
dpc-3412	19	6	mr	mr	PROPN
dpc-3412	19	7	study	study	NOUN
dpc-3412	19	8	was	be	AUX
dpc-3412	19	9	performed	perform	VERB
dpc-3412	19	10	to	to	PART
dpc-3412	19	11	determine	determine	VERB
dpc-3412	19	12	their	their	PRON
dpc-3412	19	13	causal	causal	ADJ
dpc-3412	19	14	association	association	NOUN
dpc-3412	19	15	,	,	PUNCT
dpc-3412	19	16	and	and	CCONJ
dpc-3412	19	17	inverse	inverse	NOUN
dpc-3412	19	18	-	-	PUNCT
dpc-3412	19	19	variance	variance	NOUN
dpc-3412	19	20	-	-	PUNCT
dpc-3412	19	21	weighted	weight	VERB
dpc-3412	19	22	mr	mr	PROPN
dpc-3412	19	23	(	(	PUNCT
dpc-3412	19	24	ivw	ivw	PROPN
dpc-3412	19	25	-	-	PUNCT
dpc-3412	19	26	mr	mr	NOUN
dpc-3412	19	27	)	)	PUNCT
dpc-3412	19	28	was	be	AUX
dpc-3412	19	29	applied	apply	VERB
dpc-3412	19	30	to	to	PART
dpc-3412	19	31	calculate	calculate	VERB
dpc-3412	19	32	the	the	DET
dpc-3412	19	33	effect	effect	NOUN
dpc-3412	19	34	estimates	estimate	NOUN
dpc-3412	19	35	.	.	PUNCT
dpc-3412	20	1	results	result	NOUN
dpc-3412	20	2	:	:	PUNCT
dpc-3412	20	3	the	the	DET
dpc-3412	20	4	ivw	ivw	NOUN
dpc-3412	20	5	-	-	PUNCT
dpc-3412	20	6	mr	mr	NOUN
dpc-3412	20	7	analysis	analysis	NOUN
dpc-3412	20	8	uncovered	uncover	VERB
dpc-3412	20	9	a	a	DET
dpc-3412	20	10	positive	positive	ADJ
dpc-3412	20	11	correlation	correlation	NOUN
dpc-3412	20	12	between	between	ADP
dpc-3412	20	13	the	the	DET
dpc-3412	20	14	intake	intake	NOUN
dpc-3412	20	15	of	of	ADP
dpc-3412	20	16	hmg	hmg	PROPN
dpc-3412	20	17	coa	coa	NOUN
dpc-3412	20	18	reductase	reductase	NOUN
dpc-3412	20	19	inhibitors	inhibitor	NOUN
dpc-3412	20	20	and	and	CCONJ
dpc-3412	20	21	the	the	DET
dpc-3412	20	22	increased	increase	VERB
dpc-3412	20	23	risk	risk	NOUN
dpc-3412	20	24	of	of	ADP
dpc-3412	20	25	psoriasis	psoriasis	NOUN
dpc-3412	20	26	(	(	PUNCT
dpc-3412	20	27	odds	odd	NOUN
dpc-3412	20	28	ratio	ratio	NOUN
dpc-3412	20	29	[	[	X
dpc-3412	20	30	or	or	CCONJ
dpc-3412	20	31	]	]	PUNCT
dpc-3412	20	32	=	=	SYM
dpc-3412	20	33	1.167	1.167	NUM
dpc-3412	20	34	,	,	PUNCT
dpc-3412	20	35	95	95	NUM
dpc-3412	20	36	%	%	NOUN
dpc-3412	20	37	confidence	confidence	NOUN
dpc-3412	20	38	interval	interval	NOUN
dpc-3412	21	1	[	[	X
dpc-3412	21	2	ci	ci	X
dpc-3412	21	3	]	]	X
dpc-3412	21	4	=	=	PUNCT
dpc-3412	21	5	1.084	1.084	NUM
dpc-3412	21	6	-	-	SYM
dpc-3412	21	7	1.257	1.257	NUM
dpc-3412	21	8	)	)	PUNCT
dpc-3412	21	9	.	.	PUNCT
dpc-3412	22	1	similarly	similarly	ADV
dpc-3412	22	2	,	,	PUNCT
dpc-3412	22	3	the	the	DET
dpc-3412	22	4	use	use	NOUN
dpc-3412	22	5	of	of	ADP
dpc-3412	22	6	thyroid	thyroid	NOUN
dpc-3412	22	7	preparations	preparation	NOUN
dpc-3412	22	8	(	(	PUNCT
dpc-3412	22	9	or=1.080	or=1.080	NOUN
dpc-3412	22	10	,	,	PUNCT
dpc-3412	22	11	95	95	NUM
dpc-3412	22	12	%	%	NOUN
dpc-3412	22	13	ci=1.026	ci=1.026	NOUN
dpc-3412	22	14	-	-	PUNCT
dpc-3412	22	15	1.138	1.138	NUM
dpc-3412	22	16	)	)	PUNCT
dpc-3412	22	17	,	,	PUNCT
dpc-3412	22	18	nonsteroidal	nonsteroidal	NOUN
dpc-3412	22	19	anti	anti	ADJ
dpc-3412	22	20	-	-	ADJ
dpc-3412	22	21	inflammatory	inflammatory	ADJ
dpc-3412	22	22	and	and	CCONJ
dpc-3412	22	23	antirheumatic	antirheumatic	ADJ
dpc-3412	22	24	products	product	NOUN
dpc-3412	22	25	(	(	PUNCT
dpc-3412	22	26	or=1.406	or=1.406	ADJ
dpc-3412	22	27	,	,	PUNCT
dpc-3412	22	28	95	95	NUM
dpc-3412	22	29	%	%	NOUN
dpc-3412	22	30	ci=1.037	ci=1.037	NOUN
dpc-3412	22	31	-	-	PUNCT
dpc-3412	22	32	1.908	1.908	NUM
dpc-3412	22	33	)	)	PUNCT
dpc-3412	22	34	,	,	PUNCT
dpc-3412	22	35	anilides	anilide	NOUN
dpc-3412	22	36	(	(	PUNCT
dpc-3412	22	37	or=1.379	or=1.379	ADJ
dpc-3412	22	38	,	,	PUNCT
dpc-3412	22	39	95	95	NUM
dpc-3412	22	40	%	%	NOUN
dpc-3412	22	41	ci=1.004	ci=1.004	NOUN
dpc-3412	22	42	-	-	PUNCT
dpc-3412	22	43	1.894	1.894	NUM
dpc-3412	22	44	)	)	PUNCT
dpc-3412	22	45	,	,	PUNCT
dpc-3412	22	46	antihistamines	antihistamine	NOUN
dpc-3412	22	47	for	for	ADP
dpc-3412	22	48	systemic	systemic	ADJ
dpc-3412	22	49	use	use	NOUN
dpc-3412	22	50	(	(	PUNCT
dpc-3412	22	51	or=1.341	or=1.341	ADJ
dpc-3412	22	52	,	,	PUNCT
dpc-3412	22	53	95	95	NUM
dpc-3412	22	54	%	%	NOUN
dpc-3412	22	55	ci=1.104	ci=1.104	NOUN
dpc-3412	22	56	-	-	PUNCT
dpc-3412	22	57	1.630	1.630	NUM
dpc-3412	22	58	)	)	PUNCT
dpc-3412	22	59	,	,	PUNCT
dpc-3412	22	60	and	and	CCONJ
dpc-3412	22	61	antihypertensives	antihypertensive	NOUN
dpc-3412	22	62	(	(	PUNCT
dpc-3412	22	63	or=1.099	or=1.099	VERB
dpc-3412	22	64	,	,	PUNCT
dpc-3412	22	65	95	95	NUM
dpc-3412	22	66	%	%	NOUN
dpc-3412	22	67	ci=1.016	ci=1.016	NOUN
dpc-3412	22	68	-	-	PUNCT
dpc-3412	22	69	1.190	1.190	NUM
dpc-3412	22	70	)	)	PUNCT
dpc-3412	22	71	were	be	AUX
dpc-3412	22	72	associated	associate	VERB
dpc-3412	22	73	with	with	ADP
dpc-3412	22	74	an	an	DET
dpc-3412	22	75	increased	increase	VERB
dpc-3412	22	76	risk	risk	NOUN
dpc-3412	22	77	of	of	ADP
dpc-3412	22	78	psoriasis	psoriasis	NOUN
dpc-3412	22	79	.	.	PUNCT
dpc-3412	23	1	we	we	PRON
dpc-3412	23	2	did	do	AUX
dpc-3412	23	3	not	not	PART
dpc-3412	23	4	find	find	VERB
dpc-3412	23	5	evidence	evidence	NOUN
dpc-3412	23	6	from	from	ADP
dpc-3412	23	7	ivw	ivw	NOUN
dpc-3412	23	8	-	-	PUNCT
dpc-3412	23	9	mr	mr	PROPN
dpc-3412	23	10	for	for	ADP
dpc-3412	23	11	other	other	ADJ
dpc-3412	23	12	associations	association	NOUN
dpc-3412	23	13	.	.	PUNCT
dpc-3412	24	1	abstract	abstract	ADJ
dpc-3412	24	2	2	2	NUM
dpc-3412	24	3	original	original	ADJ
dpc-3412	24	4	article	article	NOUN
dpc-3412	24	5	|	|	ADV
dpc-3412	24	6	dermatol	dermatol	ADJ
dpc-3412	24	7	pract	pract	NOUN
dpc-3412	24	8	concept	concept	NOUN
dpc-3412	24	9	.	.	PUNCT
dpc-3412	25	1	2024;14(1):e2024041	2024;14(1):e2024041	NUM
dpc-3412	25	2	conclusions	conclusion	NOUN
dpc-3412	25	3	:	:	PUNCT
dpc-3412	25	4	our	our	PRON
dpc-3412	25	5	study	study	NOUN
dpc-3412	25	6	offers	offer	VERB
dpc-3412	25	7	a	a	DET
dpc-3412	25	8	causal	causal	ADJ
dpc-3412	25	9	testimony	testimony	NOUN
dpc-3412	25	10	that	that	SCONJ
dpc-3412	25	11	the	the	DET
dpc-3412	25	12	intake	intake	NOUN
dpc-3412	25	13	of	of	ADP
dpc-3412	25	14	hmg	hmg	PROPN
dpc-3412	25	15	coa	coa	NOUN
dpc-3412	25	16	reductase	reductase	NOUN
dpc-3412	25	17	inhibitors	inhibitor	NOUN
dpc-3412	25	18	,	,	PUNCT
dpc-3412	25	19	thyroid	thyroid	NOUN
dpc-3412	25	20	preparations	preparation	NOUN
dpc-3412	25	21	,	,	PUNCT
dpc-3412	25	22	nonsteroidal	nonsteroidal	NOUN
dpc-3412	25	23	anti	anti	ADJ
dpc-3412	25	24	-	-	ADJ
dpc-3412	25	25	inflammatory	inflammatory	ADJ
dpc-3412	25	26	and	and	CCONJ
dpc-3412	25	27	antirheumatic	antirheumatic	ADJ
dpc-3412	25	28	products	product	NOUN
dpc-3412	25	29	,	,	PUNCT
dpc-3412	25	30	anilides	anilide	NOUN
dpc-3412	25	31	,	,	PUNCT
dpc-3412	25	32	antihistamines	antihistamine	NOUN
dpc-3412	25	33	for	for	ADP
dpc-3412	25	34	systemic	systemic	ADJ
dpc-3412	25	35	use	use	NOUN
dpc-3412	25	36	,	,	PUNCT
dpc-3412	25	37	and	and	CCONJ
dpc-3412	25	38	antihypertensives	antihypertensive	NOUN
dpc-3412	25	39	will	will	AUX
dpc-3412	25	40	potentially	potentially	ADV
dpc-3412	25	41	increase	increase	VERB
dpc-3412	25	42	the	the	DET
dpc-3412	25	43	risk	risk	NOUN
dpc-3412	25	44	of	of	ADP
dpc-3412	25	45	psoriasis	psoriasis	NOUN
dpc-3412	25	46	.	.	PUNCT
dpc-3412	26	1	introduction	introduction	NOUN
dpc-3412	26	2	psoriasis	psoriasis	NOUN
dpc-3412	26	3	is	be	AUX
dpc-3412	26	4	a	a	DET
dpc-3412	26	5	chronic	chronic	NOUN
dpc-3412	26	6	,	,	PUNCT
dpc-3412	26	7	inflammatory	inflammatory	ADJ
dpc-3412	26	8	,	,	PUNCT
dpc-3412	26	9	and	and	CCONJ
dpc-3412	26	10	papulo	papulo	NOUN
dpc-3412	26	11	-	-	PUNCT
dpc-3412	26	12	squamous	squamous	ADJ
dpc-3412	26	13	skin	skin	NOUN
dpc-3412	26	14	disorder	disorder	NOUN
dpc-3412	26	15	.	.	PUNCT
dpc-3412	27	1	psoriasis	psoriasis	NOUN
dpc-3412	27	2	vulgaris	vulgaris	NOUN
dpc-3412	27	3	is	be	AUX
dpc-3412	27	4	the	the	DET
dpc-3412	27	5	most	most	ADV
dpc-3412	27	6	common	common	ADJ
dpc-3412	27	7	subtype	subtype	NOUN
dpc-3412	27	8	,	,	PUNCT
dpc-3412	27	9	accounting	account	VERB
dpc-3412	27	10	for	for	ADP
dpc-3412	27	11	approximately	approximately	ADV
dpc-3412	27	12	90	90	NUM
dpc-3412	27	13	%	%	NOUN
dpc-3412	27	14	of	of	ADP
dpc-3412	27	15	cases	case	NOUN
dpc-3412	27	16	  	  	SPACE
dpc-3412	27	17	[	[	X
dpc-3412	27	18	1	1	NUM
dpc-3412	27	19	]	]	PUNCT
dpc-3412	27	20	.	.	PUNCT
dpc-3412	28	1	clinically	clinically	ADV
dpc-3412	28	2	,	,	PUNCT
dpc-3412	28	3	it	it	PRON
dpc-3412	28	4	is	be	AUX
dpc-3412	28	5	characterized	characterize	VERB
dpc-3412	28	6	by	by	ADP
dpc-3412	28	7	sharply	sharply	ADV
dpc-3412	28	8	demarcated	demarcate	VERB
dpc-3412	28	9	salmon	salmon	NOUN
dpc-3412	28	10	-	-	PUNCT
dpc-3412	28	11	pink	pink	ADJ
dpc-3412	28	12	plaques	plaque	NOUN
dpc-3412	28	13	in	in	ADP
dpc-3412	28	14	individuals	individual	NOUN
dpc-3412	28	15	with	with	ADP
dpc-3412	28	16	white	white	ADJ
dpc-3412	28	17	skin	skin	NOUN
dpc-3412	28	18	but	but	CCONJ
dpc-3412	28	19	gray	gray	ADJ
dpc-3412	28	20	plaques	plaque	NOUN
dpc-3412	28	21	in	in	ADP
dpc-3412	28	22	those	those	PRON
dpc-3412	28	23	with	with	ADP
dpc-3412	28	24	black	black	ADJ
dpc-3412	28	25	skin	skin	NOUN
dpc-3412	28	26	,	,	PUNCT
dpc-3412	28	27	both	both	PRON
dpc-3412	28	28	covered	cover	VERB
dpc-3412	28	29	by	by	ADP
dpc-3412	28	30	silvery	silvery	NOUN
dpc-3412	28	31	scales	scale	NOUN
dpc-3412	28	32	[	[	X
dpc-3412	28	33	2	2	NUM
dpc-3412	28	34	]	]	PUNCT
dpc-3412	28	35	.	.	PUNCT
dpc-3412	29	1	according	accord	VERB
dpc-3412	29	2	to	to	ADP
dpc-3412	29	3	a	a	DET
dpc-3412	29	4	systematic	systematic	ADJ
dpc-3412	29	5	review	review	NOUN
dpc-3412	29	6	[	[	X
dpc-3412	29	7	3	3	NUM
dpc-3412	29	8	]	]	PUNCT
dpc-3412	29	9	,	,	PUNCT
dpc-3412	29	10	the	the	DET
dpc-3412	29	11	prevalence	prevalence	NOUN
dpc-3412	29	12	of	of	ADP
dpc-3412	29	13	psoriasis	psoriasis	NOUN
dpc-3412	29	14	varied	vary	VERB
dpc-3412	29	15	widely	widely	ADV
dpc-3412	29	16	across	across	ADP
dpc-3412	29	17	different	different	ADJ
dpc-3412	29	18	regions	region	NOUN
dpc-3412	29	19	,	,	PUNCT
dpc-3412	29	20	ranging	range	VERB
dpc-3412	29	21	from	from	ADP
dpc-3412	29	22	0.09	0.09	NUM
dpc-3412	29	23	%	%	NOUN
dpc-3412	29	24	in	in	ADP
dpc-3412	29	25	tanzania	tanzania	PROPN
dpc-3412	29	26	to	to	ADP
dpc-3412	29	27	5.1	5.1	NUM
dpc-3412	29	28	%	%	NOUN
dpc-3412	29	29	in	in	ADP
dpc-3412	29	30	the	the	DET
dpc-3412	29	31	usa	usa	PROPN
dpc-3412	29	32	.	.	PUNCT
dpc-3412	30	1	the	the	DET
dpc-3412	30	2	distribution	distribution	NOUN
dpc-3412	30	3	of	of	ADP
dpc-3412	30	4	psoriasis	psoriasis	NOUN
dpc-3412	30	5	patients	patient	NOUN
dpc-3412	30	6	was	be	AUX
dpc-3412	30	7	also	also	ADV
dpc-3412	30	8	unequal	unequal	ADJ
dpc-3412	30	9	regarding	regard	VERB
dpc-3412	30	10	race	race	NOUN
dpc-3412	30	11	,	,	PUNCT
dpc-3412	30	12	age	age	NOUN
dpc-3412	30	13	,	,	PUNCT
dpc-3412	30	14	and	and	CCONJ
dpc-3412	30	15	geography	geography	NOUN
dpc-3412	30	16	.	.	PUNCT
dpc-3412	31	1	for	for	ADP
dpc-3412	31	2	instance	instance	NOUN
dpc-3412	31	3	,	,	PUNCT
dpc-3412	31	4	it	it	PRON
dpc-3412	31	5	occurred	occur	VERB
dpc-3412	31	6	more	more	ADV
dpc-3412	31	7	commonly	commonly	ADV
dpc-3412	31	8	in	in	ADP
dpc-3412	31	9	caucasians	caucasian	NOUN
dpc-3412	31	10	,	,	PUNCT
dpc-3412	31	11	adults	adult	NOUN
dpc-3412	31	12	,	,	PUNCT
dpc-3412	31	13	and	and	CCONJ
dpc-3412	31	14	individuals	individual	NOUN
dpc-3412	31	15	from	from	ADP
dpc-3412	31	16	wealthy	wealthy	ADJ
dpc-3412	31	17	countries	country	NOUN
dpc-3412	31	18	[	[	X
dpc-3412	31	19	2	2	NUM
dpc-3412	31	20	-	-	SYM
dpc-3412	31	21	4	4	NUM
dpc-3412	31	22	]	]	PUNCT
dpc-3412	31	23	.	.	PUNCT
dpc-3412	32	1	furthermore	furthermore	ADV
dpc-3412	32	2	,	,	PUNCT
dpc-3412	32	3	psoriasis	psoriasis	NOUN
dpc-3412	32	4	patients	patient	NOUN
dpc-3412	32	5	often	often	ADV
dpc-3412	32	6	experienced	experience	VERB
dpc-3412	32	7	poor	poor	ADJ
dpc-3412	32	8	self	self	NOUN
dpc-3412	32	9	-	-	PUNCT
dpc-3412	32	10	esteem	esteem	NOUN
dpc-3412	32	11	,	,	PUNCT
dpc-3412	32	12	anxiety	anxiety	NOUN
dpc-3412	32	13	,	,	PUNCT
dpc-3412	32	14	depression	depression	NOUN
dpc-3412	32	15	,	,	PUNCT
dpc-3412	32	16	insomnia	insomnia	NOUN
dpc-3412	32	17	,	,	PUNCT
dpc-3412	32	18	and	and	CCONJ
dpc-3412	32	19	even	even	ADV
dpc-3412	32	20	suicidality	suicidality	NOUN
dpc-3412	32	21	because	because	SCONJ
dpc-3412	32	22	of	of	ADP
dpc-3412	32	23	their	their	PRON
dpc-3412	32	24	unsightly	unsightly	ADV
dpc-3412	32	25	external	external	ADJ
dpc-3412	32	26	appearance	appearance	NOUN
dpc-3412	32	27	[	[	X
dpc-3412	32	28	5	5	NUM
dpc-3412	32	29	-	-	SYM
dpc-3412	32	30	8	8	NUM
dpc-3412	32	31	]	]	PUNCT
dpc-3412	32	32	,	,	PUNCT
dpc-3412	32	33	which	which	PRON
dpc-3412	32	34	placed	place	VERB
dpc-3412	32	35	a	a	DET
dpc-3412	32	36	heavy	heavy	ADJ
dpc-3412	32	37	burden	burden	NOUN
dpc-3412	32	38	on	on	ADP
dpc-3412	32	39	individuals	individual	NOUN
dpc-3412	32	40	and	and	CCONJ
dpc-3412	32	41	society	society	NOUN
dpc-3412	32	42	.	.	PUNCT
dpc-3412	33	1	a	a	DET
dpc-3412	33	2	previous	previous	ADJ
dpc-3412	33	3	study	study	NOUN
dpc-3412	33	4	indicated	indicate	VERB
dpc-3412	33	5	that	that	SCONJ
dpc-3412	33	6	the	the	DET
dpc-3412	33	7	intake	intake	NOUN
dpc-3412	33	8	of	of	ADP
dpc-3412	33	9	certain	certain	ADJ
dpc-3412	33	10	medications	medication	NOUN
dpc-3412	33	11	might	might	AUX
dpc-3412	33	12	induce	induce	VERB
dpc-3412	33	13	psoriatic	psoriatic	ADJ
dpc-3412	33	14	lesions	lesion	NOUN
dpc-3412	33	15	on	on	ADP
dpc-3412	33	16	normal	normal	ADJ
dpc-3412	33	17	skin	skin	NOUN
dpc-3412	33	18	in	in	ADP
dpc-3412	33	19	psoriasis	psoriasis	NOUN
dpc-3412	33	20	patients	patient	NOUN
dpc-3412	33	21	or	or	CCONJ
dpc-3412	33	22	trigger	trigger	VERB
dpc-3412	33	23	psoriasis	psoriasis	NOUN
dpc-3412	33	24	in	in	ADP
dpc-3412	33	25	predisposed	predisposed	ADJ
dpc-3412	33	26	individuals	individual	NOUN
dpc-3412	33	27	,	,	PUNCT
dpc-3412	33	28	even	even	ADV
dpc-3412	33	29	in	in	ADP
dpc-3412	33	30	those	those	PRON
dpc-3412	33	31	without	without	ADP
dpc-3412	33	32	a	a	DET
dpc-3412	33	33	family	family	NOUN
dpc-3412	33	34	history	history	NOUN
dpc-3412	33	35	of	of	ADP
dpc-3412	33	36	this	this	DET
dpc-3412	33	37	disease	disease	NOUN
dpc-3412	33	38	[	[	X
dpc-3412	33	39	9	9	NUM
dpc-3412	33	40	]	]	PUNCT
dpc-3412	33	41	.	.	PUNCT
dpc-3412	34	1	these	these	DET
dpc-3412	34	2	medications	medication	NOUN
dpc-3412	34	3	included	include	VERB
dpc-3412	34	4	nonsteroidal	nonsteroidal	ADJ
dpc-3412	34	5	anti	anti	ADJ
dpc-3412	34	6	-	-	ADJ
dpc-3412	34	7	inflammatory	inflammatory	ADJ
dpc-3412	34	8	drugs	drug	NOUN
dpc-3412	34	9	(	(	PUNCT
dpc-3412	34	10	nsaids	nsaid	NOUN
dpc-3412	34	11	)	)	PUNCT
dpc-3412	34	12	,	,	PUNCT
dpc-3412	34	13	penicillins	penicillin	NOUN
dpc-3412	34	14	,	,	PUNCT
dpc-3412	34	15	antimalarial	antimalarial	ADJ
dpc-3412	34	16	drugs	drug	NOUN
dpc-3412	34	17	,	,	PUNCT
dpc-3412	34	18	psychotropic	psychotropic	ADJ
dpc-3412	34	19	drugs	drug	NOUN
dpc-3412	34	20	,	,	PUNCT
dpc-3412	34	21	and	and	CCONJ
dpc-3412	34	22	others	other	NOUN
dpc-3412	35	1	[	[	X
dpc-3412	35	2	10	10	NUM
dpc-3412	35	3	]	]	PUNCT
dpc-3412	35	4	.	.	PUNCT
dpc-3412	36	1	psoriasis	psoriasis	NOUN
dpc-3412	36	2	is	be	AUX
dpc-3412	36	3	closely	closely	ADV
dpc-3412	36	4	associated	associate	VERB
dpc-3412	36	5	with	with	ADP
dpc-3412	36	6	various	various	ADJ
dpc-3412	36	7	comorbidities	comorbiditie	NOUN
dpc-3412	36	8	.	.	PUNCT
dpc-3412	37	1	for	for	ADP
dpc-3412	37	2	example	example	NOUN
dpc-3412	37	3	,	,	PUNCT
dpc-3412	37	4	studies	study	NOUN
dpc-3412	37	5	have	have	AUX
dpc-3412	37	6	demonstrated	demonstrate	VERB
dpc-3412	37	7	that	that	SCONJ
dpc-3412	37	8	psoriasis	psoriasis	NOUN
dpc-3412	37	9	patients	patient	NOUN
dpc-3412	37	10	had	have	VERB
dpc-3412	37	11	a	a	DET
dpc-3412	37	12	risk	risk	NOUN
dpc-3412	37	13	of	of	ADP
dpc-3412	37	14	developing	develop	VERB
dpc-3412	37	15	metabolic	metabolic	NOUN
dpc-3412	37	16	syndromes	syndrome	NOUN
dpc-3412	37	17	such	such	ADJ
dpc-3412	37	18	as	as	ADP
dpc-3412	37	19	type	type	NOUN
dpc-3412	37	20	ii	ii	NOUN
dpc-3412	37	21	diabetes	diabetes	NOUN
dpc-3412	37	22	,	,	PUNCT
dpc-3412	37	23	hypertension	hypertension	NOUN
dpc-3412	37	24	,	,	PUNCT
dpc-3412	37	25	atherogenic	atherogenic	ADJ
dpc-3412	37	26	dyslipidemia	dyslipidemia	NOUN
dpc-3412	37	27	,	,	PUNCT
dpc-3412	37	28	and	and	CCONJ
dpc-3412	37	29	nonalcoholic	nonalcoholic	ADJ
dpc-3412	37	30	fatty	fatty	NOUN
dpc-3412	37	31	liver	liver	NOUN
dpc-3412	37	32	,	,	PUNCT
dpc-3412	37	33	that	that	PRON
dpc-3412	37	34	was	be	AUX
dpc-3412	37	35	at	at	ADV
dpc-3412	37	36	least	least	ADJ
dpc-3412	37	37	twice	twice	ADV
dpc-3412	37	38	as	as	ADV
dpc-3412	37	39	high	high	ADJ
dpc-3412	37	40	as	as	ADP
dpc-3412	37	41	that	that	PRON
dpc-3412	37	42	of	of	ADP
dpc-3412	37	43	healthy	healthy	ADJ
dpc-3412	37	44	individuals	individual	NOUN
dpc-3412	37	45	 	 	SPACE
dpc-3412	38	1	[	[	X
dpc-3412	38	2	11	11	NUM
dpc-3412	38	3	]	]	PUNCT
dpc-3412	38	4	.	.	PUNCT
dpc-3412	39	1	besides	besides	SCONJ
dpc-3412	39	2	,	,	PUNCT
dpc-3412	39	3	psoriasis	psoriasis	NOUN
dpc-3412	39	4	patients	patient	NOUN
dpc-3412	39	5	were	be	AUX
dpc-3412	39	6	susceptible	susceptible	ADJ
dpc-3412	39	7	to	to	ADP
dpc-3412	39	8	coronary	coronary	ADJ
dpc-3412	39	9	atherosclerosis	atherosclerosis	NOUN
dpc-3412	39	10	and	and	CCONJ
dpc-3412	39	11	even	even	ADV
dpc-3412	39	12	coronary	coronary	ADJ
dpc-3412	39	13	artery	artery	NOUN
dpc-3412	39	14	disease	disease	NOUN
dpc-3412	39	15	[	[	X
dpc-3412	39	16	12,13	12,13	NUM
dpc-3412	39	17	]	]	PUNCT
dpc-3412	39	18	.	.	PUNCT
dpc-3412	40	1	moreover	moreover	ADV
dpc-3412	40	2	,	,	PUNCT
dpc-3412	40	3	a	a	DET
dpc-3412	40	4	meta	meta	ADJ
dpc-3412	40	5	-	-	PUNCT
dpc-3412	40	6	analysis	analysis	NOUN
dpc-3412	40	7	indicated	indicate	VERB
dpc-3412	40	8	that	that	SCONJ
dpc-3412	40	9	psoriasis	psoriasis	NOUN
dpc-3412	40	10	patients	patient	NOUN
dpc-3412	40	11	had	have	VERB
dpc-3412	40	12	a	a	DET
dpc-3412	40	13	tremendously	tremendously	ADV
dpc-3412	40	14	increased	increase	VERB
dpc-3412	40	15	risk	risk	NOUN
dpc-3412	40	16	of	of	ADP
dpc-3412	40	17	asthma	asthma	NOUN
dpc-3412	40	18	,	,	PUNCT
dpc-3412	40	19	inflammatory	inflammatory	ADJ
dpc-3412	40	20	bowel	bowel	NOUN
dpc-3412	40	21	disease	disease	NOUN
dpc-3412	40	22	,	,	PUNCT
dpc-3412	40	23	chronic	chronic	ADJ
dpc-3412	40	24	kidney	kidney	NOUN
dpc-3412	40	25	disease	disease	NOUN
dpc-3412	40	26	,	,	PUNCT
dpc-3412	40	27	and	and	CCONJ
dpc-3412	40	28	end	end	NOUN
dpc-3412	40	29	-	-	PUNCT
dpc-3412	40	30	stage	stage	NOUN
dpc-3412	40	31	renal	renal	ADJ
dpc-3412	40	32	disease	disease	NOUN
dpc-3412	41	1	[	[	X
dpc-3412	41	2	14	14	NUM
dpc-3412	41	3	-	-	SYM
dpc-3412	41	4	16	16	NUM
dpc-3412	41	5	]	]	PUNCT
dpc-3412	41	6	.	.	PUNCT
dpc-3412	42	1	in	in	ADP
dpc-3412	42	2	such	such	ADJ
dpc-3412	42	3	cases	case	NOUN
dpc-3412	42	4	,	,	PUNCT
dpc-3412	42	5	they	they	PRON
dpc-3412	42	6	should	should	AUX
dpc-3412	42	7	treat	treat	VERB
dpc-3412	42	8	not	not	PART
dpc-3412	42	9	only	only	ADV
dpc-3412	42	10	the	the	DET
dpc-3412	42	11	primary	primary	ADJ
dpc-3412	42	12	illness	illness	NOUN
dpc-3412	42	13	but	but	CCONJ
dpc-3412	42	14	also	also	ADV
dpc-3412	42	15	the	the	DET
dpc-3412	42	16	associated	associated	ADJ
dpc-3412	42	17	complications	complication	NOUN
dpc-3412	42	18	.	.	PUNCT
dpc-3412	43	1	however	however	ADV
dpc-3412	43	2	,	,	PUNCT
dpc-3412	43	3	medications	medication	NOUN
dpc-3412	43	4	used	use	VERB
dpc-3412	43	5	for	for	ADP
dpc-3412	43	6	treating	treat	VERB
dpc-3412	43	7	its	its	PRON
dpc-3412	43	8	complications	complication	NOUN
dpc-3412	43	9	may	may	AUX
dpc-3412	43	10	,	,	PUNCT
dpc-3412	43	11	in	in	ADP
dpc-3412	43	12	turn	turn	NOUN
dpc-3412	43	13	,	,	PUNCT
dpc-3412	43	14	exacerbate	exacerbate	VERB
dpc-3412	43	15	psoriasis	psoriasis	NOUN
dpc-3412	43	16	.	.	PUNCT
dpc-3412	44	1	consequently	consequently	ADV
dpc-3412	44	2	,	,	PUNCT
dpc-3412	44	3	regardless	regardless	ADV
dpc-3412	44	4	of	of	ADP
dpc-3412	44	5	the	the	DET
dpc-3412	44	6	patient	patient	NOUN
dpc-3412	44	7	’s	’s	PART
dpc-3412	44	8	disease	disease	NOUN
dpc-3412	44	9	control	control	PROPN
dpc-3412	44	10	status	status	NOUN
dpc-3412	44	11	,	,	PUNCT
dpc-3412	44	12	clinicians	clinician	NOUN
dpc-3412	44	13	need	need	VERB
dpc-3412	44	14	to	to	PART
dpc-3412	44	15	evaluate	evaluate	VERB
dpc-3412	44	16	the	the	DET
dpc-3412	44	17	potential	potential	ADJ
dpc-3412	44	18	effects	effect	NOUN
dpc-3412	44	19	of	of	ADP
dpc-3412	44	20	medication	medication	NOUN
dpc-3412	44	21	intake	intake	NOUN
dpc-3412	44	22	on	on	ADP
dpc-3412	44	23	the	the	DET
dpc-3412	44	24	occurrence	occurrence	NOUN
dpc-3412	44	25	,	,	PUNCT
dpc-3412	44	26	recurrence	recurrence	NOUN
dpc-3412	44	27	,	,	PUNCT
dpc-3412	44	28	or	or	CCONJ
dpc-3412	44	29	aggravation	aggravation	NOUN
dpc-3412	44	30	of	of	ADP
dpc-3412	44	31	psoriasis	psoriasis	NOUN
dpc-3412	44	32	.	.	PUNCT
dpc-3412	45	1	objectives	objective	NOUN
dpc-3412	45	2	it	it	PRON
dpc-3412	45	3	is	be	AUX
dpc-3412	45	4	widely	widely	ADV
dpc-3412	45	5	accepted	accept	VERB
dpc-3412	45	6	that	that	SCONJ
dpc-3412	45	7	genetic	genetic	ADJ
dpc-3412	45	8	variants	variant	NOUN
dpc-3412	45	9	are	be	AUX
dpc-3412	45	10	randomly	randomly	ADV
dpc-3412	45	11	distributed	distribute	VERB
dpc-3412	45	12	during	during	ADP
dpc-3412	45	13	meiosis	meiosis	NOUN
dpc-3412	45	14	and	and	CCONJ
dpc-3412	45	15	scarcely	scarcely	ADV
dpc-3412	45	16	influenced	influence	VERB
dpc-3412	45	17	by	by	ADP
dpc-3412	45	18	environmental	environmental	ADJ
dpc-3412	45	19	factors	factor	NOUN
dpc-3412	45	20	.	.	PUNCT
dpc-3412	46	1	unlike	unlike	ADP
dpc-3412	46	2	traditional	traditional	ADJ
dpc-3412	46	3	observational	observational	ADJ
dpc-3412	46	4	analyses	analysis	NOUN
dpc-3412	46	5	,	,	PUNCT
dpc-3412	46	6	the	the	DET
dpc-3412	46	7	mendelian	mendelian	ADJ
dpc-3412	46	8	randomization	randomization	NOUN
dpc-3412	46	9	(	(	PUNCT
dpc-3412	46	10	mr	mr	PROPN
dpc-3412	46	11	)	)	PUNCT
dpc-3412	46	12	study	study	NOUN
dpc-3412	46	13	leverages	leverage	VERB
dpc-3412	46	14	this	this	DET
dpc-3412	46	15	advantage	advantage	NOUN
dpc-3412	46	16	of	of	ADP
dpc-3412	46	17	genetic	genetic	ADJ
dpc-3412	46	18	variants	variant	NOUN
dpc-3412	46	19	by	by	ADP
dpc-3412	46	20	utilizing	utilize	VERB
dpc-3412	46	21	them	they	PRON
dpc-3412	46	22	as	as	ADP
dpc-3412	46	23	instrumental	instrumental	ADJ
dpc-3412	46	24	variables	variable	NOUN
dpc-3412	46	25	,	,	PUNCT
dpc-3412	46	26	thereby	thereby	ADV
dpc-3412	46	27	mitigating	mitigate	VERB
dpc-3412	46	28	limitations	limitation	NOUN
dpc-3412	46	29	such	such	ADJ
dpc-3412	46	30	as	as	ADP
dpc-3412	46	31	potential	potential	ADJ
dpc-3412	46	32	confounders	confounder	NOUN
dpc-3412	46	33	,	,	PUNCT
dpc-3412	46	34	information	information	NOUN
dpc-3412	46	35	biases	bias	NOUN
dpc-3412	46	36	,	,	PUNCT
dpc-3412	46	37	and	and	CCONJ
dpc-3412	46	38	reverse	reverse	VERB
dpc-3412	46	39	causality	causality	NOUN
dpc-3412	46	40	to	to	ADP
dpc-3412	46	41	the	the	DET
dpc-3412	46	42	greatest	great	ADJ
dpc-3412	46	43	extent	extent	NOUN
dpc-3412	46	44	[	[	X
dpc-3412	46	45	17	17	NUM
dpc-3412	46	46	]	]	PUNCT
dpc-3412	46	47	.	.	PUNCT
dpc-3412	47	1	accordingly	accordingly	ADV
dpc-3412	47	2	,	,	PUNCT
dpc-3412	47	3	we	we	PRON
dpc-3412	47	4	conducted	conduct	VERB
dpc-3412	47	5	an	an	DET
dpc-3412	47	6	mr	mr	PROPN
dpc-3412	47	7	study	study	NOUN
dpc-3412	47	8	and	and	CCONJ
dpc-3412	47	9	explored	explore	VERB
dpc-3412	47	10	the	the	DET
dpc-3412	47	11	causal	causal	NOUN
dpc-3412	47	12	association	association	NOUN
dpc-3412	47	13	between	between	ADP
dpc-3412	47	14	medication	medication	NOUN
dpc-3412	47	15	intake	intake	NOUN
dpc-3412	47	16	and	and	CCONJ
dpc-3412	47	17	increased	increase	VERB
dpc-3412	47	18	risk	risk	NOUN
dpc-3412	47	19	of	of	ADP
dpc-3412	47	20	psoriasis	psoriasis	NOUN
dpc-3412	47	21	in	in	ADP
dpc-3412	47	22	this	this	DET
dpc-3412	47	23	article	article	NOUN
dpc-3412	47	24	.	.	PUNCT
dpc-3412	48	1	methods	method	NOUN
dpc-3412	48	2	source	source	NOUN
dpc-3412	48	3	of	of	ADP
dpc-3412	48	4	genome	genome	NOUN
dpc-3412	48	5	-	-	PUNCT
dpc-3412	48	6	wide	wide	ADJ
dpc-3412	48	7	association	association	NOUN
dpc-3412	48	8	study	study	NOUN
dpc-3412	48	9	(	(	PUNCT
dpc-3412	48	10	gwas	gwas	PROPN
dpc-3412	48	11	)	)	PUNCT
dpc-3412	48	12	data	datum	NOUN
dpc-3412	48	13	and	and	CCONJ
dpc-3412	48	14	harmonization	harmonization	NOUN
dpc-3412	48	15	our	our	PRON
dpc-3412	48	16	mr	mr	PROPN
dpc-3412	48	17	study	study	NOUN
dpc-3412	48	18	included	include	VERB
dpc-3412	48	19	23	23	NUM
dpc-3412	48	20	types	type	NOUN
dpc-3412	48	21	of	of	ADP
dpc-3412	48	22	medications	medication	NOUN
dpc-3412	48	23	in	in	ADP
dpc-3412	48	24	the	the	DET
dpc-3412	48	25	exposure	exposure	NOUN
dpc-3412	48	26	group	group	NOUN
dpc-3412	48	27	,	,	PUNCT
dpc-3412	48	28	derived	derive	VERB
dpc-3412	48	29	from	from	ADP
dpc-3412	48	30	the	the	DET
dpc-3412	48	31	gwas	gwas	PROPN
dpc-3412	48	32	data	datum	NOUN
dpc-3412	48	33	and	and	CCONJ
dpc-3412	48	34	used	use	VERB
dpc-3412	48	35	to	to	PART
dpc-3412	48	36	quantify	quantify	VERB
dpc-3412	48	37	the	the	DET
dpc-3412	48	38	future	future	ADJ
dpc-3412	48	39	risk	risk	NOUN
dpc-3412	48	40	associated	associate	VERB
dpc-3412	48	41	with	with	ADP
dpc-3412	48	42	medication	medication	NOUN
dpc-3412	48	43	use	use	NOUN
dpc-3412	48	44	.	.	PUNCT
dpc-3412	49	1	the	the	DET
dpc-3412	49	2	study	study	NOUN
dpc-3412	49	3	samples	sample	NOUN
dpc-3412	49	4	were	be	AUX
dpc-3412	49	5	drawn	draw	VERB
dpc-3412	49	6	from	from	ADP
dpc-3412	49	7	the	the	DET
dpc-3412	49	8	uk	uk	PROPN
dpc-3412	49	9	biobank	biobank	NOUN
dpc-3412	49	10	(	(	PUNCT
dpc-3412	49	11	ukb	ukb	PROPN
dpc-3412	49	12	)	)	PUNCT
dpc-3412	49	13	and	and	CCONJ
dpc-3412	49	14	consisted	consist	VERB
dpc-3412	49	15	of	of	ADP
dpc-3412	49	16	502,616	502,616	NUM
dpc-3412	49	17	participants	participant	NOUN
dpc-3412	49	18	with	with	ADP
dpc-3412	49	19	medication	medication	NOUN
dpc-3412	49	20	records	record	NOUN
dpc-3412	49	21	during	during	ADP
dpc-3412	49	22	their	their	PRON
dpc-3412	49	23	first	first	ADJ
dpc-3412	49	24	visit	visit	NOUN
dpc-3412	49	25	to	to	ADP
dpc-3412	49	26	the	the	DET
dpc-3412	49	27	ukb	ukb	ADJ
dpc-3412	49	28	evaluation	evaluation	NOUN
dpc-3412	49	29	[	[	X
dpc-3412	49	30	18	18	NUM
dpc-3412	49	31	]	]	PUNCT
dpc-3412	49	32	.	.	PUNCT
dpc-3412	50	1	out	out	ADP
dpc-3412	50	2	of	of	ADP
dpc-3412	50	3	the	the	DET
dpc-3412	50	4	6,745	6,745	NUM
dpc-3412	50	5	types	type	NOUN
dpc-3412	50	6	of	of	ADP
dpc-3412	50	7	medications	medication	NOUN
dpc-3412	50	8	recorded	record	VERB
dpc-3412	50	9	in	in	ADP
dpc-3412	50	10	the	the	DET
dpc-3412	50	11	ukb	ukb	PROPN
dpc-3412	50	12	,	,	PUNCT
dpc-3412	50	13	1,809	1,809	NUM
dpc-3412	50	14	were	be	AUX
dpc-3412	50	15	reported	report	VERB
dpc-3412	50	16	by	by	ADP
dpc-3412	50	17	at	at	ADV
dpc-3412	50	18	least	least	ADV
dpc-3412	50	19	ten	ten	NUM
dpc-3412	50	20	individuals	individual	NOUN
dpc-3412	50	21	and	and	CCONJ
dpc-3412	50	22	subsequently	subsequently	ADV
dpc-3412	50	23	included	include	VERB
dpc-3412	50	24	in	in	ADP
dpc-3412	50	25	the	the	DET
dpc-3412	50	26	gwas	gwas	NOUN
dpc-3412	50	27	.	.	PUNCT
dpc-3412	51	1	these	these	DET
dpc-3412	51	2	medications	medication	NOUN
dpc-3412	51	3	were	be	AUX
dpc-3412	51	4	integrated	integrate	VERB
dpc-3412	51	5	into	into	ADP
dpc-3412	51	6	23	23	NUM
dpc-3412	51	7	categories	category	NOUN
dpc-3412	51	8	and	and	CCONJ
dpc-3412	51	9	underwent	undergo	VERB
dpc-3412	51	10	a	a	DET
dpc-3412	51	11	series	series	NOUN
dpc-3412	51	12	of	of	ADP
dpc-3412	51	13	quality	quality	NOUN
dpc-3412	51	14	control	control	NOUN
dpc-3412	51	15	measures	measure	NOUN
dpc-3412	51	16	to	to	PART
dpc-3412	51	17	form	form	VERB
dpc-3412	51	18	the	the	DET
dpc-3412	51	19	aggregated	aggregate	VERB
dpc-3412	51	20	gwas	gwas	NOUN
dpc-3412	51	21	data	datum	NOUN
dpc-3412	51	22	.	.	PUNCT
dpc-3412	52	1	we	we	PRON
dpc-3412	52	2	obtained	obtain	VERB
dpc-3412	52	3	these	these	DET
dpc-3412	52	4	gwas	gwas	PROPN
dpc-3412	52	5	data	datum	NOUN
dpc-3412	52	6	and	and	CCONJ
dpc-3412	52	7	used	use	VERB
dpc-3412	52	8	the	the	DET
dpc-3412	52	9	“	"	PUNCT
dpc-3412	52	10	format_data	format_data	NOUN
dpc-3412	52	11	”	"	PUNCT
dpc-3412	52	12	function	function	NOUN
dpc-3412	52	13	of	of	ADP
dpc-3412	52	14	the	the	DET
dpc-3412	52	15	twosamplemr	twosamplemr	NOUN
dpc-3412	52	16	package	package	NOUN
dpc-3412	52	17	to	to	PART
dpc-3412	52	18	transform	transform	VERB
dpc-3412	52	19	them	they	PRON
dpc-3412	52	20	into	into	ADP
dpc-3412	52	21	a	a	DET
dpc-3412	52	22	recognizable	recognizable	ADJ
dpc-3412	52	23	format	format	NOUN
dpc-3412	52	24	.	.	PUNCT
dpc-3412	53	1	to	to	PART
dpc-3412	53	2	select	select	VERB
dpc-3412	53	3	instrumental	instrumental	ADJ
dpc-3412	53	4	variables	variable	NOUN
dpc-3412	53	5	for	for	ADP
dpc-3412	53	6	each	each	DET
dpc-3412	53	7	medication	medication	NOUN
dpc-3412	53	8	gwas	gwas	NOUN
dpc-3412	53	9	,	,	PUNCT
dpc-3412	53	10	we	we	PRON
dpc-3412	53	11	applied	apply	VERB
dpc-3412	53	12	the	the	DET
dpc-3412	53	13	following	follow	VERB
dpc-3412	53	14	thresholds	threshold	NOUN
dpc-3412	53	15	:	:	PUNCT
dpc-3412	53	16	1	1	X
dpc-3412	53	17	)	)	PUNCT
dpc-3412	53	18	the	the	DET
dpc-3412	53	19	p	p	PROPN
dpc-3412	53	20	-value	-value	PROPN
dpc-3412	53	21	was	be	AUX
dpc-3412	53	22	less	less	ADJ
dpc-3412	53	23	than	than	ADP
dpc-3412	53	24	5e-08	5e-08	NOUN
dpc-3412	53	25	;	;	PUNCT
dpc-3412	53	26	2	2	X
dpc-3412	53	27	)	)	PUNCT
dpc-3412	53	28	we	we	PRON
dpc-3412	53	29	conducted	conduct	VERB
dpc-3412	53	30	clump	clump	VERB
dpc-3412	53	31	analysis	analysis	NOUN
dpc-3412	53	32	with	with	ADP
dpc-3412	53	33	an	an	DET
dpc-3412	53	34	r2	r2	NOUN
dpc-3412	53	35	=	=	SYM
dpc-3412	53	36	0.001	0.001	NUM
dpc-3412	53	37	and	and	CCONJ
dpc-3412	53	38	kb=10000	kb=10000	PROPN
dpc-3412	53	39	setting	setting	NOUN
dpc-3412	53	40	;	;	PUNCT
dpc-3412	53	41	3	3	X
dpc-3412	53	42	)	)	PUNCT
dpc-3412	53	43	we	we	PRON
dpc-3412	53	44	calculated	calculate	VERB
dpc-3412	53	45	the	the	DET
dpc-3412	53	46	f	f	PROPN
dpc-3412	53	47	statistic	statistic	NOUN
dpc-3412	53	48	for	for	ADP
dpc-3412	53	49	each	each	DET
dpc-3412	53	50	instrumental	instrumental	ADJ
dpc-3412	53	51	variable	variable	NOUN
dpc-3412	53	52	,	,	PUNCT
dpc-3412	53	53	and	and	CCONJ
dpc-3412	53	54	those	those	PRON
dpc-3412	53	55	with	with	ADP
dpc-3412	53	56	an	an	DET
dpc-3412	53	57	f	f	PROPN
dpc-3412	53	58	value	value	NOUN
dpc-3412	53	59	less	less	ADJ
dpc-3412	53	60	than	than	ADP
dpc-3412	53	61	ten	ten	NUM
dpc-3412	53	62	were	be	AUX
dpc-3412	53	63	eliminated	eliminate	VERB
dpc-3412	53	64	[	[	X
dpc-3412	53	65	19	19	NUM
dpc-3412	53	66	]	]	PUNCT
dpc-3412	53	67	.	.	PUNCT
dpc-3412	54	1	the	the	DET
dpc-3412	54	2	calculation	calculation	NOUN
dpc-3412	54	3	formula	formula	NOUN
dpc-3412	54	4	was	be	AUX
dpc-3412	54	5	as	as	SCONJ
dpc-3412	54	6	follows	follow	VERB
dpc-3412	54	7	[	[	X
dpc-3412	54	8	20	20	NUM
dpc-3412	54	9	]	]	PUNCT
dpc-3412	54	10	where	where	SCONJ
dpc-3412	54	11	n	n	PRON
dpc-3412	54	12	is	be	AUX
dpc-3412	54	13	the	the	DET
dpc-3412	54	14	sample	sample	NOUN
dpc-3412	54	15	size	size	NOUN
dpc-3412	54	16	and	and	CCONJ
dpc-3412	54	17	r2	r2	NOUN
dpc-3412	55	1	the	the	DET
dpc-3412	55	2	variance	variance	NOUN
dpc-3412	55	3	explained	explain	VERB
dpc-3412	55	4	by	by	ADP
dpc-3412	55	5	ivs	ivs	NOUN
dpc-3412	55	6	:	:	PUNCT
dpc-3412	55	7	r	r	NOUN
dpc-3412	55	8	n	n	NOUN
dpc-3412	55	9	r	r	NOUN
dpc-3412	55	10	2	2	NUM
dpc-3412	55	11	2	2	NUM
dpc-3412	55	12	(	(	PUNCT
dpc-3412	55	13	2	2	NUM
dpc-3412	55	14	)	)	PUNCT
dpc-3412	55	15	(	(	PUNCT
dpc-3412	55	16	1	1	NUM
dpc-3412	55	17	)	)	PUNCT
dpc-3412	55	18	–	–	PUNCT
dpc-3412	55	19	–	–	PUNCT
dpc-3412	55	20	original	original	ADJ
dpc-3412	55	21	article	article	NOUN
dpc-3412	55	22	|	|	ADV
dpc-3412	55	23	dermatol	dermatol	ADJ
dpc-3412	55	24	pract	pract	NOUN
dpc-3412	55	25	concept	concept	NOUN
dpc-3412	55	26	.	.	PUNCT
dpc-3412	56	1	2024;14(1):e2024041	2024;14(1):e2024041	NUM
dpc-3412	56	2	3	3	NUM
dpc-3412	56	3	since	since	SCONJ
dpc-3412	56	4	we	we	PRON
dpc-3412	56	5	required	require	VERB
dpc-3412	56	6	at	at	ADP
dpc-3412	56	7	least	least	ADV
dpc-3412	56	8	four	four	NUM
dpc-3412	56	9	single	single	ADJ
dpc-3412	56	10	nucleotide	nucleotide	NOUN
dpc-3412	56	11	polymorphisms	polymorphism	NOUN
dpc-3412	56	12	(	(	PUNCT
dpc-3412	56	13	snps	snps	PROPN
dpc-3412	56	14	)	)	PUNCT
dpc-3412	56	15	as	as	ADP
dpc-3412	56	16	instrumental	instrumental	ADJ
dpc-3412	56	17	variables	variable	NOUN
dpc-3412	56	18	for	for	ADP
dpc-3412	56	19	subsequent	subsequent	ADJ
dpc-3412	56	20	analysis	analysis	NOUN
dpc-3412	56	21	,	,	PUNCT
dpc-3412	56	22	we	we	PRON
dpc-3412	56	23	set	set	VERB
dpc-3412	56	24	a	a	DET
dpc-3412	56	25	p	p	NOUN
dpc-3412	56	26	-value	-value	ADJ
dpc-3412	56	27	threshold	threshold	NOUN
dpc-3412	56	28	of	of	ADP
dpc-3412	56	29	p	p	X
dpc-3412	56	30	<	<	X
dpc-3412	56	31	5e-07	5e-07	NUM
dpc-3412	56	32	in	in	ADP
dpc-3412	56	33	case	case	NOUN
dpc-3412	56	34	the	the	DET
dpc-3412	56	35	medications	medication	NOUN
dpc-3412	56	36	gwas	gwa	VERB
dpc-3412	56	37	yielded	yield	VERB
dpc-3412	56	38	insufficient	insufficient	ADJ
dpc-3412	56	39	instrumental	instrumental	ADJ
dpc-3412	56	40	variables	variable	NOUN
dpc-3412	56	41	after	after	ADP
dpc-3412	56	42	screening	screening	NOUN
dpc-3412	56	43	and	and	CCONJ
dpc-3412	56	44	normalization	normalization	NOUN
dpc-3412	56	45	.	.	PUNCT
dpc-3412	57	1	if	if	SCONJ
dpc-3412	57	2	still	still	ADV
dpc-3412	57	3	inadequate	inadequate	ADJ
dpc-3412	57	4	,	,	PUNCT
dpc-3412	57	5	we	we	PRON
dpc-3412	57	6	would	would	AUX
dpc-3412	57	7	adjust	adjust	VERB
dpc-3412	57	8	the	the	DET
dpc-3412	57	9	cutoff	cutoff	NOUN
dpc-3412	57	10	point	point	NOUN
dpc-3412	57	11	to	to	ADP
dpc-3412	57	12	p	p	X
dpc-3412	57	13	<	<	X
dpc-3412	57	14	5e-06	5e-06	NUM
dpc-3412	57	15	.	.	PUNCT
dpc-3412	58	1	the	the	DET
dpc-3412	58	2	study	study	NOUN
dpc-3412	58	3	focused	focus	VERB
dpc-3412	58	4	on	on	ADP
dpc-3412	58	5	psoriasis	psoriasis	NOUN
dpc-3412	58	6	as	as	ADP
dpc-3412	58	7	the	the	DET
dpc-3412	58	8	primary	primary	ADJ
dpc-3412	58	9	outcome	outcome	NOUN
dpc-3412	58	10	of	of	ADP
dpc-3412	58	11	interest	interest	NOUN
dpc-3412	58	12	.	.	PUNCT
dpc-3412	59	1	we	we	PRON
dpc-3412	59	2	obtained	obtain	VERB
dpc-3412	59	3	the	the	DET
dpc-3412	59	4	gwas	gwas	PROPN
dpc-3412	59	5	data	datum	NOUN
dpc-3412	59	6	for	for	ADP
dpc-3412	59	7	psoriasis	psoriasis	NOUN
dpc-3412	59	8	from	from	ADP
dpc-3412	59	9	the	the	DET
dpc-3412	59	10	8th	8th	ADJ
dpc-3412	59	11	release	release	NOUN
dpc-3412	59	12	of	of	ADP
dpc-3412	59	13	the	the	DET
dpc-3412	59	14	finngen	finngen	ADJ
dpc-3412	59	15	database	database	NOUN
dpc-3412	60	1	[	[	X
dpc-3412	60	2	21	21	NUM
dpc-3412	60	3	]	]	PUNCT
dpc-3412	60	4	,	,	PUNCT
dpc-3412	60	5	where	where	SCONJ
dpc-3412	60	6	the	the	DET
dpc-3412	60	7	phenocode	phenocode	NOUN
dpc-3412	60	8	for	for	ADP
dpc-3412	60	9	psoriasis	psoriasis	NOUN
dpc-3412	60	10	was	be	AUX
dpc-3412	60	11	l12_psoriasis	l12_psoriasis	NOUN
dpc-3412	60	12	(	(	PUNCT
dpc-3412	60	13	https://	https://	PROPN
dpc-3412	60	14	finngen.gitbook.io/documentation/	finngen.gitbook.io/documentation/	PROPN
dpc-3412	60	15	)	)	PUNCT
dpc-3412	60	16	.	.	PUNCT
dpc-3412	61	1	the	the	DET
dpc-3412	61	2	dataset	dataset	NOUN
dpc-3412	61	3	included	include	VERB
dpc-3412	61	4	8,075	8,075	NUM
dpc-3412	61	5	cases	case	NOUN
dpc-3412	61	6	and	and	CCONJ
dpc-3412	61	7	330,975	330,975	NUM
dpc-3412	61	8	controls	control	NOUN
dpc-3412	61	9	,	,	PUNCT
dpc-3412	61	10	with	with	ADP
dpc-3412	61	11	a	a	DET
dpc-3412	61	12	total	total	ADJ
dpc-3412	61	13	sample	sample	NOUN
dpc-3412	61	14	size	size	NOUN
dpc-3412	61	15	of	of	ADP
dpc-3412	61	16	339,050	339,050	NUM
dpc-3412	61	17	.	.	PUNCT
dpc-3412	62	1	finngen	finngen	PROPN
dpc-3412	62	2	conducted	conduct	VERB
dpc-3412	62	3	a	a	DET
dpc-3412	62	4	series	series	NOUN
dpc-3412	62	5	of	of	ADP
dpc-3412	62	6	quality	quality	NOUN
dpc-3412	62	7	control	control	NOUN
dpc-3412	62	8	measures	measure	NOUN
dpc-3412	62	9	on	on	ADP
dpc-3412	62	10	the	the	DET
dpc-3412	62	11	gwas	gwas	PROPN
dpc-3412	62	12	data	data	PROPN
dpc-3412	62	13	(	(	PUNCT
dpc-3412	62	14	doi	doi	NOUN
dpc-3412	62	15	:	:	PUNCT
dpc-3412	62	16	https://doi.org/10.1101/	https://doi.org/10.1101/	PROPN
dpc-3412	62	17	2022.03.03.22271360	2022.03.03.22271360	NOUN
dpc-3412	62	18	)	)	PUNCT
dpc-3412	62	19	.	.	PUNCT
dpc-3412	63	1	and	and	CCONJ
dpc-3412	63	2	we	we	PRON
dpc-3412	63	3	used	use	VERB
dpc-3412	63	4	national	national	ADJ
dpc-3412	63	5	registries	registry	NOUN
dpc-3412	63	6	to	to	PART
dpc-3412	63	7	define	define	VERB
dpc-3412	63	8	psoriasis	psoriasis	NOUN
dpc-3412	63	9	cases	case	NOUN
dpc-3412	63	10	.	.	PUNCT
dpc-3412	64	1	we	we	PRON
dpc-3412	64	2	harmonized	harmonize	VERB
dpc-3412	64	3	the	the	DET
dpc-3412	64	4	exposure	exposure	NOUN
dpc-3412	64	5	and	and	CCONJ
dpc-3412	64	6	outcome	outcome	NOUN
dpc-3412	64	7	groups	group	NOUN
dpc-3412	64	8	data	datum	NOUN
dpc-3412	64	9	to	to	PART
dpc-3412	64	10	ensure	ensure	VERB
dpc-3412	64	11	that	that	SCONJ
dpc-3412	64	12	the	the	DET
dpc-3412	64	13	effect	effect	NOUN
dpc-3412	64	14	allele	allele	NOUN
dpc-3412	64	15	was	be	AUX
dpc-3412	64	16	consistently	consistently	ADV
dpc-3412	64	17	related	relate	VERB
dpc-3412	64	18	to	to	ADP
dpc-3412	64	19	the	the	DET
dpc-3412	64	20	same	same	ADJ
dpc-3412	64	21	allele	allele	NOUN
dpc-3412	64	22	.	.	PUNCT
dpc-3412	65	1	this	this	PRON
dpc-3412	65	2	was	be	AUX
dpc-3412	65	3	achieved	achieve	VERB
dpc-3412	65	4	using	use	VERB
dpc-3412	65	5	the	the	DET
dpc-3412	65	6	effect	effect	NOUN
dpc-3412	65	7	allele	allele	NOUN
dpc-3412	65	8	frequency	frequency	NOUN
dpc-3412	65	9	(	(	PUNCT
dpc-3412	65	10	eaf	eaf	NOUN
dpc-3412	65	11	)	)	PUNCT
dpc-3412	65	12	to	to	PART
dpc-3412	65	13	deduce	deduce	VERB
dpc-3412	65	14	the	the	DET
dpc-3412	65	15	orientation	orientation	NOUN
dpc-3412	65	16	of	of	ADP
dpc-3412	65	17	all	all	DET
dpc-3412	65	18	snps	snps	PROPN
dpc-3412	65	19	on	on	ADP
dpc-3412	65	20	the	the	DET
dpc-3412	65	21	forward	forward	ADJ
dpc-3412	65	22	strand	strand	NOUN
dpc-3412	65	23	.	.	PUNCT
dpc-3412	66	1	snps	snps	PROPN
dpc-3412	66	2	with	with	ADP
dpc-3412	66	3	incorrect	incorrect	ADJ
dpc-3412	66	4	effects	effect	NOUN
dpc-3412	66	5	or	or	CCONJ
dpc-3412	66	6	reference	reference	NOUN
dpc-3412	66	7	alleles	allele	NOUN
dpc-3412	66	8	,	,	PUNCT
dpc-3412	66	9	and	and	CCONJ
dpc-3412	66	10	those	those	PRON
dpc-3412	66	11	with	with	ADP
dpc-3412	66	12	ambiguous	ambiguous	ADJ
dpc-3412	66	13	palindromic	palindromic	ADJ
dpc-3412	66	14	sequences	sequence	NOUN
dpc-3412	66	15	that	that	PRON
dpc-3412	66	16	eaf	eaf	PROPN
dpc-3412	66	17	could	could	AUX
dpc-3412	66	18	not	not	PART
dpc-3412	66	19	resolve	resolve	VERB
dpc-3412	66	20	,	,	PUNCT
dpc-3412	66	21	were	be	AUX
dpc-3412	66	22	excluded	exclude	VERB
dpc-3412	66	23	from	from	ADP
dpc-3412	66	24	further	further	ADJ
dpc-3412	66	25	analysis	analysis	NOUN
dpc-3412	66	26	.	.	PUNCT
dpc-3412	67	1	mendelian	mendelian	ADJ
dpc-3412	67	2	randomization	randomization	NOUN
dpc-3412	67	3	and	and	CCONJ
dpc-3412	67	4	sensitivity	sensitivity	NOUN
dpc-3412	67	5	test	test	NOUN
dpc-3412	67	6	to	to	PART
dpc-3412	67	7	validate	validate	VERB
dpc-3412	67	8	the	the	DET
dpc-3412	67	9	primary	primary	ADJ
dpc-3412	67	10	mr	mr	PROPN
dpc-3412	67	11	analysis	analysis	NOUN
dpc-3412	67	12	method	method	NOUN
dpc-3412	67	13	,	,	PUNCT
dpc-3412	67	14	we	we	PRON
dpc-3412	67	15	performed	perform	VERB
dpc-3412	67	16	mr	mr	PROPN
dpc-3412	67	17	-	-	PUNCT
dpc-3412	67	18	presso	presso	NOUN
dpc-3412	67	19	analysis	analysis	NOUN
dpc-3412	67	20	[	[	X
dpc-3412	67	21	22	22	NUM
dpc-3412	67	22	]	]	PUNCT
dpc-3412	67	23	with	with	ADP
dpc-3412	67	24	an	an	DET
dpc-3412	67	25	element	element	NOUN
dpc-3412	67	26	set	set	VERB
dpc-3412	67	27	to	to	ADP
dpc-3412	67	28	10,000	10,000	NUM
dpc-3412	67	29	to	to	PART
dpc-3412	67	30	identify	identify	VERB
dpc-3412	67	31	and	and	CCONJ
dpc-3412	67	32	remove	remove	VERB
dpc-3412	67	33	outliers	outlier	NOUN
dpc-3412	67	34	.	.	PUNCT
dpc-3412	68	1	we	we	PRON
dpc-3412	68	2	simultaneously	simultaneously	ADV
dpc-3412	68	3	conducted	conduct	VERB
dpc-3412	68	4	mr	mr	PROPN
dpc-3412	68	5	analysis	analysis	NOUN
dpc-3412	68	6	and	and	CCONJ
dpc-3412	68	7	computed	compute	VERB
dpc-3412	68	8	p	p	ADJ
dpc-3412	68	9	values	value	NOUN
dpc-3412	68	10	.	.	PUNCT
dpc-3412	69	1	the	the	DET
dpc-3412	69	2	data	datum	NOUN
dpc-3412	69	3	with	with	ADP
dpc-3412	69	4	outliers	outlier	NOUN
dpc-3412	69	5	removed	remove	VERB
dpc-3412	69	6	were	be	AUX
dpc-3412	69	7	the	the	DET
dpc-3412	69	8	corrected	correct	VERB
dpc-3412	69	9	data	datum	NOUN
dpc-3412	69	10	for	for	ADP
dpc-3412	69	11	subsequent	subsequent	ADJ
dpc-3412	69	12	studies	study	NOUN
dpc-3412	69	13	.	.	PUNCT
dpc-3412	70	1	inverse	inverse	NOUN
dpc-3412	70	2	-	-	PUNCT
dpc-3412	70	3	variance	variance	NOUN
dpc-3412	70	4	-	-	PUNCT
dpc-3412	70	5	weighted	weight	VERB
dpc-3412	70	6	(	(	PUNCT
dpc-3412	70	7	ivw	ivw	NOUN
dpc-3412	70	8	)	)	PUNCT
dpc-3412	70	9	was	be	AUX
dpc-3412	70	10	chosen	choose	VERB
dpc-3412	70	11	as	as	ADP
dpc-3412	70	12	the	the	DET
dpc-3412	70	13	primary	primary	ADJ
dpc-3412	70	14	mr	mr	PROPN
dpc-3412	70	15	method	method	NOUN
dpc-3412	70	16	due	due	ADP
dpc-3412	70	17	to	to	ADP
dpc-3412	70	18	its	its	PRON
dpc-3412	70	19	robustness	robustness	NOUN
dpc-3412	70	20	and	and	CCONJ
dpc-3412	70	21	reliability	reliability	NOUN
dpc-3412	70	22	[	[	X
dpc-3412	70	23	23	23	NUM
dpc-3412	70	24	]	]	PUNCT
dpc-3412	70	25	.	.	PUNCT
dpc-3412	71	1	the	the	DET
dpc-3412	71	2	results	result	NOUN
dpc-3412	71	3	obtained	obtain	VERB
dpc-3412	71	4	through	through	ADP
dpc-3412	71	5	ivw	ivw	NOUN
dpc-3412	71	6	were	be	AUX
dpc-3412	71	7	considered	consider	VERB
dpc-3412	71	8	the	the	DET
dpc-3412	71	9	main	main	ADJ
dpc-3412	71	10	mr	mr	PROPN
dpc-3412	71	11	results	result	NOUN
dpc-3412	71	12	.	.	PUNCT
dpc-3412	72	1	at	at	ADP
dpc-3412	72	2	the	the	DET
dpc-3412	72	3	same	same	ADJ
dpc-3412	72	4	time	time	NOUN
dpc-3412	72	5	,	,	PUNCT
dpc-3412	72	6	we	we	PRON
dpc-3412	72	7	conducted	conduct	VERB
dpc-3412	72	8	four	four	NUM
dpc-3412	72	9	additional	additional	ADJ
dpc-3412	72	10	mr	mr	PROPN
dpc-3412	72	11	methods	method	NOUN
dpc-3412	72	12	(	(	PUNCT
dpc-3412	72	13	mr‒egger	mr‒egger	NOUN
dpc-3412	72	14	,	,	PUNCT
dpc-3412	72	15	simple	simple	ADJ
dpc-3412	72	16	mode	mode	NOUN
dpc-3412	72	17	,	,	PUNCT
dpc-3412	72	18	weighted	weight	VERB
dpc-3412	72	19	median	median	NOUN
dpc-3412	72	20	,	,	PUNCT
dpc-3412	72	21	and	and	CCONJ
dpc-3412	72	22	weighted	weighted	ADJ
dpc-3412	72	23	mode	mode	NOUN
dpc-3412	72	24	)	)	PUNCT
dpc-3412	72	25	to	to	PART
dpc-3412	72	26	complement	complement	VERB
dpc-3412	72	27	ivw	ivw	NOUN
dpc-3412	72	28	and	and	CCONJ
dpc-3412	72	29	to	to	PART
dpc-3412	72	30	observe	observe	VERB
dpc-3412	72	31	if	if	SCONJ
dpc-3412	72	32	their	their	PRON
dpc-3412	72	33	results	result	NOUN
dpc-3412	72	34	were	be	AUX
dpc-3412	72	35	consistent	consistent	ADJ
dpc-3412	72	36	with	with	ADP
dpc-3412	72	37	those	those	PRON
dpc-3412	72	38	of	of	ADP
dpc-3412	72	39	ivw	ivw	NOUN
dpc-3412	72	40	.	.	PUNCT
dpc-3412	73	1	to	to	PART
dpc-3412	73	2	ensure	ensure	VERB
dpc-3412	73	3	the	the	DET
dpc-3412	73	4	reliability	reliability	NOUN
dpc-3412	73	5	of	of	ADP
dpc-3412	73	6	the	the	DET
dpc-3412	73	7	mr	mr	PROPN
dpc-3412	73	8	results	result	NOUN
dpc-3412	73	9	,	,	PUNCT
dpc-3412	73	10	we	we	PRON
dpc-3412	73	11	performed	perform	VERB
dpc-3412	73	12	sensitivity	sensitivity	NOUN
dpc-3412	73	13	analyses	analysis	NOUN
dpc-3412	73	14	after	after	ADP
dpc-3412	73	15	obtaining	obtain	VERB
dpc-3412	73	16	them	they	PRON
dpc-3412	73	17	.	.	PUNCT
dpc-3412	74	1	we	we	PRON
dpc-3412	74	2	employed	employ	VERB
dpc-3412	74	3	the	the	DET
dpc-3412	74	4	mr‒egger	mr‒egg	ADJ
dpc-3412	74	5	intercept	intercept	NOUN
dpc-3412	74	6	method	method	NOUN
dpc-3412	74	7	to	to	PART
dpc-3412	74	8	test	test	VERB
dpc-3412	74	9	whether	whether	SCONJ
dpc-3412	74	10	they	they	PRON
dpc-3412	74	11	were	be	AUX
dpc-3412	74	12	affected	affect	VERB
dpc-3412	74	13	by	by	ADP
dpc-3412	74	14	horizontal	horizontal	ADJ
dpc-3412	74	15	pleiotropy	pleiotropy	NOUN
dpc-3412	74	16	[	[	X
dpc-3412	74	17	24	24	NUM
dpc-3412	74	18	]	]	PUNCT
dpc-3412	74	19	.	.	PUNCT
dpc-3412	75	1	a	a	DET
dpc-3412	75	2	p	p	NOUN
dpc-3412	75	3	value	value	NOUN
dpc-3412	75	4	less	less	ADJ
dpc-3412	75	5	than	than	ADP
dpc-3412	75	6	0.05	0.05	NUM
dpc-3412	75	7	was	be	AUX
dpc-3412	75	8	considered	consider	VERB
dpc-3412	75	9	evidence	evidence	NOUN
dpc-3412	75	10	of	of	ADP
dpc-3412	75	11	horizontal	horizontal	ADJ
dpc-3412	75	12	pleiotropy	pleiotropy	NOUN
dpc-3412	75	13	,	,	PUNCT
dpc-3412	75	14	indicating	indicate	VERB
dpc-3412	75	15	unreliable	unreliable	ADJ
dpc-3412	75	16	results	result	NOUN
dpc-3412	75	17	.	.	PUNCT
dpc-3412	76	1	we	we	PRON
dpc-3412	76	2	evaluated	evaluate	VERB
dpc-3412	76	3	heterogeneity	heterogeneity	NOUN
dpc-3412	76	4	using	use	VERB
dpc-3412	76	5	the	the	DET
dpc-3412	76	6	cochrane	cochrane	NOUN
dpc-3412	76	7	q	q	PROPN
dpc-3412	76	8	test	test	NOUN
dpc-3412	76	9	with	with	ADP
dpc-3412	76	10	ivw	ivw	NOUN
dpc-3412	76	11	and	and	CCONJ
dpc-3412	76	12	mr‒egger	mr‒egger	NOUN
dpc-3412	76	13	.	.	PUNCT
dpc-3412	77	1	a	a	DET
dpc-3412	77	2	p	p	NOUN
dpc-3412	77	3	-	-	PUNCT
dpc-3412	77	4	value	value	NOUN
dpc-3412	77	5	less	less	ADJ
dpc-3412	77	6	than	than	ADP
dpc-3412	77	7	0.05	0.05	NUM
dpc-3412	77	8	indicated	indicate	VERB
dpc-3412	77	9	the	the	DET
dpc-3412	77	10	presence	presence	NOUN
dpc-3412	77	11	of	of	ADP
dpc-3412	77	12	heterogeneity	heterogeneity	NOUN
dpc-3412	77	13	among	among	ADP
dpc-3412	77	14	the	the	DET
dpc-3412	77	15	instrumental	instrumental	ADJ
dpc-3412	77	16	variables	variable	NOUN
dpc-3412	77	17	.	.	PUNCT
dpc-3412	78	1	since	since	SCONJ
dpc-3412	78	2	ivw	ivw	NOUN
dpc-3412	78	3	can	can	AUX
dpc-3412	78	4	effectively	effectively	ADV
dpc-3412	78	5	handle	handle	VERB
dpc-3412	78	6	heterogeneity	heterogeneity	NOUN
dpc-3412	78	7	,	,	PUNCT
dpc-3412	78	8	we	we	PRON
dpc-3412	78	9	should	should	AUX
dpc-3412	78	10	regard	regard	VERB
dpc-3412	78	11	its	its	PRON
dpc-3412	78	12	results	result	NOUN
dpc-3412	78	13	as	as	ADP
dpc-3412	78	14	the	the	DET
dpc-3412	78	15	main	main	ADJ
dpc-3412	78	16	mr	mr	PROPN
dpc-3412	78	17	results	result	VERB
dpc-3412	78	18	[	[	X
dpc-3412	78	19	23	23	NUM
dpc-3412	78	20	]	]	PUNCT
dpc-3412	78	21	.	.	PUNCT
dpc-3412	79	1	results	result	VERB
dpc-3412	79	2	causality	causality	NOUN
dpc-3412	79	3	of	of	ADP
dpc-3412	79	4	medicine	medicine	NOUN
dpc-3412	79	5	intake	intake	NOUN
dpc-3412	79	6	on	on	ADP
dpc-3412	79	7	psoriasis	psoriasis	NOUN
dpc-3412	79	8	occurrence	occurrence	NOUN
dpc-3412	79	9	after	after	ADP
dpc-3412	79	10	conducting	conduct	VERB
dpc-3412	79	11	ivw	ivw	NOUN
dpc-3412	79	12	on	on	ADP
dpc-3412	79	13	23	23	NUM
dpc-3412	79	14	different	different	ADJ
dpc-3412	79	15	types	type	NOUN
dpc-3412	79	16	of	of	ADP
dpc-3412	79	17	medications	medication	NOUN
dpc-3412	79	18	,	,	PUNCT
dpc-3412	79	19	we	we	PRON
dpc-3412	79	20	identified	identify	VERB
dpc-3412	79	21	six	six	NUM
dpc-3412	79	22	of	of	ADP
dpc-3412	79	23	them	they	PRON
dpc-3412	79	24	as	as	ADP
dpc-3412	79	25	significant	significant	ADJ
dpc-3412	79	26	risk	risk	NOUN
dpc-3412	79	27	factors	factor	NOUN
dpc-3412	79	28	for	for	ADP
dpc-3412	79	29	psoriasis	psoriasis	NOUN
dpc-3412	79	30	(	(	PUNCT
dpc-3412	79	31	p	p	X
dpc-3412	79	32	<	<	X
dpc-3412	79	33	0.05	0.05	NUM
dpc-3412	79	34	)	)	PUNCT
dpc-3412	79	35	.	.	PUNCT
dpc-3412	80	1	supplementary	supplementary	ADJ
dpc-3412	80	2	table	table	NOUN
dpc-3412	80	3	1	1	NUM
dpc-3412	80	4	provided	provide	VERB
dpc-3412	80	5	all	all	DET
dpc-3412	80	6	the	the	DET
dpc-3412	80	7	drug	drug	NOUN
dpc-3412	80	8	ids	id	NOUN
dpc-3412	80	9	and	and	CCONJ
dpc-3412	80	10	their	their	PRON
dpc-3412	80	11	corresponding	corresponding	ADJ
dpc-3412	80	12	detailed	detailed	ADJ
dpc-3412	80	13	names	name	NOUN
dpc-3412	80	14	.	.	PUNCT
dpc-3412	81	1	as	as	SCONJ
dpc-3412	81	2	depicted	depict	VERB
dpc-3412	81	3	in	in	ADP
dpc-3412	81	4	figure	figure	NOUN
dpc-3412	81	5	1	1	NUM
dpc-3412	81	6	,	,	PUNCT
dpc-3412	81	7	the	the	DET
dpc-3412	81	8	intake	intake	NOUN
dpc-3412	81	9	of	of	ADP
dpc-3412	81	10	hmg	hmg	NOUN
dpc-3412	81	11	-	-	PUNCT
dpc-3412	81	12	coa	coa	NOUN
dpc-3412	81	13	reductase	reductase	NOUN
dpc-3412	81	14	inhibitors	inhibitor	NOUN
dpc-3412	81	15	(	(	PUNCT
dpc-3412	81	16	or=1.167	or=1.167	ADJ
dpc-3412	81	17	,	,	PUNCT
dpc-3412	81	18	95	95	NUM
dpc-3412	81	19	%	%	NOUN
dpc-3412	81	20	ci	ci	NOUN
dpc-3412	81	21	:	:	PUNCT
dpc-3412	81	22	1.084	1.084	NUM
dpc-3412	81	23	-	-	SYM
dpc-3412	81	24	1.257	1.257	NUM
dpc-3412	81	25	,	,	PUNCT
dpc-3412	81	26	p	p	X
dpc-3412	81	27	<	<	X
dpc-3412	81	28	0.001	0.001	NUM
dpc-3412	81	29	)	)	PUNCT
dpc-3412	81	30	substantially	substantially	ADV
dpc-3412	81	31	increased	increase	VERB
dpc-3412	81	32	the	the	DET
dpc-3412	81	33	risk	risk	NOUN
dpc-3412	81	34	of	of	ADP
dpc-3412	81	35	developing	develop	VERB
dpc-3412	81	36	psoriasis	psoriasis	NOUN
dpc-3412	81	37	.	.	PUNCT
dpc-3412	82	1	thyroid	thyroid	NOUN
dpc-3412	82	2	preparations	preparation	NOUN
dpc-3412	82	3	(	(	PUNCT
dpc-3412	82	4	or=1.080	or=1.080	NOUN
dpc-3412	82	5	,	,	PUNCT
dpc-3412	82	6	95	95	NUM
dpc-3412	82	7	%	%	NOUN
dpc-3412	82	8	ci	ci	NOUN
dpc-3412	82	9	:	:	PUNCT
dpc-3412	82	10	1.026	1.026	NUM
dpc-3412	82	11	-	-	SYM
dpc-3412	82	12	1.138	1.138	NUM
dpc-3412	82	13	,	,	PUNCT
dpc-3412	82	14	p	p	X
dpc-3412	82	15	=	=	NOUN
dpc-3412	82	16	0.004	0.004	NUM
dpc-3412	82	17	)	)	PUNCT
dpc-3412	82	18	and	and	CCONJ
dpc-3412	82	19	antihistamines	antihistamine	NOUN
dpc-3412	82	20	for	for	ADP
dpc-3412	82	21	systemic	systemic	ADJ
dpc-3412	82	22	use	use	NOUN
dpc-3412	82	23	(	(	PUNCT
dpc-3412	82	24	or=1.341	or=1.341	ADJ
dpc-3412	82	25	,	,	PUNCT
dpc-3412	82	26	95	95	NUM
dpc-3412	82	27	%	%	NOUN
dpc-3412	82	28	ci	ci	NOUN
dpc-3412	82	29	:	:	PUNCT
dpc-3412	82	30	1.1041.630	1.1041.630	NUM
dpc-3412	82	31	,	,	PUNCT
dpc-3412	82	32	p	p	X
dpc-3412	82	33	=	=	NOUN
dpc-3412	82	34	0.003	0.003	NUM
dpc-3412	82	35	)	)	PUNCT
dpc-3412	82	36	also	also	ADV
dpc-3412	82	37	showed	show	VERB
dpc-3412	82	38	significant	significant	ADJ
dpc-3412	82	39	associations	association	NOUN
dpc-3412	82	40	.	.	PUNCT
dpc-3412	83	1	additionally	additionally	ADV
dpc-3412	83	2	,	,	PUNCT
dpc-3412	83	3	nsaids	nsaid	NOUN
dpc-3412	83	4	and	and	CCONJ
dpc-3412	83	5	antirheumatic	antirheumatic	ADJ
dpc-3412	83	6	products	product	NOUN
dpc-3412	83	7	(	(	PUNCT
dpc-3412	83	8	or=1.406	or=1.406	ADJ
dpc-3412	83	9	,	,	PUNCT
dpc-3412	83	10	95	95	NUM
dpc-3412	83	11	%	%	NOUN
dpc-3412	83	12	ci	ci	NOUN
dpc-3412	83	13	:	:	PUNCT
dpc-3412	83	14	1.037	1.037	NUM
dpc-3412	83	15	-	-	SYM
dpc-3412	83	16	1.908	1.908	NUM
dpc-3412	83	17	,	,	PUNCT
dpc-3412	83	18	p	p	X
dpc-3412	83	19	=	=	NOUN
dpc-3412	83	20	0.028	0.028	NUM
dpc-3412	83	21	)	)	PUNCT
dpc-3412	83	22	,	,	PUNCT
dpc-3412	83	23	antihypertensives	antihypertensive	NOUN
dpc-3412	83	24	(	(	PUNCT
dpc-3412	83	25	or=1.099	or=1.099	VERB
dpc-3412	83	26	,	,	PUNCT
dpc-3412	83	27	95	95	NUM
dpc-3412	83	28	%	%	NOUN
dpc-3412	83	29	ci	ci	NOUN
dpc-3412	83	30	:	:	PUNCT
dpc-3412	83	31	1.016	1.016	NUM
dpc-3412	83	32	-	-	SYM
dpc-3412	83	33	1.190	1.190	NUM
dpc-3412	83	34	,	,	PUNCT
dpc-3412	83	35	p	p	X
dpc-3412	83	36	=	=	NOUN
dpc-3412	83	37	0.019	0.019	NUM
dpc-3412	83	38	)	)	PUNCT
dpc-3412	83	39	,	,	PUNCT
dpc-3412	83	40	and	and	CCONJ
dpc-3412	83	41	anilides	anilide	NOUN
dpc-3412	83	42	(	(	PUNCT
dpc-3412	83	43	or=1.379	or=1.379	ADJ
dpc-3412	83	44	,	,	PUNCT
dpc-3412	83	45	95	95	NUM
dpc-3412	83	46	%	%	NOUN
dpc-3412	83	47	ci	ci	NOUN
dpc-3412	83	48	:	:	PUNCT
dpc-3412	83	49	1.004	1.004	NUM
dpc-3412	83	50	-	-	SYM
dpc-3412	83	51	1.894	1.894	NUM
dpc-3412	83	52	,	,	PUNCT
dpc-3412	83	53	p	p	NOUN
dpc-3412	83	54	=	=	NOUN
dpc-3412	83	55	0.047	0.047	NUM
dpc-3412	83	56	)	)	PUNCT
dpc-3412	83	57	contributed	contribute	VERB
dpc-3412	83	58	to	to	ADP
dpc-3412	83	59	the	the	DET
dpc-3412	83	60	occurrence	occurrence	NOUN
dpc-3412	83	61	or	or	CCONJ
dpc-3412	83	62	aggravation	aggravation	NOUN
dpc-3412	83	63	of	of	ADP
dpc-3412	83	64	psoriasis	psoriasis	NOUN
dpc-3412	83	65	.	.	PUNCT
dpc-3412	84	1	supplementary	supplementary	ADJ
dpc-3412	84	2	table	table	NOUN
dpc-3412	84	3	2	2	NUM
dpc-3412	84	4	provided	provide	VERB
dpc-3412	84	5	detailed	detailed	ADJ
dpc-3412	84	6	outcomes	outcome	NOUN
dpc-3412	84	7	of	of	ADP
dpc-3412	84	8	the	the	DET
dpc-3412	84	9	other	other	ADJ
dpc-3412	84	10	four	four	NUM
dpc-3412	84	11	mr	mr	PROPN
dpc-3412	84	12	methods	method	NOUN
dpc-3412	84	13	.	.	PUNCT
dpc-3412	85	1	sensitivity	sensitivity	NOUN
dpc-3412	85	2	analyses	analysis	NOUN
dpc-3412	85	3	for	for	ADP
dpc-3412	85	4	the	the	DET
dpc-3412	85	5	ivw	ivw	NOUN
dpc-3412	85	6	-	-	PUNCT
dpc-3412	85	7	mr	mr	NOUN
dpc-3412	85	8	analysis	analysis	NOUN
dpc-3412	85	9	,	,	PUNCT
dpc-3412	85	10	the	the	DET
dpc-3412	85	11	cochran	cochran	PROPN
dpc-3412	85	12	q	q	PROPN
dpc-3412	85	13	test	test	NOUN
dpc-3412	85	14	indicated	indicate	VERB
dpc-3412	85	15	no	no	DET
dpc-3412	85	16	heterogeneity	heterogeneity	NOUN
dpc-3412	85	17	among	among	ADP
dpc-3412	85	18	the	the	DET
dpc-3412	85	19	reported	report	VERB
dpc-3412	85	20	results	result	NOUN
dpc-3412	85	21	(	(	PUNCT
dpc-3412	85	22	p	p	X
dpc-3412	85	23	>	>	X
dpc-3412	85	24	0.05	0.05	NUM
dpc-3412	85	25	)	)	PUNCT
dpc-3412	85	26	.	.	PUNCT
dpc-3412	86	1	moreover	moreover	ADV
dpc-3412	86	2	,	,	PUNCT
dpc-3412	86	3	the	the	DET
dpc-3412	86	4	mr‒egger	mr‒egg	ADJ
dpc-3412	86	5	regression	regression	NOUN
dpc-3412	86	6	analysis	analysis	NOUN
dpc-3412	86	7	demonstrated	demonstrate	VERB
dpc-3412	86	8	that	that	SCONJ
dpc-3412	86	9	overall	overall	ADJ
dpc-3412	86	10	horizontal	horizontal	ADJ
dpc-3412	86	11	pleiotropy	pleiotropy	NOUN
dpc-3412	86	12	did	do	AUX
dpc-3412	86	13	not	not	PART
dpc-3412	86	14	significantly	significantly	ADV
dpc-3412	86	15	affect	affect	VERB
dpc-3412	86	16	the	the	DET
dpc-3412	86	17	results	result	NOUN
dpc-3412	86	18	obtained	obtain	VERB
dpc-3412	86	19	through	through	ADP
dpc-3412	86	20	ivw	ivw	NOUN
dpc-3412	86	21	-	-	PUNCT
dpc-3412	86	22	mr	mr	PROPN
dpc-3412	86	23	(	(	PUNCT
dpc-3412	86	24	p	p	X
dpc-3412	86	25	>	>	X
dpc-3412	86	26	0.05	0.05	NUM
dpc-3412	86	27	)	)	PUNCT
dpc-3412	86	28	.	.	PUNCT
dpc-3412	87	1	supplementary	supplementary	ADJ
dpc-3412	87	2	table	table	NOUN
dpc-3412	87	3	2	2	NUM
dpc-3412	87	4	provided	provide	VERB
dpc-3412	87	5	the	the	DET
dpc-3412	87	6	integrated	integrate	VERB
dpc-3412	87	7	outcomes	outcome	NOUN
dpc-3412	87	8	of	of	ADP
dpc-3412	87	9	mr	mr	PROPN
dpc-3412	87	10	presso	presso	PROPN
dpc-3412	87	11	and	and	CCONJ
dpc-3412	87	12	detailed	detailed	ADJ
dpc-3412	87	13	sensitivity	sensitivity	NOUN
dpc-3412	87	14	analyses	analysis	NOUN
dpc-3412	87	15	.	.	PUNCT
dpc-3412	88	1	based	base	VERB
dpc-3412	88	2	on	on	ADP
dpc-3412	88	3	these	these	DET
dpc-3412	88	4	findings	finding	NOUN
dpc-3412	88	5	,	,	PUNCT
dpc-3412	88	6	we	we	PRON
dpc-3412	88	7	could	could	AUX
dpc-3412	88	8	assert	assert	VERB
dpc-3412	88	9	their	their	PRON
dpc-3412	88	10	causal	causal	ADJ
dpc-3412	88	11	relationship	relationship	NOUN
dpc-3412	88	12	’s	’s	PART
dpc-3412	88	13	credibility	credibility	NOUN
dpc-3412	88	14	.	.	PUNCT
dpc-3412	89	1	conclusions	conclusion	NOUN
dpc-3412	89	2	psoriasis	psoriasis	NOUN
dpc-3412	89	3	is	be	AUX
dpc-3412	89	4	an	an	DET
dpc-3412	89	5	immune	immune	NOUN
dpc-3412	89	6	-	-	PUNCT
dpc-3412	89	7	mediated	mediate	VERB
dpc-3412	89	8	chronic	chronic	ADJ
dpc-3412	89	9	inflammatory	inflammatory	ADJ
dpc-3412	89	10	skin	skin	NOUN
dpc-3412	89	11	disease	disease	NOUN
dpc-3412	89	12	mainly	mainly	ADV
dpc-3412	89	13	affecting	affect	VERB
dpc-3412	89	14	the	the	DET
dpc-3412	89	15	knees	knee	NOUN
dpc-3412	89	16	,	,	PUNCT
dpc-3412	89	17	elbow	elbow	VERB
dpc-3412	89	18	,	,	PUNCT
dpc-3412	89	19	trunk	trunk	NOUN
dpc-3412	89	20	,	,	PUNCT
dpc-3412	89	21	and	and	CCONJ
dpc-3412	89	22	scalps	scalp	NOUN
dpc-3412	89	23	,	,	PUNCT
dpc-3412	89	24	which	which	PRON
dpc-3412	89	25	presents	present	VERB
dpc-3412	89	26	with	with	ADP
dpc-3412	89	27	well	well	ADV
dpc-3412	89	28	-	-	PUNCT
dpc-3412	89	29	demarcated	demarcate	VERB
dpc-3412	89	30	erythematous	erythematous	ADJ
dpc-3412	89	31	plaques	plaque	NOUN
dpc-3412	89	32	covered	cover	VERB
dpc-3412	89	33	by	by	ADP
dpc-3412	89	34	silvery	silvery	NOUN
dpc-3412	89	35	-	-	PUNCT
dpc-3412	89	36	white	white	ADJ
dpc-3412	89	37	scales	scale	NOUN
dpc-3412	89	38	.	.	PUNCT
dpc-3412	90	1	medication	medication	NOUN
dpc-3412	90	2	-	-	PUNCT
dpc-3412	90	3	provoked	provoke	VERB
dpc-3412	90	4	psoriasis	psoriasis	NOUN
dpc-3412	90	5	can	can	AUX
dpc-3412	90	6	be	be	AUX
dpc-3412	90	7	classified	classify	VERB
dpc-3412	90	8	into	into	ADP
dpc-3412	90	9	two	two	NUM
dpc-3412	90	10	types	type	NOUN
dpc-3412	90	11	.	.	PUNCT
dpc-3412	91	1	medication	medication	NOUN
dpc-3412	91	2	-	-	PUNCT
dpc-3412	91	3	induced	induce	VERB
dpc-3412	91	4	psoriasis	psoriasis	NOUN
dpc-3412	91	5	often	often	ADV
dpc-3412	91	6	occurs	occur	VERB
dpc-3412	91	7	in	in	ADP
dpc-3412	91	8	patients	patient	NOUN
dpc-3412	91	9	with	with	ADP
dpc-3412	91	10	no	no	DET
dpc-3412	91	11	family	family	NOUN
dpc-3412	91	12	or	or	CCONJ
dpc-3412	91	13	personal	personal	ADJ
dpc-3412	91	14	history	history	NOUN
dpc-3412	91	15	of	of	ADP
dpc-3412	91	16	psoriasis	psoriasis	NOUN
dpc-3412	91	17	,	,	PUNCT
dpc-3412	91	18	whose	whose	DET
dpc-3412	91	19	lesions	lesion	NOUN
dpc-3412	91	20	typically	typically	ADV
dpc-3412	91	21	subsided	subside	VERB
dpc-3412	91	22	after	after	ADP
dpc-3412	91	23	ceasing	cease	VERB
dpc-3412	91	24	medication	medication	NOUN
dpc-3412	91	25	use	use	NOUN
dpc-3412	91	26	[	[	X
dpc-3412	91	27	25	25	NUM
dpc-3412	91	28	]	]	PUNCT
dpc-3412	91	29	.	.	PUNCT
dpc-3412	92	1	medication	medication	NOUN
dpc-3412	92	2	-	-	PUNCT
dpc-3412	92	3	aggravated	aggravate	VERB
dpc-3412	92	4	psoriasis	psoriasis	NOUN
dpc-3412	92	5	usually	usually	ADV
dpc-3412	92	6	affects	affect	VERB
dpc-3412	92	7	patients	patient	NOUN
dpc-3412	92	8	with	with	ADP
dpc-3412	92	9	a	a	DET
dpc-3412	92	10	history	history	NOUN
dpc-3412	92	11	of	of	ADP
dpc-3412	92	12	psoriasis	psoriasis	NOUN
dpc-3412	92	13	or	or	CCONJ
dpc-3412	92	14	a	a	DET
dpc-3412	92	15	genetic	genetic	ADJ
dpc-3412	92	16	predisposition	predisposition	NOUN
dpc-3412	92	17	,	,	PUNCT
dpc-3412	92	18	generally	generally	ADV
dpc-3412	92	19	exacerbating	exacerbate	VERB
dpc-3412	92	20	their	their	PRON
dpc-3412	92	21	existing	exist	VERB
dpc-3412	92	22	lesions	lesion	NOUN
dpc-3412	92	23	or	or	CCONJ
dpc-3412	92	24	developing	develop	VERB
dpc-3412	92	25	new	new	ADJ
dpc-3412	92	26	ones	one	NOUN
dpc-3412	92	27	[	[	X
dpc-3412	92	28	25	25	NUM
dpc-3412	92	29	]	]	PUNCT
dpc-3412	92	30	.	.	PUNCT
dpc-3412	93	1	however	however	ADV
dpc-3412	93	2	,	,	PUNCT
dpc-3412	93	3	identifying	identify	VERB
dpc-3412	93	4	medication	medication	NOUN
dpc-3412	93	5	-	-	PUNCT
dpc-3412	93	6	related	relate	VERB
dpc-3412	93	7	triggers	trigger	NOUN
dpc-3412	93	8	for	for	ADP
dpc-3412	93	9	psoriasis	psoriasis	NOUN
dpc-3412	93	10	flares	flare	NOUN
dpc-3412	93	11	in	in	ADP
dpc-3412	93	12	clinical	clinical	ADJ
dpc-3412	93	13	practice	practice	NOUN
dpc-3412	93	14	can	can	AUX
dpc-3412	93	15	be	be	AUX
dpc-3412	93	16	challenging	challenge	VERB
dpc-3412	93	17	for	for	ADP
dpc-3412	93	18	various	various	ADJ
dpc-3412	93	19	reasons	reason	NOUN
dpc-3412	93	20	.	.	PUNCT
dpc-3412	94	1	for	for	ADP
dpc-3412	94	2	example	example	NOUN
dpc-3412	94	3	,	,	PUNCT
dpc-3412	94	4	variations	variation	NOUN
dpc-3412	94	5	in	in	ADP
dpc-3412	94	6	the	the	DET
dpc-3412	94	7	absorption	absorption	NOUN
dpc-3412	94	8	rate	rate	NOUN
dpc-3412	94	9	and	and	CCONJ
dpc-3412	94	10	half	half	ADJ
dpc-3412	94	11	-	-	PUNCT
dpc-3412	94	12	time	time	NOUN
dpc-3412	94	13	period	period	NOUN
dpc-3412	94	14	among	among	ADP
dpc-3412	94	15	different	different	ADJ
dpc-3412	94	16	medications	medication	NOUN
dpc-3412	94	17	may	may	AUX
dpc-3412	94	18	lead	lead	VERB
dpc-3412	94	19	to	to	ADP
dpc-3412	94	20	an	an	DET
dpc-3412	94	21	inconspicuous	inconspicuous	ADJ
dpc-3412	94	22	temporal	temporal	ADJ
dpc-3412	94	23	relationship	relationship	NOUN
dpc-3412	94	24	[	[	X
dpc-3412	94	25	26	26	NUM
dpc-3412	94	26	]	]	PUNCT
dpc-3412	94	27	.	.	PUNCT
dpc-3412	95	1	as	as	SCONJ
dpc-3412	95	2	mentioned	mention	VERB
dpc-3412	95	3	earlier	early	ADV
dpc-3412	95	4	,	,	PUNCT
dpc-3412	95	5	mr	mr	PROPN
dpc-3412	95	6	analysis	analysis	NOUN
dpc-3412	95	7	can	can	AUX
dpc-3412	95	8	4	4	NUM
dpc-3412	95	9	original	original	ADJ
dpc-3412	95	10	article	article	NOUN
dpc-3412	95	11	|	|	ADV
dpc-3412	95	12	dermatol	dermatol	ADJ
dpc-3412	95	13	pract	pract	NOUN
dpc-3412	95	14	concept	concept	NOUN
dpc-3412	95	15	.	.	PUNCT
dpc-3412	96	1	2024;14(1):e2024041	2024;14(1):e2024041	NUM
dpc-3412	96	2	pruritus	pruritus	NOUN
dpc-3412	96	3	is	be	AUX
dpc-3412	96	4	a	a	DET
dpc-3412	96	5	common	common	ADJ
dpc-3412	96	6	symptom	symptom	NOUN
dpc-3412	96	7	experienced	experience	VERB
dpc-3412	96	8	by	by	ADP
dpc-3412	96	9	most	most	ADJ
dpc-3412	96	10	psoriasis	psoriasis	NOUN
dpc-3412	96	11	patients	patient	NOUN
dpc-3412	96	12	and	and	CCONJ
dpc-3412	96	13	can	can	AUX
dpc-3412	96	14	significantly	significantly	ADV
dpc-3412	96	15	impact	impact	VERB
dpc-3412	96	16	their	their	PRON
dpc-3412	96	17	quality	quality	NOUN
dpc-3412	96	18	of	of	ADP
dpc-3412	96	19	life	life	NOUN
dpc-3412	96	20	.	.	PUNCT
dpc-3412	97	1	itching	itching	NOUN
dpc-3412	97	2	often	often	ADV
dpc-3412	97	3	leads	lead	VERB
dpc-3412	97	4	to	to	ADP
dpc-3412	97	5	the	the	DET
dpc-3412	97	6	scratching	scratching	NOUN
dpc-3412	97	7	of	of	ADP
dpc-3412	97	8	psoriatic	psoriatic	ADJ
dpc-3412	97	9	lesions	lesion	NOUN
dpc-3412	97	10	,	,	PUNCT
dpc-3412	97	11	further	far	ADV
dpc-3412	97	12	intensifying	intensify	VERB
dpc-3412	97	13	the	the	DET
dpc-3412	97	14	itch	itch	NOUN
dpc-3412	97	15	and	and	CCONJ
dpc-3412	97	16	creating	create	VERB
dpc-3412	97	17	a	a	DET
dpc-3412	97	18	vicious	vicious	ADJ
dpc-3412	97	19	cycle	cycle	NOUN
dpc-3412	97	20	of	of	ADP
dpc-3412	97	21	“	"	PUNCT
dpc-3412	97	22	itching	itching	NOUN
dpc-3412	97	23	-	-	PUNCT
dpc-3412	97	24	scratching	scratching	NOUN
dpc-3412	97	25	,	,	PUNCT
dpc-3412	97	26	”	"	PUNCT
dpc-3412	97	27	ultimately	ultimately	ADV
dpc-3412	97	28	worsening	worsen	VERB
dpc-3412	97	29	skin	skin	NOUN
dpc-3412	97	30	inflammation	inflammation	NOUN
dpc-3412	97	31	.	.	PUNCT
dpc-3412	98	1	in	in	ADP
dpc-3412	98	2	clinical	clinical	ADJ
dpc-3412	98	3	practice	practice	NOUN
dpc-3412	98	4	,	,	PUNCT
dpc-3412	98	5	dermatologists	dermatologist	NOUN
dpc-3412	98	6	use	use	VERB
dpc-3412	98	7	antihistamines	antihistamine	NOUN
dpc-3412	98	8	to	to	PART
dpc-3412	98	9	alleviate	alleviate	VERB
dpc-3412	98	10	itch	itch	NOUN
dpc-3412	98	11	in	in	ADP
dpc-3412	98	12	skin	skin	NOUN
dpc-3412	98	13	disorders	disorder	NOUN
dpc-3412	98	14	.	.	PUNCT
dpc-3412	99	1	few	few	ADJ
dpc-3412	99	2	large	large	ADJ
dpc-3412	99	3	-	-	PUNCT
dpc-3412	99	4	scale	scale	NOUN
dpc-3412	99	5	,	,	PUNCT
dpc-3412	99	6	randomized	randomize	VERB
dpc-3412	99	7	,	,	PUNCT
dpc-3412	99	8	controlled	control	VERB
dpc-3412	99	9	trials	trial	NOUN
dpc-3412	99	10	have	have	AUX
dpc-3412	99	11	examined	examine	VERB
dpc-3412	99	12	whether	whether	SCONJ
dpc-3412	99	13	antihistamines	antihistamine	NOUN
dpc-3412	99	14	use	use	VERB
dpc-3412	99	15	increases	increase	VERB
dpc-3412	99	16	the	the	DET
dpc-3412	99	17	risk	risk	NOUN
dpc-3412	99	18	of	of	ADP
dpc-3412	99	19	psoriasis	psoriasis	NOUN
dpc-3412	99	20	.	.	PUNCT
dpc-3412	100	1	some	some	DET
dpc-3412	100	2	case	case	NOUN
dpc-3412	100	3	reports	report	NOUN
dpc-3412	100	4	have	have	AUX
dpc-3412	100	5	suggested	suggest	VERB
dpc-3412	100	6	that	that	SCONJ
dpc-3412	100	7	fexofenadine	fexofenadine	NOUN
dpc-3412	100	8	and	and	CCONJ
dpc-3412	100	9	terfenadine	terfenadine	NOUN
dpc-3412	100	10	may	may	AUX
dpc-3412	100	11	exacerbate	exacerbate	VERB
dpc-3412	100	12	psoriasis	psoriasis	NOUN
dpc-3412	100	13	[	[	X
dpc-3412	100	14	33,34	33,34	NOUN
dpc-3412	100	15	]	]	X
dpc-3412	100	16	.	.	PUNCT
dpc-3412	101	1	our	our	PRON
dpc-3412	101	2	research	research	NOUN
dpc-3412	101	3	provided	provide	VERB
dpc-3412	101	4	theoretical	theoretical	ADJ
dpc-3412	101	5	evidence	evidence	NOUN
dpc-3412	101	6	that	that	PRON
dpc-3412	101	7	antihistamines	antihistamine	NOUN
dpc-3412	101	8	use	use	NOUN
dpc-3412	101	9	may	may	AUX
dpc-3412	101	10	be	be	AUX
dpc-3412	101	11	a	a	DET
dpc-3412	101	12	risk	risk	NOUN
dpc-3412	101	13	factor	factor	NOUN
dpc-3412	101	14	for	for	ADP
dpc-3412	101	15	psoriasis	psoriasis	NOUN
dpc-3412	101	16	,	,	PUNCT
dpc-3412	101	17	but	but	CCONJ
dpc-3412	101	18	the	the	DET
dpc-3412	101	19	underlying	underlying	ADJ
dpc-3412	101	20	reason	reason	NOUN
dpc-3412	101	21	for	for	ADP
dpc-3412	101	22	this	this	PRON
dpc-3412	101	23	remained	remain	VERB
dpc-3412	101	24	unclear	unclear	ADJ
dpc-3412	101	25	.	.	PUNCT
dpc-3412	102	1	further	further	ADJ
dpc-3412	102	2	pharmacological	pharmacological	ADJ
dpc-3412	102	3	studies	study	NOUN
dpc-3412	102	4	are	be	AUX
dpc-3412	102	5	required	require	VERB
dpc-3412	102	6	to	to	PART
dpc-3412	102	7	elucidate	elucidate	VERB
dpc-3412	102	8	the	the	DET
dpc-3412	102	9	mechanism	mechanism	NOUN
dpc-3412	102	10	of	of	ADP
dpc-3412	102	11	this	this	DET
dpc-3412	102	12	adverse	adverse	ADJ
dpc-3412	102	13	reaction	reaction	NOUN
dpc-3412	102	14	.	.	PUNCT
dpc-3412	103	1	recent	recent	ADJ
dpc-3412	103	2	studies	study	NOUN
dpc-3412	103	3	have	have	AUX
dpc-3412	103	4	shed	shed	VERB
dpc-3412	103	5	light	light	NOUN
dpc-3412	103	6	on	on	ADP
dpc-3412	103	7	the	the	DET
dpc-3412	103	8	relationship	relationship	NOUN
dpc-3412	103	9	between	between	ADP
dpc-3412	103	10	psoriasis	psoriasis	NOUN
dpc-3412	103	11	and	and	CCONJ
dpc-3412	103	12	thyroid	thyroid	NOUN
dpc-3412	103	13	disease	disease	NOUN
dpc-3412	103	14	.	.	PUNCT
dpc-3412	104	1	for	for	ADP
dpc-3412	104	2	instance	instance	NOUN
dpc-3412	104	3	,	,	PUNCT
dpc-3412	104	4	hypothyroidism	hypothyroidism	NOUN
dpc-3412	104	5	was	be	AUX
dpc-3412	104	6	highly	highly	ADV
dpc-3412	104	7	prevalent	prevalent	ADJ
dpc-3412	104	8	in	in	ADP
dpc-3412	104	9	psoriasis	psoriasis	NOUN
dpc-3412	104	10	patients	patient	NOUN
dpc-3412	104	11	  	  	SPACE
dpc-3412	105	1	[	[	X
dpc-3412	105	2	35	35	NUM
dpc-3412	105	3	]	]	PUNCT
dpc-3412	105	4	.	.	PUNCT
dpc-3412	106	1	hashimoto	hashimoto	NOUN
dpc-3412	106	2	’s	’s	PART
dpc-3412	106	3	thyroiditis	thyroiditis	NOUN
dpc-3412	106	4	was	be	AUX
dpc-3412	106	5	also	also	ADV
dpc-3412	106	6	more	more	ADV
dpc-3412	106	7	prevalent	prevalent	ADJ
dpc-3412	106	8	in	in	ADP
dpc-3412	106	9	psoriasis	psoriasis	NOUN
dpc-3412	106	10	patients	patient	NOUN
dpc-3412	106	11	(	(	PUNCT
dpc-3412	106	12	especially	especially	ADV
dpc-3412	106	13	in	in	ADP
dpc-3412	106	14	females	female	NOUN
dpc-3412	106	15	)	)	PUNCT
dpc-3412	106	16	than	than	ADP
dpc-3412	106	17	in	in	ADP
dpc-3412	106	18	healthy	healthy	ADJ
dpc-3412	106	19	people	people	NOUN
dpc-3412	106	20	 	 	SPACE
dpc-3412	107	1	[	[	X
dpc-3412	107	2	35	35	NUM
dpc-3412	107	3	-	-	SYM
dpc-3412	107	4	37	37	NUM
dpc-3412	107	5	]	]	PUNCT
dpc-3412	107	6	.	.	PUNCT
dpc-3412	108	1	levothyroxine	levothyroxine	PROPN
dpc-3412	108	2	is	be	AUX
dpc-3412	108	3	usually	usually	ADV
dpc-3412	108	4	used	use	VERB
dpc-3412	108	5	to	to	PART
dpc-3412	108	6	treat	treat	VERB
dpc-3412	108	7	hypothyroidism	hypothyroidism	NOUN
dpc-3412	108	8	and	and	CCONJ
dpc-3412	108	9	hashimoto	hashimoto	NOUN
dpc-3412	108	10	’s	’s	PART
dpc-3412	108	11	thyroiditis	thyroiditis	NOUN
dpc-3412	108	12	.	.	PUNCT
dpc-3412	109	1	to	to	ADP
dpc-3412	109	2	date	date	NOUN
dpc-3412	109	3	,	,	PUNCT
dpc-3412	109	4	few	few	ADJ
dpc-3412	109	5	studies	study	NOUN
dpc-3412	109	6	effectively	effectively	ADV
dpc-3412	109	7	dispose	dispose	VERB
dpc-3412	109	8	of	of	ADP
dpc-3412	109	9	this	this	DET
dpc-3412	109	10	drawback	drawback	NOUN
dpc-3412	109	11	,	,	PUNCT
dpc-3412	109	12	making	make	VERB
dpc-3412	109	13	it	it	PRON
dpc-3412	109	14	a	a	DET
dpc-3412	109	15	more	more	ADV
dpc-3412	109	16	credible	credible	ADJ
dpc-3412	109	17	tool	tool	NOUN
dpc-3412	109	18	for	for	ADP
dpc-3412	109	19	causal	causal	ADJ
dpc-3412	109	20	estimation	estimation	NOUN
dpc-3412	109	21	between	between	ADP
dpc-3412	109	22	medication	medication	NOUN
dpc-3412	109	23	intake	intake	NOUN
dpc-3412	109	24	and	and	CCONJ
dpc-3412	109	25	the	the	DET
dpc-3412	109	26	increased	increase	VERB
dpc-3412	109	27	risk	risk	NOUN
dpc-3412	109	28	of	of	ADP
dpc-3412	109	29	psoriasis	psoriasis	NOUN
dpc-3412	109	30	.	.	PUNCT
dpc-3412	110	1	psoriasis	psoriasis	NOUN
dpc-3412	110	2	patients	patient	NOUN
dpc-3412	110	3	are	be	AUX
dpc-3412	110	4	susceptible	susceptible	ADJ
dpc-3412	110	5	to	to	ADP
dpc-3412	110	6	developing	develop	VERB
dpc-3412	110	7	cardiovascular	cardiovascular	ADJ
dpc-3412	110	8	episodes	episode	NOUN
dpc-3412	110	9	[	[	X
dpc-3412	110	10	12,13	12,13	NUM
dpc-3412	110	11	]	]	PUNCT
dpc-3412	110	12	.	.	PUNCT
dpc-3412	111	1	statins	statin	NOUN
dpc-3412	111	2	,	,	PUNCT
dpc-3412	111	3	also	also	ADV
dpc-3412	111	4	known	know	VERB
dpc-3412	111	5	as	as	ADP
dpc-3412	111	6	hmg	hmg	NOUN
dpc-3412	111	7	-	-	PUNCT
dpc-3412	111	8	coa	coa	NOUN
dpc-3412	111	9	reductase	reductase	NOUN
dpc-3412	111	10	inhibitors	inhibitor	NOUN
dpc-3412	111	11	,	,	PUNCT
dpc-3412	111	12	are	be	AUX
dpc-3412	111	13	commonly	commonly	ADV
dpc-3412	111	14	prescribed	prescribe	VERB
dpc-3412	111	15	to	to	PART
dpc-3412	111	16	lower	lower	VERB
dpc-3412	111	17	cholesterol	cholesterol	NOUN
dpc-3412	111	18	levels	level	NOUN
dpc-3412	111	19	and	and	CCONJ
dpc-3412	111	20	decrease	decrease	VERB
dpc-3412	111	21	the	the	DET
dpc-3412	111	22	incidence	incidence	NOUN
dpc-3412	111	23	of	of	ADP
dpc-3412	111	24	cardiovascular	cardiovascular	ADJ
dpc-3412	111	25	diseases	disease	NOUN
dpc-3412	111	26	.	.	PUNCT
dpc-3412	112	1	however	however	ADV
dpc-3412	112	2	,	,	PUNCT
dpc-3412	112	3	there	there	PRON
dpc-3412	112	4	is	be	VERB
dpc-3412	112	5	an	an	DET
dpc-3412	112	6	ongoing	ongoing	ADJ
dpc-3412	112	7	debate	debate	NOUN
dpc-3412	112	8	among	among	ADP
dpc-3412	112	9	researchers	researcher	NOUN
dpc-3412	112	10	regarding	regard	VERB
dpc-3412	112	11	the	the	DET
dpc-3412	112	12	relationship	relationship	NOUN
dpc-3412	112	13	between	between	ADP
dpc-3412	112	14	statin	statin	ADJ
dpc-3412	112	15	use	use	NOUN
dpc-3412	112	16	and	and	CCONJ
dpc-3412	112	17	psoriasis	psoriasis	NOUN
dpc-3412	112	18	.	.	PUNCT
dpc-3412	113	1	some	some	DET
dpc-3412	113	2	studies	study	NOUN
dpc-3412	113	3	suggested	suggest	VERB
dpc-3412	113	4	that	that	SCONJ
dpc-3412	113	5	statins	statin	NOUN
dpc-3412	113	6	had	have	VERB
dpc-3412	113	7	beneficial	beneficial	ADJ
dpc-3412	113	8	effects	effect	NOUN
dpc-3412	113	9	on	on	ADP
dpc-3412	113	10	plaque	plaque	NOUN
dpc-3412	113	11	psoriasis	psoriasis	NOUN
dpc-3412	113	12	and	and	CCONJ
dpc-3412	113	13	could	could	AUX
dpc-3412	113	14	reduce	reduce	VERB
dpc-3412	113	15	its	its	PRON
dpc-3412	113	16	severity	severity	NOUN
dpc-3412	113	17	[	[	X
dpc-3412	113	18	27,28	27,28	NOUN
dpc-3412	113	19	]	]	X
dpc-3412	113	20	.	.	PUNCT
dpc-3412	114	1	conversely	conversely	ADV
dpc-3412	114	2	,	,	PUNCT
dpc-3412	114	3	others	other	NOUN
dpc-3412	114	4	argued	argue	VERB
dpc-3412	114	5	that	that	SCONJ
dpc-3412	114	6	there	there	PRON
dpc-3412	114	7	was	be	VERB
dpc-3412	114	8	insufficient	insufficient	ADJ
dpc-3412	114	9	evidence	evidence	NOUN
dpc-3412	114	10	that	that	SCONJ
dpc-3412	114	11	using	use	VERB
dpc-3412	114	12	oral	oral	ADJ
dpc-3412	114	13	statins	statin	NOUN
dpc-3412	114	14	as	as	ADP
dpc-3412	114	15	an	an	DET
dpc-3412	114	16	auxiliary	auxiliary	ADJ
dpc-3412	114	17	treatment	treatment	NOUN
dpc-3412	114	18	could	could	AUX
dpc-3412	114	19	reduce	reduce	VERB
dpc-3412	114	20	the	the	DET
dpc-3412	114	21	severity	severity	NOUN
dpc-3412	114	22	of	of	ADP
dpc-3412	114	23	psoriasis	psoriasis	NOUN
dpc-3412	114	24	[	[	X
dpc-3412	114	25	29	29	NUM
dpc-3412	114	26	]	]	PUNCT
dpc-3412	114	27	.	.	PUNCT
dpc-3412	115	1	psoriasis	psoriasis	NOUN
dpc-3412	115	2	patients	patient	NOUN
dpc-3412	115	3	with	with	ADP
dpc-3412	115	4	hypercholesterolemia	hypercholesterolemia	NOUN
dpc-3412	115	5	may	may	AUX
dpc-3412	115	6	even	even	ADV
dpc-3412	115	7	worsen	worsen	VERB
dpc-3412	115	8	their	their	PRON
dpc-3412	115	9	pre	pre	ADJ
dpc-3412	115	10	-	-	ADJ
dpc-3412	115	11	existing	exist	VERB
dpc-3412	115	12	psoriasis	psoriasis	NOUN
dpc-3412	115	13	after	after	ADP
dpc-3412	115	14	using	use	VERB
dpc-3412	115	15	statins	statin	NOUN
dpc-3412	115	16	due	due	ADP
dpc-3412	115	17	to	to	ADP
dpc-3412	115	18	the	the	DET
dpc-3412	115	19	activation	activation	NOUN
dpc-3412	115	20	of	of	ADP
dpc-3412	115	21	signal	signal	ADJ
dpc-3412	115	22	transducer	transducer	NOUN
dpc-3412	115	23	and	and	CCONJ
dpc-3412	115	24	activator	activator	NOUN
dpc-3412	115	25	of	of	ADP
dpc-3412	115	26	transcription	transcription	NOUN
dpc-3412	115	27	3	3	NUM
dpc-3412	115	28	(	(	PUNCT
dpc-3412	115	29	stat3	stat3	NOUN
dpc-3412	115	30	)	)	PUNCT
dpc-3412	116	1	[	[	X
dpc-3412	116	2	30	30	NUM
dpc-3412	116	3	]	]	PUNCT
dpc-3412	116	4	.	.	PUNCT
dpc-3412	117	1	these	these	DET
dpc-3412	117	2	studies	study	NOUN
dpc-3412	117	3	also	also	ADV
dpc-3412	117	4	stated	state	VERB
dpc-3412	117	5	that	that	SCONJ
dpc-3412	117	6	statins	statin	NOUN
dpc-3412	117	7	could	could	AUX
dpc-3412	117	8	result	result	VERB
dpc-3412	117	9	in	in	ADP
dpc-3412	117	10	the	the	DET
dpc-3412	117	11	deterioration	deterioration	NOUN
dpc-3412	117	12	of	of	ADP
dpc-3412	117	13	psoriasis	psoriasis	NOUN
dpc-3412	117	14	lesions	lesion	NOUN
dpc-3412	117	15	[	[	X
dpc-3412	117	16	31,32	31,32	NUM
dpc-3412	117	17	]	]	PUNCT
dpc-3412	117	18	.	.	PUNCT
dpc-3412	118	1	our	our	PRON
dpc-3412	118	2	study	study	NOUN
dpc-3412	118	3	found	find	VERB
dpc-3412	118	4	that	that	SCONJ
dpc-3412	118	5	statin	statin	PROPN
dpc-3412	118	6	intake	intake	NOUN
dpc-3412	118	7	increased	increase	VERB
dpc-3412	118	8	the	the	DET
dpc-3412	118	9	risk	risk	NOUN
dpc-3412	118	10	of	of	ADP
dpc-3412	118	11	triggering	trigger	VERB
dpc-3412	118	12	or	or	CCONJ
dpc-3412	118	13	exacerbating	exacerbate	VERB
dpc-3412	118	14	psoriasis	psoriasis	NOUN
dpc-3412	118	15	,	,	PUNCT
dpc-3412	118	16	providing	provide	VERB
dpc-3412	118	17	genetic	genetic	ADJ
dpc-3412	118	18	evidence	evidence	NOUN
dpc-3412	118	19	for	for	ADP
dpc-3412	118	20	exploring	explore	VERB
dpc-3412	118	21	the	the	DET
dpc-3412	118	22	concrete	concrete	ADJ
dpc-3412	118	23	pharmacological	pharmacological	ADJ
dpc-3412	118	24	mechanism	mechanism	NOUN
dpc-3412	118	25	of	of	ADP
dpc-3412	118	26	statins	statin	NOUN
dpc-3412	118	27	in	in	ADP
dpc-3412	118	28	psoriasis	psoriasis	NOUN
dpc-3412	118	29	patients	patient	NOUN
dpc-3412	118	30	.	.	PUNCT
dpc-3412	119	1	figure	figure	VERB
dpc-3412	119	2	1	1	NUM
dpc-3412	119	3	.	.	PUNCT
dpc-3412	120	1	the	the	DET
dpc-3412	120	2	forest	forest	NOUN
dpc-3412	120	3	plot	plot	NOUN
dpc-3412	120	4	displayed	display	VERB
dpc-3412	120	5	the	the	DET
dpc-3412	120	6	results	result	NOUN
dpc-3412	120	7	of	of	ADP
dpc-3412	120	8	a	a	DET
dpc-3412	120	9	two	two	NUM
dpc-3412	120	10	-	-	PUNCT
dpc-3412	120	11	sample	sample	NOUN
dpc-3412	120	12	mendelian	mendelian	ADJ
dpc-3412	120	13	randomization	randomization	NOUN
dpc-3412	120	14	analysis	analysis	NOUN
dpc-3412	120	15	,	,	PUNCT
dpc-3412	120	16	investigating	investigate	VERB
dpc-3412	120	17	the	the	DET
dpc-3412	120	18	relationship	relationship	NOUN
dpc-3412	120	19	between	between	ADP
dpc-3412	120	20	the	the	DET
dpc-3412	120	21	intake	intake	NOUN
dpc-3412	120	22	of	of	ADP
dpc-3412	120	23	23	23	NUM
dpc-3412	120	24	different	different	ADJ
dpc-3412	120	25	types	type	NOUN
dpc-3412	120	26	of	of	ADP
dpc-3412	120	27	medications	medication	NOUN
dpc-3412	120	28	and	and	CCONJ
dpc-3412	120	29	the	the	DET
dpc-3412	120	30	risk	risk	NOUN
dpc-3412	120	31	of	of	ADP
dpc-3412	120	32	psoriasis	psoriasis	NOUN
dpc-3412	120	33	.	.	PUNCT
dpc-3412	121	1	the	the	DET
dpc-3412	121	2	effect	effect	NOUN
dpc-3412	121	3	estimates	estimate	NOUN
dpc-3412	121	4	were	be	AUX
dpc-3412	121	5	presented	present	VERB
dpc-3412	121	6	as	as	ADP
dpc-3412	121	7	odds	odd	NOUN
dpc-3412	121	8	ratios	ratio	NOUN
dpc-3412	121	9	.	.	PUNCT
dpc-3412	122	1	ci	ci	NOUN
dpc-3412	122	2	=	=	NOUN
dpc-3412	122	3	confidence	confidence	NOUN
dpc-3412	122	4	interval	interval	NOUN
dpc-3412	122	5	;	;	PUNCT
dpc-3412	122	6	or	or	CCONJ
dpc-3412	122	7	=	=	NOUN
dpc-3412	122	8	odds	odd	NOUN
dpc-3412	122	9	ratio	ratio	NOUN
dpc-3412	122	10	.	.	PUNCT
dpc-3412	123	1	original	original	ADJ
dpc-3412	123	2	article	article	NOUN
dpc-3412	123	3	|	|	ADV
dpc-3412	123	4	dermatol	dermatol	ADJ
dpc-3412	123	5	pract	pract	NOUN
dpc-3412	123	6	concept	concept	NOUN
dpc-3412	123	7	.	.	PUNCT
dpc-3412	124	1	2024;14(1):e2024041	2024;14(1):e2024041	NUM
dpc-3412	124	2	5	5	NUM
dpc-3412	124	3	instrumental	instrumental	ADJ
dpc-3412	124	4	variable	variable	ADJ
dpc-3412	124	5	assumptions	assumption	NOUN
dpc-3412	124	6	can	can	AUX
dpc-3412	124	7	not	not	PART
dpc-3412	124	8	be	be	AUX
dpc-3412	124	9	empirically	empirically	ADV
dpc-3412	124	10	verified	verify	VERB
dpc-3412	124	11	,	,	PUNCT
dpc-3412	124	12	but	but	CCONJ
dpc-3412	124	13	we	we	PRON
dpc-3412	124	14	have	have	AUX
dpc-3412	124	15	conducted	conduct	VERB
dpc-3412	124	16	sensitivity	sensitivity	NOUN
dpc-3412	124	17	analyses	analysis	NOUN
dpc-3412	124	18	to	to	PART
dpc-3412	124	19	ensure	ensure	VERB
dpc-3412	124	20	no	no	DET
dpc-3412	124	21	heterogeneity	heterogeneity	NOUN
dpc-3412	124	22	or	or	CCONJ
dpc-3412	124	23	horizontal	horizontal	ADJ
dpc-3412	124	24	pleiotropy	pleiotropy	NOUN
dpc-3412	124	25	.	.	PUNCT
dpc-3412	125	1	our	our	PRON
dpc-3412	125	2	study	study	NOUN
dpc-3412	125	3	offers	offer	VERB
dpc-3412	125	4	a	a	DET
dpc-3412	125	5	causal	causal	ADJ
dpc-3412	125	6	testimony	testimony	NOUN
dpc-3412	125	7	that	that	SCONJ
dpc-3412	125	8	the	the	DET
dpc-3412	125	9	intake	intake	NOUN
dpc-3412	125	10	of	of	ADP
dpc-3412	125	11	hmg	hmg	PROPN
dpc-3412	125	12	coa	coa	NOUN
dpc-3412	125	13	reductase	reductase	NOUN
dpc-3412	125	14	inhibitors	inhibitor	NOUN
dpc-3412	125	15	,	,	PUNCT
dpc-3412	125	16	thyroid	thyroid	NOUN
dpc-3412	125	17	preparations	preparation	NOUN
dpc-3412	125	18	,	,	PUNCT
dpc-3412	125	19	nonsteroidal	nonsteroidal	NOUN
dpc-3412	125	20	anti	anti	ADJ
dpc-3412	125	21	-	-	ADJ
dpc-3412	125	22	inflammatory	inflammatory	ADJ
dpc-3412	125	23	and	and	CCONJ
dpc-3412	125	24	antirheumatic	antirheumatic	ADJ
dpc-3412	125	25	products	product	NOUN
dpc-3412	125	26	,	,	PUNCT
dpc-3412	125	27	anilides	anilide	NOUN
dpc-3412	125	28	,	,	PUNCT
dpc-3412	125	29	antihistamines	antihistamine	NOUN
dpc-3412	125	30	for	for	ADP
dpc-3412	125	31	systemic	systemic	ADJ
dpc-3412	125	32	use	use	NOUN
dpc-3412	125	33	,	,	PUNCT
dpc-3412	125	34	and	and	CCONJ
dpc-3412	125	35	antihypertensives	antihypertensive	NOUN
dpc-3412	125	36	are	be	AUX
dpc-3412	125	37	substantially	substantially	ADV
dpc-3412	125	38	associated	associate	VERB
dpc-3412	125	39	with	with	ADP
dpc-3412	125	40	the	the	DET
dpc-3412	125	41	increased	increase	VERB
dpc-3412	125	42	risk	risk	NOUN
dpc-3412	125	43	of	of	ADP
dpc-3412	125	44	psoriasis	psoriasis	NOUN
dpc-3412	125	45	.	.	PUNCT
dpc-3412	126	1	references	reference	NOUN
dpc-3412	126	2	1	1	NUM
dpc-3412	126	3	.	.	PUNCT
dpc-3412	126	4	griffiths	griffiths	PROPN
dpc-3412	126	5	ce	ce	PROPN
dpc-3412	126	6	,	,	PUNCT
dpc-3412	126	7	barker	barker	PROPN
dpc-3412	127	1	jn	jn	PROPN
dpc-3412	127	2	.	.	PROPN
dpc-3412	128	1	pathogenesis	pathogenesis	PROPN
dpc-3412	128	2	and	and	CCONJ
dpc-3412	128	3	clinical	clinical	ADJ
dpc-3412	128	4	features	feature	NOUN
dpc-3412	128	5	of	of	ADP
dpc-3412	128	6	psoriasis	psoriasis	NOUN
dpc-3412	128	7	.	.	PUNCT
dpc-3412	129	1	lancet	lancet	NOUN
dpc-3412	129	2	.	.	PUNCT
dpc-3412	130	1	2007;370(9583):263	2007;370(9583):263	NUM
dpc-3412	130	2	-	-	SYM
dpc-3412	130	3	271	271	NUM
dpc-3412	130	4	.	.	PUNCT
dpc-3412	130	5	doi	doi	NOUN
dpc-3412	130	6	:	:	PUNCT
dpc-3412	130	7	10.1016	10.1016	NUM
dpc-3412	130	8	/s0140	/s0140	PROPN
dpc-3412	130	9	-	-	PUNCT
dpc-3412	130	10	6736(07)61128	6736(07)61128	NUM
dpc-3412	130	11	-	-	PUNCT
dpc-3412	130	12	3	3	NUM
dpc-3412	130	13	.	.	PUNCT
dpc-3412	131	1	pmid	pmid	NOUN
dpc-3412	131	2	:	:	PUNCT
dpc-3412	131	3	17658397	17658397	NUM
dpc-3412	131	4	.	.	PUNCT
dpc-3412	132	1	2	2	X
dpc-3412	132	2	.	.	X
dpc-3412	132	3	griffiths	griffiths	PROPN
dpc-3412	132	4	cem	cem	PROPN
dpc-3412	132	5	,	,	PUNCT
dpc-3412	132	6	armstrong	armstrong	PROPN
dpc-3412	132	7	aw	aw	INTJ
dpc-3412	132	8	,	,	PUNCT
dpc-3412	132	9	gudjonsson	gudjonsson	PROPN
dpc-3412	132	10	je	je	PROPN
dpc-3412	132	11	,	,	PUNCT
dpc-3412	132	12	barker	barker	PROPN
dpc-3412	132	13	jnwn	jnwn	PROPN
dpc-3412	132	14	.	.	PUNCT
dpc-3412	133	1	psoriasis	psoriasis	NOUN
dpc-3412	133	2	.	.	PUNCT
dpc-3412	134	1	lancet	lancet	PROPN
dpc-3412	134	2	.	.	PUNCT
dpc-3412	135	1	2021;397(10281):1301	2021;397(10281):1301	NUM
dpc-3412	135	2	-	-	SYM
dpc-3412	135	3	1315	1315	NUM
dpc-3412	135	4	.	.	PUNCT
dpc-3412	136	1	doi	doi	NOUN
dpc-3412	136	2	:	:	PUNCT
dpc-3412	136	3	10.1016	10.1016	NUM
dpc-3412	136	4	/s0140	/s0140	PROPN
dpc-3412	136	5	-	-	PUNCT
dpc-3412	136	6	6736(20)32549	6736(20)32549	NUM
dpc-3412	136	7	-	-	PUNCT
dpc-3412	136	8	6	6	NUM
dpc-3412	136	9	.	.	PUNCT
dpc-3412	137	1	pmid	pmid	NOUN
dpc-3412	137	2	:	:	PUNCT
dpc-3412	137	3	33812489	33812489	NUM
dpc-3412	137	4	.	.	PUNCT
dpc-3412	138	1	3	3	X
dpc-3412	138	2	.	.	X
dpc-3412	138	3	michalek	michalek	VERB
dpc-3412	138	4	i	i	PRON
dpc-3412	138	5	m	m	PROPN
dpc-3412	138	6	,	,	PUNCT
dpc-3412	138	7	loring	lore	VERB
dpc-3412	138	8	b	b	PROPN
dpc-3412	138	9	,	,	PUNCT
dpc-3412	138	10	john	john	PROPN
dpc-3412	138	11	sm	sm	PROPN
dpc-3412	138	12	.	.	PUNCT
dpc-3412	139	1	a	a	DET
dpc-3412	139	2	systematic	systematic	ADJ
dpc-3412	139	3	review	review	NOUN
dpc-3412	139	4	of	of	ADP
dpc-3412	139	5	worldwide	worldwide	ADJ
dpc-3412	139	6	epidemiology	epidemiology	NOUN
dpc-3412	139	7	of	of	ADP
dpc-3412	139	8	psoriasis	psoriasis	NOUN
dpc-3412	139	9	.	.	PUNCT
dpc-3412	140	1	j	j	PROPN
dpc-3412	140	2	eur	eur	PROPN
dpc-3412	140	3	acad	acad	PROPN
dpc-3412	140	4	dermatol	dermatol	NOUN
dpc-3412	140	5	venereol	venereol	NOUN
dpc-3412	140	6	.	.	PUNCT
dpc-3412	141	1	2017;31(2):205	2017;31(2):205	NUM
dpc-3412	141	2	-	-	PUNCT
dpc-3412	141	3	212	212	NUM
dpc-3412	141	4	.	.	PUNCT
dpc-3412	142	1	doi	doi	NOUN
dpc-3412	142	2	:	:	PUNCT
dpc-3412	142	3	10.1111	10.1111	NUM
dpc-3412	142	4	/	/	SYM
dpc-3412	142	5	jdv.13854	jdv.13854	X
dpc-3412	142	6	.	.	PUNCT
dpc-3412	143	1	pmid	pmid	NOUN
dpc-3412	143	2	:	:	PUNCT
dpc-3412	143	3	27573025	27573025	NUM
dpc-3412	143	4	.	.	PUNCT
dpc-3412	144	1	4	4	X
dpc-3412	144	2	.	.	X
dpc-3412	144	3	parisi	parisi	PROPN
dpc-3412	144	4	r	r	PROPN
dpc-3412	144	5	,	,	PUNCT
dpc-3412	144	6	iskandar	iskandar	PROPN
dpc-3412	144	7	iyk	iyk	PROPN
dpc-3412	144	8	,	,	PUNCT
dpc-3412	144	9	kontopantelis	kontopantelis	PROPN
dpc-3412	144	10	e	e	PROPN
dpc-3412	144	11	,	,	PUNCT
dpc-3412	144	12	augustin	augustin	PROPN
dpc-3412	144	13	m	m	PROPN
dpc-3412	144	14	,	,	PUNCT
dpc-3412	144	15	griffiths	griffiths	PROPN
dpc-3412	144	16	cem	cem	PROPN
dpc-3412	144	17	,	,	PUNCT
dpc-3412	144	18	ashcroft	ashcroft	PROPN
dpc-3412	144	19	dm	dm	PROPN
dpc-3412	144	20	;	;	PUNCT
dpc-3412	144	21	global	global	ADJ
dpc-3412	144	22	psoriasis	psoriasis	NOUN
dpc-3412	144	23	atlas	atlas	PROPN
dpc-3412	144	24	.	.	PUNCT
dpc-3412	145	1	national	national	ADJ
dpc-3412	145	2	,	,	PUNCT
dpc-3412	145	3	regional	regional	ADJ
dpc-3412	145	4	,	,	PUNCT
dpc-3412	145	5	and	and	CCONJ
dpc-3412	145	6	worldwide	worldwide	ADJ
dpc-3412	145	7	epidemiology	epidemiology	NOUN
dpc-3412	145	8	of	of	ADP
dpc-3412	145	9	psoriasis	psoriasis	NOUN
dpc-3412	145	10	:	:	PUNCT
dpc-3412	145	11	systematic	systematic	ADJ
dpc-3412	145	12	analysis	analysis	NOUN
dpc-3412	145	13	and	and	CCONJ
dpc-3412	145	14	modelling	model	VERB
dpc-3412	145	15	study	study	NOUN
dpc-3412	145	16	.	.	PUNCT
dpc-3412	146	1	bmj	bmj	PROPN
dpc-3412	146	2	.	.	PUNCT
dpc-3412	147	1	2020;369	2020;369	NUM
dpc-3412	147	2	:	:	PUNCT
dpc-3412	147	3	m1590	m1590	NOUN
dpc-3412	147	4	.	.	PROPN
dpc-3412	147	5	doi	doi	PROPN
dpc-3412	147	6	:	:	PUNCT
dpc-3412	147	7	10.1136	10.1136	NUM
dpc-3412	147	8	/bmj.m1590	/bmj.m1590	NOUN
dpc-3412	147	9	.	.	PUNCT
dpc-3412	148	1	pmid	pmid	NOUN
dpc-3412	148	2	:	:	PUNCT
dpc-3412	148	3	32467098	32467098	NUM
dpc-3412	148	4	.	.	PUNCT
dpc-3412	149	1	pmcid	pmcid	NOUN
dpc-3412	149	2	:	:	PUNCT
dpc-3412	149	3	pmc7254147	pmc7254147	ADJ
dpc-3412	149	4	.	.	PUNCT
dpc-3412	150	1	5	5	X
dpc-3412	150	2	.	.	X
dpc-3412	150	3	fleming	fleme	VERB
dpc-3412	150	4	p	p	PROPN
dpc-3412	150	5	,	,	PUNCT
dpc-3412	150	6	bai	bai	PROPN
dpc-3412	150	7	jw	jw	PROPN
dpc-3412	150	8	,	,	PUNCT
dpc-3412	150	9	pratt	pratt	PROPN
dpc-3412	150	10	m	m	PROPN
dpc-3412	150	11	,	,	PUNCT
dpc-3412	150	12	sibbald	sibbald	PROPN
dpc-3412	150	13	c	c	NOUN
dpc-3412	150	14	,	,	PUNCT
dpc-3412	150	15	lynde	lynde	PROPN
dpc-3412	150	16	c	c	AUX
dpc-3412	150	17	,	,	PUNCT
dpc-3412	150	18	gulliver	gulliver	VERB
dpc-3412	150	19	wp	wp	PROPN
dpc-3412	150	20	.	.	PUNCT
dpc-3412	151	1	the	the	DET
dpc-3412	151	2	prevalence	prevalence	NOUN
dpc-3412	151	3	of	of	ADP
dpc-3412	151	4	anxiety	anxiety	NOUN
dpc-3412	151	5	in	in	ADP
dpc-3412	151	6	patients	patient	NOUN
dpc-3412	151	7	with	with	ADP
dpc-3412	151	8	psoriasis	psoriasis	NOUN
dpc-3412	151	9	:	:	PUNCT
dpc-3412	151	10	a	a	DET
dpc-3412	151	11	systematic	systematic	ADJ
dpc-3412	151	12	review	review	NOUN
dpc-3412	151	13	of	of	ADP
dpc-3412	151	14	observational	observational	ADJ
dpc-3412	151	15	studies	study	NOUN
dpc-3412	151	16	and	and	CCONJ
dpc-3412	151	17	clinical	clinical	ADJ
dpc-3412	151	18	trials	trial	NOUN
dpc-3412	151	19	.	.	PUNCT
dpc-3412	152	1	j	j	PROPN
dpc-3412	152	2	eur	eur	PROPN
dpc-3412	152	3	acad	acad	PROPN
dpc-3412	152	4	dermatol	dermatol	NOUN
dpc-3412	152	5	venereol	venereol	NOUN
dpc-3412	152	6	.	.	PUNCT
dpc-3412	153	1	2017;31(5):798	2017;31(5):798	NUM
dpc-3412	153	2	-	-	SYM
dpc-3412	153	3	807	807	NUM
dpc-3412	153	4	.	.	PUNCT
dpc-3412	154	1	doi	doi	NOUN
dpc-3412	154	2	:	:	PUNCT
dpc-3412	154	3	10.1111	10.1111	NUM
dpc-3412	154	4	/	/	SYM
dpc-3412	154	5	jdv.13891	jdv.13891	PROPN
dpc-3412	154	6	.	.	PUNCT
dpc-3412	155	1	pmid	pmid	NOUN
dpc-3412	155	2	:	:	PUNCT
dpc-3412	155	3	27620704	27620704	NUM
dpc-3412	155	4	.	.	PUNCT
dpc-3412	156	1	6	6	X
dpc-3412	156	2	.	.	PUNCT
dpc-3412	156	3	gonzalez	gonzalez	PROPN
dpc-3412	156	4	j	j	PROPN
dpc-3412	156	5	,	,	PUNCT
dpc-3412	156	6	cunningham	cunningham	PROPN
dpc-3412	156	7	k	k	PROPN
dpc-3412	156	8	,	,	PUNCT
dpc-3412	156	9	perlmutter	perlmutter	PROPN
dpc-3412	156	10	j	j	PROPN
dpc-3412	156	11	,	,	PUNCT
dpc-3412	156	12	gottlieb	gottlieb	PROPN
dpc-3412	156	13	a.	a.	PROPN
dpc-3412	156	14	systematic	systematic	PROPN
dpc-3412	156	15	review	review	PROPN
dpc-3412	156	16	of	of	ADP
dpc-3412	156	17	health	health	NOUN
dpc-3412	156	18	-	-	PUNCT
dpc-3412	156	19	related	relate	VERB
dpc-3412	156	20	quality	quality	NOUN
dpc-3412	156	21	of	of	ADP
dpc-3412	156	22	life	life	NOUN
dpc-3412	156	23	in	in	ADP
dpc-3412	156	24	adolescents	adolescent	NOUN
dpc-3412	156	25	with	with	ADP
dpc-3412	156	26	psoriasis	psoriasis	NOUN
dpc-3412	156	27	.	.	PUNCT
dpc-3412	157	1	dermatology	dermatology	NOUN
dpc-3412	157	2	.	.	PUNCT
dpc-3412	158	1	2016;232(5):541	2016;232(5):541	NUM
dpc-3412	158	2	-	-	SYM
dpc-3412	158	3	549	549	NUM
dpc-3412	158	4	.	.	PUNCT
dpc-3412	159	1	doi	doi	NOUN
dpc-3412	159	2	:	:	PUNCT
dpc-3412	159	3	10.1159/000450826	10.1159/000450826	NUM
dpc-3412	159	4	.	.	PUNCT
dpc-3412	160	1	pmid	pmid	NOUN
dpc-3412	160	2	:	:	PUNCT
dpc-3412	160	3	27811471	27811471	NUM
dpc-3412	160	4	.	.	PUNCT
dpc-3412	161	1	7	7	X
dpc-3412	161	2	.	.	X
dpc-3412	161	3	soliman	soliman	PROPN
dpc-3412	161	4	mm	mm	PROPN
dpc-3412	161	5	.	.	PUNCT
dpc-3412	162	1	depressive	depressive	PROPN
dpc-3412	162	2	,	,	PUNCT
dpc-3412	162	3	anxiety	anxiety	NOUN
dpc-3412	162	4	,	,	PUNCT
dpc-3412	162	5	stress	stress	NOUN
dpc-3412	162	6	,	,	PUNCT
dpc-3412	162	7	and	and	CCONJ
dpc-3412	162	8	insomnia	insomnia	NOUN
dpc-3412	162	9	symptoms	symptom	NOUN
dpc-3412	162	10	in	in	ADP
dpc-3412	162	11	patients	patient	NOUN
dpc-3412	162	12	with	with	ADP
dpc-3412	162	13	psoriasis	psoriasis	NOUN
dpc-3412	162	14	:	:	PUNCT
dpc-3412	162	15	a	a	DET
dpc-3412	162	16	cross	cross	ADJ
dpc-3412	162	17	-	-	ADJ
dpc-3412	162	18	sectional	sectional	ADJ
dpc-3412	162	19	study	study	NOUN
dpc-3412	162	20	.	.	PUNCT
dpc-3412	163	1	postepy	postepy	ADJ
dpc-3412	163	2	dermatol	dermatol	NOUN
dpc-3412	163	3	alergol	alergol	NOUN
dpc-3412	163	4	.	.	PUNCT
dpc-3412	164	1	2021;38(3):510	2021;38(3):510	PROPN
dpc-3412	164	2	-	-	SYM
dpc-3412	164	3	519	519	NUM
dpc-3412	164	4	.	.	PUNCT
dpc-3412	164	5	doi	doi	NOUN
dpc-3412	164	6	:	:	PUNCT
dpc-3412	164	7	10.5114	10.5114	NUM
dpc-3412	164	8	/ada.2020.98726	/ada.2020.98726	X
dpc-3412	164	9	.	.	PUNCT
dpc-3412	165	1	pmid	pmid	NOUN
dpc-3412	165	2	:	:	PUNCT
dpc-3412	165	3	34377136	34377136	NUM
dpc-3412	165	4	.	.	PUNCT
dpc-3412	166	1	pmcid	pmcid	NOUN
dpc-3412	166	2	:	:	PUNCT
dpc-3412	166	3	pmc8330873	pmc8330873	ADJ
dpc-3412	166	4	.	.	PUNCT
dpc-3412	167	1	8	8	X
dpc-3412	167	2	.	.	X
dpc-3412	167	3	liang	liang	PROPN
dpc-3412	167	4	se	se	PROPN
dpc-3412	167	5	,	,	PUNCT
dpc-3412	167	6	cohen	cohen	PROPN
dpc-3412	167	7	jm	jm	PROPN
dpc-3412	167	8	,	,	PUNCT
dpc-3412	167	9	ho	ho	PROPN
dpc-3412	167	10	rs	rs	NOUN
dpc-3412	167	11	.	.	PUNCT
dpc-3412	168	1	psoriasis	psoriasis	NOUN
dpc-3412	168	2	and	and	CCONJ
dpc-3412	168	3	suicidality	suicidality	NOUN
dpc-3412	168	4	:	:	PUNCT
dpc-3412	168	5	a	a	DET
dpc-3412	168	6	review	review	NOUN
dpc-3412	168	7	of	of	ADP
dpc-3412	168	8	the	the	DET
dpc-3412	168	9	literature	literature	NOUN
dpc-3412	168	10	.	.	PUNCT
dpc-3412	169	1	dermatol	dermatol	NOUN
dpc-3412	169	2	ther	ther	ADV
dpc-3412	169	3	.	.	PUNCT
dpc-3412	170	1	2019;32(1):e12771	2019;32(1):e12771	NUM
dpc-3412	170	2	.	.	PUNCT
dpc-3412	171	1	doi	doi	NOUN
dpc-3412	171	2	:	:	PUNCT
dpc-3412	171	3	10.1111	10.1111	NUM
dpc-3412	171	4	/	/	SYM
dpc-3412	171	5	dth.12771	dth.12771	NOUN
dpc-3412	171	6	.	.	PUNCT
dpc-3412	172	1	pmid	pmid	NOUN
dpc-3412	172	2	:	:	PUNCT
dpc-3412	172	3	30315629	30315629	NUM
dpc-3412	172	4	.	.	PUNCT
dpc-3412	173	1	9	9	X
dpc-3412	173	2	.	.	X
dpc-3412	173	3	basavaraj	basavaraj	PROPN
dpc-3412	173	4	kh	kh	PROPN
dpc-3412	173	5	,	,	PUNCT
dpc-3412	173	6	ashok	ashok	PROPN
dpc-3412	173	7	nm	nm	PROPN
dpc-3412	173	8	,	,	PUNCT
dpc-3412	173	9	rashmi	rashmi	PROPN
dpc-3412	173	10	r	r	PROPN
dpc-3412	173	11	,	,	PUNCT
dpc-3412	173	12	praveen	praveen	PROPN
dpc-3412	173	13	tk	tk	PROPN
dpc-3412	173	14	.	.	PUNCT
dpc-3412	174	1	the	the	DET
dpc-3412	174	2	role	role	NOUN
dpc-3412	174	3	of	of	ADP
dpc-3412	174	4	drugs	drug	NOUN
dpc-3412	174	5	in	in	ADP
dpc-3412	174	6	the	the	DET
dpc-3412	174	7	induction	induction	NOUN
dpc-3412	174	8	and/or	and/or	CCONJ
dpc-3412	174	9	exacerbation	exacerbation	NOUN
dpc-3412	174	10	of	of	ADP
dpc-3412	174	11	psoriasis	psoriasis	NOUN
dpc-3412	174	12	.	.	PUNCT
dpc-3412	175	1	int	int	NOUN
dpc-3412	175	2	j	j	PROPN
dpc-3412	175	3	dermatol	dermatol	NOUN
dpc-3412	175	4	.	.	PUNCT
dpc-3412	176	1	2010;49(12):1351	2010;49(12):1351	NUM
dpc-3412	176	2	-	-	PUNCT
dpc-3412	176	3	1361	1361	NUM
dpc-3412	176	4	.	.	PUNCT
dpc-3412	177	1	doi	doi	NOUN
dpc-3412	177	2	:	:	PUNCT
dpc-3412	177	3	10.1111	10.1111	NUM
dpc-3412	177	4	/	/	SYM
dpc-3412	177	5	j.1365	j.1365	NOUN
dpc-3412	177	6	-4632.2010.04570.x	-4632.2010.04570.x	NOUN
dpc-3412	177	7	.	.	PUNCT
dpc-3412	178	1	pmid	pmid	NOUN
dpc-3412	178	2	:	:	PUNCT
dpc-3412	178	3	21091671	21091671	NUM
dpc-3412	178	4	.	.	PUNCT
dpc-3412	179	1	10	10	NUM
dpc-3412	179	2	.	.	PUNCT
dpc-3412	179	3	fry	fry	PROPN
dpc-3412	179	4	l	l	PROPN
dpc-3412	179	5	,	,	PUNCT
dpc-3412	179	6	baker	baker	PROPN
dpc-3412	179	7	bs	bs	PROPN
dpc-3412	179	8	.	.	PUNCT
dpc-3412	179	9	triggering	trigger	VERB
dpc-3412	179	10	psoriasis	psoriasis	NOUN
dpc-3412	179	11	:	:	PUNCT
dpc-3412	179	12	the	the	DET
dpc-3412	179	13	role	role	NOUN
dpc-3412	179	14	of	of	ADP
dpc-3412	179	15	infections	infection	NOUN
dpc-3412	179	16	and	and	CCONJ
dpc-3412	179	17	medications	medication	NOUN
dpc-3412	179	18	.	.	PUNCT
dpc-3412	180	1	clin	clin	PROPN
dpc-3412	180	2	dermatol	dermatol	NOUN
dpc-3412	180	3	.	.	PUNCT
dpc-3412	181	1	2007;25(6):606	2007;25(6):606	NUM
dpc-3412	181	2	-	-	PUNCT
dpc-3412	181	3	615	615	NUM
dpc-3412	181	4	.	.	PUNCT
dpc-3412	182	1	doi	doi	NOUN
dpc-3412	182	2	:	:	PUNCT
dpc-3412	182	3	10.1016	10.1016	NUM
dpc-3412	182	4	/	/	SYM
dpc-3412	182	5	j.clindermatol.2007.08.015	j.clindermatol.2007.08.015	PROPN
dpc-3412	182	6	.	.	PUNCT
dpc-3412	183	1	pmid	pmid	NOUN
dpc-3412	183	2	:	:	PUNCT
dpc-3412	183	3	18021899	18021899	NUM
dpc-3412	183	4	.	.	PUNCT
dpc-3412	184	1	11	11	NUM
dpc-3412	184	2	.	.	PUNCT
dpc-3412	185	1	gisondi	gisondi	PROPN
dpc-3412	185	2	p	p	NOUN
dpc-3412	185	3	,	,	PUNCT
dpc-3412	185	4	fostini	fostini	ADJ
dpc-3412	185	5	ac	ac	PROPN
dpc-3412	185	6	,	,	PUNCT
dpc-3412	185	7	fossà	fossà	VERB
dpc-3412	185	8	i	i	PRON
dpc-3412	185	9	,	,	PUNCT
dpc-3412	185	10	girolomoni	girolomoni	VERB
dpc-3412	185	11	g	g	NOUN
dpc-3412	185	12	,	,	PUNCT
dpc-3412	185	13	targher	targher	ADJ
dpc-3412	185	14	g.	g.	NOUN
dpc-3412	185	15	psoriasis	psoriasis	NOUN
dpc-3412	185	16	and	and	CCONJ
dpc-3412	185	17	the	the	DET
dpc-3412	185	18	metabolic	metabolic	NOUN
dpc-3412	185	19	syndrome	syndrome	NOUN
dpc-3412	185	20	.	.	PUNCT
dpc-3412	186	1	clin	clin	PROPN
dpc-3412	186	2	dermatol	dermatol	NOUN
dpc-3412	186	3	.	.	PUNCT
dpc-3412	187	1	2018;36(1):21	2018;36(1):21	NUM
dpc-3412	187	2	-	-	SYM
dpc-3412	187	3	28	28	NUM
dpc-3412	187	4	.	.	PUNCT
dpc-3412	188	1	doi	doi	NOUN
dpc-3412	188	2	:	:	PUNCT
dpc-3412	188	3	10.1016	10.1016	NUM
dpc-3412	188	4	/	/	SYM
dpc-3412	188	5	j.clindermatol.2017.09.005	j.clindermatol.2017.09.005	PROPN
dpc-3412	188	6	.	.	PUNCT
dpc-3412	189	1	pmid	pmid	NOUN
dpc-3412	189	2	:	:	PUNCT
dpc-3412	189	3	29241748	29241748	NUM
dpc-3412	189	4	.	.	PUNCT
dpc-3412	190	1	12	12	NUM
dpc-3412	190	2	.	.	PUNCT
dpc-3412	191	1	zhang	zhang	PROPN
dpc-3412	191	2	l	l	PROPN
dpc-3412	191	3	,	,	PUNCT
dpc-3412	191	4	wang	wang	PROPN
dpc-3412	191	5	y	y	PROPN
dpc-3412	191	6	,	,	PUNCT
dpc-3412	191	7	qiu	qiu	PROPN
dpc-3412	191	8	l	l	PROPN
dpc-3412	191	9	,	,	PUNCT
dpc-3412	191	10	wu	wu	PROPN
dpc-3412	191	11	j.	j.	PROPN
dpc-3412	191	12	psoriasis	psoriasis	PROPN
dpc-3412	191	13	and	and	CCONJ
dpc-3412	191	14	cardiovascular	cardiovascular	ADJ
dpc-3412	191	15	disease	disease	NOUN
dpc-3412	191	16	risk	risk	NOUN
dpc-3412	191	17	in	in	ADP
dpc-3412	191	18	european	european	ADJ
dpc-3412	191	19	and	and	CCONJ
dpc-3412	191	20	east	east	ADJ
dpc-3412	191	21	asian	asian	ADJ
dpc-3412	191	22	populations	population	NOUN
dpc-3412	191	23	:	:	PUNCT
dpc-3412	191	24	evidence	evidence	NOUN
dpc-3412	191	25	from	from	ADP
dpc-3412	191	26	meta	meta	ADJ
dpc-3412	191	27	-	-	PUNCT
dpc-3412	191	28	analysis	analysis	NOUN
dpc-3412	191	29	and	and	CCONJ
dpc-3412	191	30	mendelian	mendelian	ADJ
dpc-3412	191	31	randomization	randomization	NOUN
dpc-3412	191	32	analysis	analysis	NOUN
dpc-3412	191	33	.	.	PUNCT
dpc-3412	192	1	bmc	bmc	PROPN
dpc-3412	192	2	med	med	PROPN
dpc-3412	192	3	.	.	PUNCT
dpc-3412	193	1	2022;20(1):421	2022;20(1):421	NOUN
dpc-3412	193	2	.	.	PUNCT
dpc-3412	194	1	doi	doi	NOUN
dpc-3412	194	2	:	:	PUNCT
dpc-3412	194	3	10.1186	10.1186	NUM
dpc-3412	194	4	/	/	SYM
dpc-3412	194	5	s12916	s12916	PROPN
dpc-3412	194	6	-	-	NOUN
dpc-3412	194	7	022	022	NUM
dpc-3412	194	8	-02617	-02617	NUM
dpc-3412	194	9	-	-	PUNCT
dpc-3412	194	10	5	5	NUM
dpc-3412	194	11	.	.	PUNCT
dpc-3412	195	1	pmid	pmid	NOUN
dpc-3412	195	2	:	:	PUNCT
dpc-3412	195	3	36320003	36320003	NUM
dpc-3412	195	4	.	.	PUNCT
dpc-3412	196	1	pmcid	pmcid	NOUN
dpc-3412	196	2	:	:	PUNCT
dpc-3412	196	3	pmc9628092	pmc9628092	PROPN
dpc-3412	196	4	.	.	PUNCT
dpc-3412	197	1	have	have	AUX
dpc-3412	197	2	investigated	investigate	VERB
dpc-3412	197	3	the	the	DET
dpc-3412	197	4	effect	effect	NOUN
dpc-3412	197	5	of	of	ADP
dpc-3412	197	6	thyroid	thyroid	NOUN
dpc-3412	197	7	preparations	preparation	NOUN
dpc-3412	197	8	on	on	ADP
dpc-3412	197	9	psoriasis	psoriasis	NOUN
dpc-3412	197	10	lesions	lesion	NOUN
dpc-3412	197	11	.	.	PUNCT
dpc-3412	198	1	our	our	PRON
dpc-3412	198	2	results	result	NOUN
dpc-3412	198	3	suggested	suggest	VERB
dpc-3412	198	4	,	,	PUNCT
dpc-3412	198	5	for	for	ADP
dpc-3412	198	6	the	the	DET
dpc-3412	198	7	first	first	ADJ
dpc-3412	198	8	time	time	NOUN
dpc-3412	198	9	,	,	PUNCT
dpc-3412	198	10	that	that	DET
dpc-3412	198	11	thyroid	thyroid	NOUN
dpc-3412	198	12	preparations	preparation	NOUN
dpc-3412	198	13	may	may	AUX
dpc-3412	198	14	contribute	contribute	VERB
dpc-3412	198	15	to	to	ADP
dpc-3412	198	16	the	the	DET
dpc-3412	198	17	onset	onset	NOUN
dpc-3412	198	18	of	of	ADP
dpc-3412	198	19	psoriasis	psoriasis	NOUN
dpc-3412	198	20	,	,	PUNCT
dpc-3412	198	21	which	which	PRON
dpc-3412	198	22	can	can	AUX
dpc-3412	198	23	guide	guide	VERB
dpc-3412	198	24	future	future	ADJ
dpc-3412	198	25	research	research	NOUN
dpc-3412	198	26	in	in	ADP
dpc-3412	198	27	exploring	explore	VERB
dpc-3412	198	28	the	the	DET
dpc-3412	198	29	role	role	NOUN
dpc-3412	198	30	of	of	ADP
dpc-3412	198	31	thyroid	thyroid	NOUN
dpc-3412	198	32	preparations	preparation	NOUN
dpc-3412	198	33	in	in	ADP
dpc-3412	198	34	the	the	DET
dpc-3412	198	35	occurrence	occurrence	NOUN
dpc-3412	198	36	,	,	PUNCT
dpc-3412	198	37	recurrence	recurrence	NOUN
dpc-3412	198	38	,	,	PUNCT
dpc-3412	198	39	and	and	CCONJ
dpc-3412	198	40	exacerbation	exacerbation	NOUN
dpc-3412	198	41	of	of	ADP
dpc-3412	198	42	psoriasis	psoriasis	NOUN
dpc-3412	198	43	.	.	PUNCT
dpc-3412	199	1	hypertension	hypertension	NOUN
dpc-3412	199	2	was	be	AUX
dpc-3412	199	3	reported	report	VERB
dpc-3412	199	4	to	to	PART
dpc-3412	199	5	have	have	VERB
dpc-3412	199	6	a	a	DET
dpc-3412	199	7	higher	high	ADJ
dpc-3412	199	8	risk	risk	NOUN
dpc-3412	199	9	of	of	ADP
dpc-3412	199	10	psoriasis	psoriasis	NOUN
dpc-3412	199	11	incidence	incidence	NOUN
dpc-3412	199	12	(	(	PUNCT
dpc-3412	199	13	hr	hr	NOUN
dpc-3412	199	14	:	:	PUNCT
dpc-3412	199	15	1.54	1.54	NUM
dpc-3412	199	16	,	,	PUNCT
dpc-3412	199	17	95	95	NUM
dpc-3412	199	18	%	%	NOUN
dpc-3412	199	19	ci	ci	NOUN
dpc-3412	199	20	:	:	PUNCT
dpc-3412	199	21	1.47	1.47	NUM
dpc-3412	199	22	-	-	SYM
dpc-3412	199	23	1.61	1.61	NUM
dpc-3412	199	24	,	,	PUNCT
dpc-3412	199	25	p	p	X
dpc-3412	199	26	<	<	X
dpc-3412	199	27	0.001	0.001	NUM
dpc-3412	199	28	)	)	PUNCT
dpc-3412	199	29	and	and	CCONJ
dpc-3412	199	30	was	be	AUX
dpc-3412	199	31	also	also	ADV
dpc-3412	199	32	known	know	VERB
dpc-3412	199	33	to	to	PART
dpc-3412	199	34	be	be	AUX
dpc-3412	199	35	more	more	ADV
dpc-3412	199	36	challenging	challenging	ADJ
dpc-3412	199	37	to	to	PART
dpc-3412	199	38	control	control	VERB
dpc-3412	199	39	in	in	ADP
dpc-3412	199	40	psoriasis	psoriasis	NOUN
dpc-3412	199	41	patients	patient	NOUN
dpc-3412	200	1	[	[	X
dpc-3412	200	2	38,39	38,39	NOUN
dpc-3412	200	3	]	]	PUNCT
dpc-3412	200	4	.	.	PUNCT
dpc-3412	201	1	antihypertensives	antihypertensive	NOUN
dpc-3412	201	2	are	be	AUX
dpc-3412	201	3	mainly	mainly	ADV
dpc-3412	201	4	divided	divide	VERB
dpc-3412	201	5	into	into	ADP
dpc-3412	201	6	five	five	NUM
dpc-3412	201	7	categories	category	NOUN
dpc-3412	201	8	:	:	PUNCT
dpc-3412	201	9	diuretics	diuretic	NOUN
dpc-3412	201	10	,	,	PUNCT
dpc-3412	201	11	β	β	NOUN
dpc-3412	201	12	-	-	ADJ
dpc-3412	201	13	receptor	receptor	NOUN
dpc-3412	201	14	blockers	blocker	NOUN
dpc-3412	201	15	,	,	PUNCT
dpc-3412	201	16	calcium	calcium	NOUN
dpc-3412	201	17	channel	channel	NOUN
dpc-3412	201	18	blockers	blocker	NOUN
dpc-3412	201	19	,	,	PUNCT
dpc-3412	201	20	angiotensin	angiotensin	NOUN
dpc-3412	201	21	-	-	PUNCT
dpc-3412	201	22	converting	convert	VERB
dpc-3412	201	23	enzyme	enzyme	NOUN
dpc-3412	201	24	inhibitors	inhibitor	NOUN
dpc-3412	201	25	,	,	PUNCT
dpc-3412	201	26	and	and	CCONJ
dpc-3412	201	27	angiotensin	angiotensin	NOUN
dpc-3412	201	28	receptor	receptor	NOUN
dpc-3412	201	29	blockers	blocker	NOUN
dpc-3412	201	30	.	.	PUNCT
dpc-3412	202	1	our	our	PRON
dpc-3412	202	2	study	study	NOUN
dpc-3412	202	3	did	do	AUX
dpc-3412	202	4	not	not	PART
dpc-3412	202	5	find	find	VERB
dpc-3412	202	6	a	a	DET
dpc-3412	202	7	correlation	correlation	NOUN
dpc-3412	202	8	between	between	ADP
dpc-3412	202	9	these	these	DET
dpc-3412	202	10	medicines	medicine	NOUN
dpc-3412	202	11	and	and	CCONJ
dpc-3412	202	12	an	an	DET
dpc-3412	202	13	increased	increase	VERB
dpc-3412	202	14	risk	risk	NOUN
dpc-3412	202	15	of	of	ADP
dpc-3412	202	16	psoriasis	psoriasis	NOUN
dpc-3412	202	17	.	.	PUNCT
dpc-3412	203	1	in	in	ADP
dpc-3412	203	2	contrast	contrast	NOUN
dpc-3412	203	3	,	,	PUNCT
dpc-3412	203	4	the	the	DET
dpc-3412	203	5	remaining	remain	VERB
dpc-3412	203	6	minorities	minority	NOUN
dpc-3412	203	7	,	,	PUNCT
dpc-3412	203	8	such	such	ADJ
dpc-3412	203	9	as	as	ADP
dpc-3412	203	10	sympatholytic	sympatholytic	ADJ
dpc-3412	203	11	agents	agent	NOUN
dpc-3412	203	12	(	(	PUNCT
dpc-3412	203	13	reserpine	reserpine	NOUN
dpc-3412	203	14	,	,	PUNCT
dpc-3412	203	15	clonidine	clonidine	NOUN
dpc-3412	203	16	)	)	PUNCT
dpc-3412	203	17	,	,	PUNCT
dpc-3412	203	18	direct	direct	ADJ
dpc-3412	203	19	vasodilators	vasodilator	NOUN
dpc-3412	203	20	(	(	PUNCT
dpc-3412	203	21	hydrazine	hydrazine	NOUN
dpc-3412	203	22	)	)	PUNCT
dpc-3412	203	23	,	,	PUNCT
dpc-3412	203	24	and	and	CCONJ
dpc-3412	203	25	α1	α1	ADJ
dpc-3412	203	26	-	-	PUNCT
dpc-3412	203	27	receptor	receptor	NOUN
dpc-3412	203	28	blockers	blocker	NOUN
dpc-3412	203	29	(	(	PUNCT
dpc-3412	203	30	prazosin	prazosin	NOUN
dpc-3412	203	31	,	,	PUNCT
dpc-3412	203	32	terazosin	terazosin	NOUN
dpc-3412	203	33	)	)	PUNCT
dpc-3412	203	34	,	,	PUNCT
dpc-3412	203	35	were	be	AUX
dpc-3412	203	36	implicated	implicate	VERB
dpc-3412	203	37	.	.	PUNCT
dpc-3412	204	1	for	for	ADP
dpc-3412	204	2	example	example	NOUN
dpc-3412	204	3	,	,	PUNCT
dpc-3412	204	4	a	a	DET
dpc-3412	204	5	large	large	ADJ
dpc-3412	204	6	population	population	NOUN
dpc-3412	204	7	-	-	PUNCT
dpc-3412	204	8	based	base	VERB
dpc-3412	204	9	,	,	PUNCT
dpc-3412	204	10	case	case	NOUN
dpc-3412	204	11	-	-	PUNCT
dpc-3412	204	12	control	control	NOUN
dpc-3412	204	13	study	study	NOUN
dpc-3412	204	14	found	find	VERB
dpc-3412	204	15	no	no	DET
dpc-3412	204	16	connection	connection	NOUN
dpc-3412	204	17	between	between	ADP
dpc-3412	204	18	the	the	DET
dpc-3412	204	19	use	use	NOUN
dpc-3412	204	20	of	of	ADP
dpc-3412	204	21	β	β	NOUN
dpc-3412	204	22	-	-	NOUN
dpc-3412	204	23	blockers	blocker	NOUN
dpc-3412	204	24	and	and	CCONJ
dpc-3412	204	25	an	an	DET
dpc-3412	204	26	increased	increase	VERB
dpc-3412	204	27	risk	risk	NOUN
dpc-3412	204	28	of	of	ADP
dpc-3412	204	29	psoriasis	psoriasis	NOUN
dpc-3412	204	30	[	[	X
dpc-3412	204	31	40	40	NUM
dpc-3412	204	32	]	]	PUNCT
dpc-3412	204	33	.	.	PUNCT
dpc-3412	205	1	however	however	ADV
dpc-3412	205	2	,	,	PUNCT
dpc-3412	205	3	clonidine	clonidine	PROPN
dpc-3412	205	4	may	may	AUX
dpc-3412	205	5	increase	increase	VERB
dpc-3412	205	6	the	the	DET
dpc-3412	205	7	risk	risk	NOUN
dpc-3412	205	8	of	of	ADP
dpc-3412	205	9	psoriasiform	psoriasiform	NOUN
dpc-3412	205	10	eruption	eruption	NOUN
dpc-3412	205	11	by	by	ADP
dpc-3412	205	12	decreasing	decrease	VERB
dpc-3412	205	13	intracellular	intracellular	ADJ
dpc-3412	205	14	cyclic	cyclic	ADJ
dpc-3412	205	15	amp	amp	NOUN
dpc-3412	205	16	and	and	CCONJ
dpc-3412	205	17	promoting	promote	VERB
dpc-3412	205	18	the	the	DET
dpc-3412	205	19	proliferation	proliferation	NOUN
dpc-3412	205	20	of	of	ADP
dpc-3412	205	21	epidermal	epidermal	ADJ
dpc-3412	205	22	cells	cell	NOUN
dpc-3412	205	23	[	[	X
dpc-3412	205	24	41	41	NUM
dpc-3412	205	25	]	]	PUNCT
dpc-3412	205	26	.	.	PUNCT
dpc-3412	206	1	taking	take	VERB
dpc-3412	206	2	urapidil	urapidil	NOUN
dpc-3412	206	3	resulted	result	VERB
dpc-3412	206	4	in	in	ADP
dpc-3412	206	5	the	the	DET
dpc-3412	206	6	observation	observation	NOUN
dpc-3412	206	7	of	of	ADP
dpc-3412	206	8	a	a	DET
dpc-3412	206	9	similar	similar	ADJ
dpc-3412	206	10	lesion	lesion	NOUN
dpc-3412	206	11	[	[	X
dpc-3412	206	12	42	42	NUM
dpc-3412	206	13	]	]	PUNCT
dpc-3412	206	14	.	.	PUNCT
dpc-3412	207	1	these	these	DET
dpc-3412	207	2	findings	finding	NOUN
dpc-3412	207	3	were	be	AUX
dpc-3412	207	4	consistent	consistent	ADJ
dpc-3412	207	5	with	with	ADP
dpc-3412	207	6	the	the	DET
dpc-3412	207	7	results	result	NOUN
dpc-3412	207	8	of	of	ADP
dpc-3412	207	9	our	our	PRON
dpc-3412	207	10	study	study	NOUN
dpc-3412	207	11	,	,	PUNCT
dpc-3412	207	12	which	which	PRON
dpc-3412	207	13	instructed	instruct	VERB
dpc-3412	207	14	us	we	PRON
dpc-3412	207	15	to	to	PART
dpc-3412	207	16	choose	choose	VERB
dpc-3412	207	17	appropriate	appropriate	ADJ
dpc-3412	207	18	antihypertensives	antihypertensive	NOUN
dpc-3412	207	19	medications	medication	NOUN
dpc-3412	207	20	for	for	ADP
dpc-3412	207	21	psoriasis	psoriasis	NOUN
dpc-3412	207	22	patients	patient	NOUN
dpc-3412	207	23	.	.	PUNCT
dpc-3412	208	1	acetaminophen	acetaminophen	NOUN
dpc-3412	208	2	and	and	CCONJ
dpc-3412	208	3	aspirin	aspirin	NOUN
dpc-3412	208	4	are	be	AUX
dpc-3412	208	5	two	two	NUM
dpc-3412	208	6	of	of	ADP
dpc-3412	208	7	the	the	DET
dpc-3412	208	8	most	most	ADV
dpc-3412	208	9	widely	widely	ADV
dpc-3412	208	10	used	use	VERB
dpc-3412	208	11	nsaids	nsaid	NOUN
dpc-3412	208	12	.	.	PUNCT
dpc-3412	209	1	shaowei	shaowei	PROPN
dpc-3412	209	2	wu	wu	PROPN
dpc-3412	209	3	et	et	PROPN
dpc-3412	209	4	al	al	PROPN
dpc-3412	209	5	.	.	PROPN
dpc-3412	209	6	reported	report	VERB
dpc-3412	209	7	that	that	SCONJ
dpc-3412	209	8	regular	regular	ADJ
dpc-3412	209	9	acetaminophen	acetaminophen	NOUN
dpc-3412	209	10	users	user	NOUN
dpc-3412	209	11	may	may	AUX
dpc-3412	209	12	increase	increase	VERB
dpc-3412	209	13	the	the	DET
dpc-3412	209	14	risk	risk	NOUN
dpc-3412	209	15	of	of	ADP
dpc-3412	209	16	developing	develop	VERB
dpc-3412	209	17	psoriasis	psoriasis	NOUN
dpc-3412	209	18	and	and	CCONJ
dpc-3412	209	19	psoriatic	psoriatic	ADJ
dpc-3412	209	20	arthritis	arthritis	NOUN
dpc-3412	209	21	[	[	X
dpc-3412	209	22	43	43	NUM
dpc-3412	209	23	]	]	PUNCT
dpc-3412	209	24	.	.	PUNCT
dpc-3412	210	1	this	this	DET
dpc-3412	210	2	phenomenon	phenomenon	NOUN
dpc-3412	210	3	may	may	AUX
dpc-3412	210	4	be	be	AUX
dpc-3412	210	5	attributed	attribute	VERB
dpc-3412	210	6	to	to	ADP
dpc-3412	210	7	its	its	PRON
dpc-3412	210	8	inhibition	inhibition	NOUN
dpc-3412	210	9	of	of	ADP
dpc-3412	210	10	arachidonic	arachidonic	ADJ
dpc-3412	210	11	acid	acid	NOUN
dpc-3412	210	12	metabolism	metabolism	NOUN
dpc-3412	210	13	via	via	ADP
dpc-3412	210	14	the	the	DET
dpc-3412	210	15	cyclo	cyclo	NOUN
dpc-3412	210	16	-	-	PUNCT
dpc-3412	210	17	oxygenase	oxygenase	NOUN
dpc-3412	210	18	pathway	pathway	NOUN
dpc-3412	210	19	,	,	PUNCT
dpc-3412	210	20	resulting	result	VERB
dpc-3412	210	21	in	in	ADP
dpc-3412	210	22	the	the	DET
dpc-3412	210	23	accumulation	accumulation	NOUN
dpc-3412	210	24	of	of	ADP
dpc-3412	210	25	leukotrienes	leukotriene	NOUN
dpc-3412	210	26	and	and	CCONJ
dpc-3412	210	27	aggravating	aggravate	VERB
dpc-3412	210	28	psoriasis	psoriasis	NOUN
dpc-3412	210	29	[	[	X
dpc-3412	210	30	10	10	NUM
dpc-3412	210	31	]	]	PUNCT
dpc-3412	210	32	.	.	PUNCT
dpc-3412	211	1	notably	notably	ADV
dpc-3412	211	2	,	,	PUNCT
dpc-3412	211	3	acetaminophen	acetaminophen	NOUN
dpc-3412	211	4	belongs	belong	VERB
dpc-3412	211	5	to	to	ADP
dpc-3412	211	6	both	both	DET
dpc-3412	211	7	nsaids	nsaid	NOUN
dpc-3412	211	8	and	and	CCONJ
dpc-3412	211	9	anilides	anilide	NOUN
dpc-3412	211	10	.	.	PUNCT
dpc-3412	212	1	this	this	DET
dpc-3412	212	2	finding	finding	NOUN
dpc-3412	212	3	aligned	align	VERB
dpc-3412	212	4	with	with	ADP
dpc-3412	212	5	our	our	PRON
dpc-3412	212	6	study	study	NOUN
dpc-3412	212	7	outcomes	outcome	NOUN
dpc-3412	212	8	,	,	PUNCT
dpc-3412	212	9	which	which	PRON
dpc-3412	212	10	indicated	indicate	VERB
dpc-3412	212	11	nsaids	nsaid	NOUN
dpc-3412	212	12	and	and	CCONJ
dpc-3412	212	13	anilides	anilide	NOUN
dpc-3412	212	14	were	be	AUX
dpc-3412	212	15	associated	associate	VERB
dpc-3412	212	16	with	with	ADP
dpc-3412	212	17	a	a	DET
dpc-3412	212	18	greater	great	ADJ
dpc-3412	212	19	risk	risk	NOUN
dpc-3412	212	20	of	of	ADP
dpc-3412	212	21	psoriasis	psoriasis	NOUN
dpc-3412	212	22	.	.	PUNCT
dpc-3412	213	1	these	these	DET
dpc-3412	213	2	results	result	NOUN
dpc-3412	213	3	reminded	remind	VERB
dpc-3412	213	4	clinicians	clinician	NOUN
dpc-3412	213	5	that	that	PRON
dpc-3412	213	6	aspirin	aspirin	NOUN
dpc-3412	213	7	may	may	AUX
dpc-3412	213	8	be	be	AUX
dpc-3412	213	9	a	a	DET
dpc-3412	213	10	safer	safe	ADJ
dpc-3412	213	11	alternative	alternative	NOUN
dpc-3412	213	12	to	to	ADP
dpc-3412	213	13	acetaminophen	acetaminophen	NOUN
dpc-3412	213	14	when	when	SCONJ
dpc-3412	213	15	prescribing	prescribing	NOUN
dpc-3412	213	16	nsaids	nsaid	NOUN
dpc-3412	213	17	to	to	ADP
dpc-3412	213	18	psoriasis	psoriasis	NOUN
dpc-3412	213	19	patients	patient	NOUN
dpc-3412	213	20	in	in	ADP
dpc-3412	213	21	the	the	DET
dpc-3412	213	22	short	short	ADJ
dpc-3412	213	23	term	term	NOUN
dpc-3412	213	24	.	.	PUNCT
dpc-3412	214	1	however	however	ADV
dpc-3412	214	2	,	,	PUNCT
dpc-3412	214	3	clinicians	clinician	NOUN
dpc-3412	214	4	should	should	AUX
dpc-3412	214	5	still	still	ADV
dpc-3412	214	6	pay	pay	VERB
dpc-3412	214	7	attention	attention	NOUN
dpc-3412	214	8	to	to	ADP
dpc-3412	214	9	psoriasis	psoriasis	NOUN
dpc-3412	214	10	occurrence	occurrence	NOUN
dpc-3412	214	11	when	when	SCONJ
dpc-3412	214	12	patients	patient	NOUN
dpc-3412	214	13	use	use	VERB
dpc-3412	214	14	nsaids	nsaid	NOUN
dpc-3412	214	15	for	for	ADP
dpc-3412	214	16	a	a	DET
dpc-3412	214	17	long	long	ADJ
dpc-3412	214	18	time	time	NOUN
dpc-3412	214	19	[	[	X
dpc-3412	214	20	43	43	NUM
dpc-3412	214	21	]	]	PUNCT
dpc-3412	214	22	.	.	PUNCT
dpc-3412	215	1	this	this	DET
dpc-3412	215	2	reliable	reliable	ADJ
dpc-3412	215	3	evidence	evidence	NOUN
dpc-3412	215	4	emphasizes	emphasize	VERB
dpc-3412	215	5	the	the	DET
dpc-3412	215	6	importance	importance	NOUN
dpc-3412	215	7	of	of	ADP
dpc-3412	215	8	rational	rational	ADJ
dpc-3412	215	9	medication	medication	NOUN
dpc-3412	215	10	administration	administration	NOUN
dpc-3412	215	11	,	,	PUNCT
dpc-3412	215	12	which	which	PRON
dpc-3412	215	13	is	be	AUX
dpc-3412	215	14	crucial	crucial	ADJ
dpc-3412	215	15	in	in	ADP
dpc-3412	215	16	preventing	prevent	VERB
dpc-3412	215	17	and	and	CCONJ
dpc-3412	215	18	managing	manage	VERB
dpc-3412	215	19	psoriasis	psoriasis	NOUN
dpc-3412	215	20	.	.	PUNCT
dpc-3412	216	1	however	however	ADV
dpc-3412	216	2	,	,	PUNCT
dpc-3412	216	3	we	we	PRON
dpc-3412	216	4	acknowledge	acknowledge	VERB
dpc-3412	216	5	that	that	SCONJ
dpc-3412	216	6	our	our	PRON
dpc-3412	216	7	research	research	NOUN
dpc-3412	216	8	has	have	VERB
dpc-3412	216	9	some	some	DET
dpc-3412	216	10	limitations	limitation	NOUN
dpc-3412	216	11	.	.	PUNCT
dpc-3412	217	1	firstly	firstly	ADV
dpc-3412	217	2	,	,	PUNCT
dpc-3412	217	3	the	the	DET
dpc-3412	217	4	study	study	NOUN
dpc-3412	217	5	samples	sample	NOUN
dpc-3412	217	6	were	be	AUX
dpc-3412	217	7	predominantly	predominantly	ADV
dpc-3412	217	8	of	of	ADP
dpc-3412	217	9	european	european	ADJ
dpc-3412	217	10	populations	population	NOUN
dpc-3412	217	11	,	,	PUNCT
dpc-3412	217	12	so	so	SCONJ
dpc-3412	217	13	the	the	DET
dpc-3412	217	14	results	result	NOUN
dpc-3412	217	15	may	may	AUX
dpc-3412	217	16	not	not	PART
dpc-3412	217	17	be	be	AUX
dpc-3412	217	18	generalizable	generalizable	ADJ
dpc-3412	217	19	to	to	ADP
dpc-3412	217	20	other	other	ADJ
dpc-3412	217	21	racial	racial	ADJ
dpc-3412	217	22	populations	population	NOUN
dpc-3412	217	23	.	.	PUNCT
dpc-3412	218	1	moreover	moreover	ADV
dpc-3412	218	2	,	,	PUNCT
dpc-3412	218	3	the	the	DET
dpc-3412	218	4	risk	risk	NOUN
dpc-3412	218	5	factors	factor	NOUN
dpc-3412	218	6	for	for	ADP
dpc-3412	218	7	disease	disease	NOUN
dpc-3412	218	8	onset	onset	NOUN
dpc-3412	218	9	may	may	AUX
dpc-3412	218	10	not	not	PART
dpc-3412	218	11	align	align	VERB
dpc-3412	218	12	with	with	ADP
dpc-3412	218	13	its	its	PRON
dpc-3412	218	14	prognosis	prognosis	NOUN
dpc-3412	218	15	or	or	CCONJ
dpc-3412	218	16	severity	severity	NOUN
dpc-3412	218	17	.	.	PUNCT
dpc-3412	219	1	in	in	ADP
dpc-3412	219	2	other	other	ADJ
dpc-3412	219	3	words	word	NOUN
dpc-3412	219	4	,	,	PUNCT
dpc-3412	219	5	the	the	DET
dpc-3412	219	6	value	value	NOUN
dpc-3412	219	7	of	of	ADP
dpc-3412	219	8	our	our	PRON
dpc-3412	219	9	research	research	NOUN
dpc-3412	219	10	findings	finding	NOUN
dpc-3412	219	11	lies	lie	VERB
dpc-3412	219	12	in	in	ADP
dpc-3412	219	13	the	the	DET
dpc-3412	219	14	prevention	prevention	NOUN
dpc-3412	219	15	instead	instead	ADV
dpc-3412	219	16	of	of	ADP
dpc-3412	219	17	treatment	treatment	NOUN
dpc-3412	219	18	for	for	ADP
dpc-3412	219	19	psoriasis	psoriasis	NOUN
dpc-3412	219	20	.	.	PUNCT
dpc-3412	220	1	finally	finally	ADV
dpc-3412	220	2	,	,	PUNCT
dpc-3412	220	3	like	like	ADP
dpc-3412	220	4	any	any	DET
dpc-3412	220	5	other	other	ADJ
dpc-3412	220	6	mr	mr	PROPN
dpc-3412	220	7	research	research	NOUN
dpc-3412	220	8	,	,	PUNCT
dpc-3412	220	9	the	the	DET
dpc-3412	220	10	6	6	NUM
dpc-3412	220	11	original	original	ADJ
dpc-3412	220	12	article	article	NOUN
dpc-3412	220	13	|	|	ADV
dpc-3412	220	14	dermatol	dermatol	ADJ
dpc-3412	220	15	pract	pract	NOUN
dpc-3412	220	16	concept	concept	NOUN
dpc-3412	220	17	.	.	PUNCT
dpc-3412	221	1	2024;14(1):e2024041	2024;14(1):e2024041	NUM
dpc-3412	221	2	28	28	NUM
dpc-3412	221	3	.	.	PUNCT
dpc-3412	222	1	socha	socha	PROPN
dpc-3412	222	2	m	m	PROPN
dpc-3412	222	3	,	,	PUNCT
dpc-3412	222	4	pietrzak	pietrzak	VERB
dpc-3412	222	5	a	a	PRON
dpc-3412	222	6	,	,	PUNCT
dpc-3412	222	7	grywalska	grywalska	NOUN
dpc-3412	222	8	e	e	NOUN
dpc-3412	222	9	,	,	PUNCT
dpc-3412	222	10	pietrzak	pietrzak	NOUN
dpc-3412	222	11	d	d	PROPN
dpc-3412	222	12	,	,	PUNCT
dpc-3412	222	13	et	et	PROPN
dpc-3412	222	14	al	al	PROPN
dpc-3412	222	15	.	.	PUNCT
dpc-3412	223	1	the	the	DET
dpc-3412	223	2	effect	effect	NOUN
dpc-3412	223	3	of	of	ADP
dpc-3412	223	4	statins	statin	NOUN
dpc-3412	223	5	on	on	ADP
dpc-3412	223	6	psoriasis	psoriasis	NOUN
dpc-3412	223	7	severity	severity	NOUN
dpc-3412	223	8	:	:	PUNCT
dpc-3412	223	9	a	a	DET
dpc-3412	223	10	meta	meta	ADJ
dpc-3412	223	11	-	-	PUNCT
dpc-3412	223	12	analysis	analysis	NOUN
dpc-3412	223	13	of	of	ADP
dpc-3412	223	14	randomized	randomized	ADJ
dpc-3412	223	15	clinical	clinical	ADJ
dpc-3412	223	16	trials	trial	NOUN
dpc-3412	223	17	.	.	PUNCT
dpc-3412	224	1	arch	arch	PROPN
dpc-3412	224	2	med	med	PROPN
dpc-3412	224	3	sci	sci	PROPN
dpc-3412	224	4	.	.	PUNCT
dpc-3412	224	5	2019;16(1):1	2019;16(1):1	NUM
dpc-3412	224	6	-	-	SYM
dpc-3412	224	7	7	7	NUM
dpc-3412	224	8	.	.	PUNCT
dpc-3412	224	9	doi	doi	NOUN
dpc-3412	224	10	:	:	PUNCT
dpc-3412	224	11	10.5114	10.5114	NUM
dpc-3412	224	12	/aoms.2019.90343	/aoms.2019.90343	NOUN
dpc-3412	224	13	.	.	PUNCT
dpc-3412	225	1	pmid	pmid	NOUN
dpc-3412	225	2	:	:	PUNCT
dpc-3412	225	3	32051699	32051699	NUM
dpc-3412	225	4	.	.	PUNCT
dpc-3412	226	1	pmcid	pmcid	ADJ
dpc-3412	226	2	:	:	PUNCT
dpc-3412	226	3	pmc6963135	pmc6963135	NOUN
dpc-3412	226	4	.	.	PUNCT
dpc-3412	227	1	29	29	NUM
dpc-3412	227	2	.	.	PUNCT
dpc-3412	228	1	ramessur	ramessur	NOUN
dpc-3412	228	2	r	r	NOUN
dpc-3412	228	3	,	,	PUNCT
dpc-3412	228	4	gill	gill	PROPN
dpc-3412	228	5	d.	d.	NOUN
dpc-3412	228	6	the	the	DET
dpc-3412	228	7	effect	effect	NOUN
dpc-3412	228	8	of	of	ADP
dpc-3412	228	9	statins	statin	NOUN
dpc-3412	228	10	on	on	ADP
dpc-3412	228	11	severity	severity	NOUN
dpc-3412	228	12	of	of	ADP
dpc-3412	228	13	psoriasis	psoriasis	NOUN
dpc-3412	228	14	:	:	PUNCT
dpc-3412	228	15	a	a	DET
dpc-3412	228	16	systematic	systematic	ADJ
dpc-3412	228	17	review	review	NOUN
dpc-3412	228	18	.	.	PUNCT
dpc-3412	229	1	indian	indian	PROPN
dpc-3412	229	2	j	j	PROPN
dpc-3412	229	3	dermatol	dermatol	PROPN
dpc-3412	229	4	venereol	venereol	ADJ
dpc-3412	229	5	leprol	leprol	PROPN
dpc-3412	229	6	.	.	PUNCT
dpc-3412	230	1	2017;83(2):154	2017;83(2):154	NOUN
dpc-3412	230	2	-	-	SYM
dpc-3412	230	3	161	161	NUM
dpc-3412	230	4	.	.	PUNCT
dpc-3412	231	1	doi	doi	NOUN
dpc-3412	231	2	:	:	PUNCT
dpc-3412	231	3	10.4103/0378	10.4103/0378	NUM
dpc-3412	231	4	-	-	PUNCT
dpc-3412	231	5	6323.188655	6323.188655	NOUN
dpc-3412	231	6	.	.	PUNCT
dpc-3412	232	1	pmid	pmid	NOUN
dpc-3412	232	2	:	:	PUNCT
dpc-3412	232	3	27549870	27549870	NUM
dpc-3412	232	4	.	.	PUNCT
dpc-3412	233	1	30	30	NUM
dpc-3412	233	2	.	.	PUNCT
dpc-3412	234	1	ibrahim	ibrahim	PROPN
dpc-3412	234	2	am	be	AUX
dpc-3412	234	3	,	,	PUNCT
dpc-3412	234	4	attwa	attwa	VERB
dpc-3412	234	5	em	em	PRON
dpc-3412	234	6	,	,	PUNCT
dpc-3412	234	7	benjuma	benjuma	NOUN
dpc-3412	234	8	hh	hh	VERB
dpc-3412	234	9	.	.	PUNCT
dpc-3412	235	1	the	the	DET
dpc-3412	235	2	exacerbating	exacerbating	ADJ
dpc-3412	235	3	effect	effect	NOUN
dpc-3412	235	4	of	of	ADP
dpc-3412	235	5	atorvastatin	atorvastatin	NOUN
dpc-3412	235	6	on	on	ADP
dpc-3412	235	7	psoriasis	psoriasis	NOUN
dpc-3412	235	8	.	.	PUNCT
dpc-3412	236	1	dermatol	dermatol	NOUN
dpc-3412	236	2	ther	ther	ADV
dpc-3412	236	3	.	.	PUNCT
dpc-3412	237	1	2022;35(8):e15603	2022;35(8):e15603	X
dpc-3412	237	2	.	.	PUNCT
dpc-3412	238	1	doi	doi	NOUN
dpc-3412	238	2	:	:	PUNCT
dpc-3412	238	3	10.1111	10.1111	NUM
dpc-3412	238	4	/	/	SYM
dpc-3412	238	5	dth.15603	dth.15603	PROPN
dpc-3412	238	6	.	.	PUNCT
dpc-3412	239	1	pmid	pmid	NOUN
dpc-3412	239	2	:	:	PUNCT
dpc-3412	239	3	35644872	35644872	NUM
dpc-3412	239	4	.	.	PUNCT
dpc-3412	240	1	31	31	NUM
dpc-3412	240	2	.	.	PUNCT
dpc-3412	241	1	cozzani	cozzani	PROPN
dpc-3412	241	2	e	e	X
dpc-3412	241	3	,	,	PUNCT
dpc-3412	241	4	scaparro	scaparro	PROPN
dpc-3412	241	5	m	m	PRON
dpc-3412	241	6	,	,	PUNCT
dpc-3412	241	7	parodi	parodi	PROPN
dpc-3412	241	8	a.	a.	NOUN
dpc-3412	241	9	a	a	DET
dpc-3412	241	10	case	case	NOUN
dpc-3412	241	11	of	of	ADP
dpc-3412	241	12	psoriasis	psoriasis	NOUN
dpc-3412	241	13	worsened	worsen	VERB
dpc-3412	241	14	by	by	ADP
dpc-3412	241	15	atorvastatin	atorvastatin	PROPN
dpc-3412	241	16	.	.	PUNCT
dpc-3412	242	1	j	j	PROPN
dpc-3412	242	2	dermatol	dermatol	NOUN
dpc-3412	242	3	case	case	NOUN
dpc-3412	242	4	rep	rep	PROPN
dpc-3412	242	5	.	.	PROPN
dpc-3412	242	6	2009;3(4):60	2009;3(4):60	NUM
dpc-3412	242	7	-	-	SYM
dpc-3412	242	8	1	1	NUM
dpc-3412	242	9	.	.	PUNCT
dpc-3412	242	10	doi	doi	NOUN
dpc-3412	242	11	:	:	PUNCT
dpc-3412	242	12	10.3315	10.3315	NUM
dpc-3412	242	13	/	/	SYM
dpc-3412	242	14	jdcr.2009.1037	jdcr.2009.1037	PROPN
dpc-3412	242	15	.	.	PUNCT
dpc-3412	243	1	pmid	pmid	NOUN
dpc-3412	243	2	:	:	PUNCT
dpc-3412	243	3	21886735	21886735	NUM
dpc-3412	243	4	.	.	PUNCT
dpc-3412	244	1	pmcid	pmcid	NOUN
dpc-3412	244	2	:	:	PUNCT
dpc-3412	244	3	pmc3163346	pmc3163346	ADJ
dpc-3412	244	4	.	.	PUNCT
dpc-3412	245	1	32	32	NUM
dpc-3412	245	2	.	.	PUNCT
dpc-3412	246	1	jacobi	jacobi	PROPN
dpc-3412	246	2	tc	tc	PROPN
dpc-3412	246	3	,	,	PUNCT
dpc-3412	246	4	highet	highet	NOUN
dpc-3412	246	5	a.	a.	NOUN
dpc-3412	246	6	a	a	DET
dpc-3412	246	7	clinical	clinical	ADJ
dpc-3412	246	8	dilemma	dilemma	NOUN
dpc-3412	246	9	while	while	SCONJ
dpc-3412	246	10	treating	treat	VERB
dpc-3412	246	11	hypercholesterolaemia	hypercholesterolaemia	NOUN
dpc-3412	246	12	in	in	ADP
dpc-3412	246	13	psoriasis	psoriasis	NOUN
dpc-3412	246	14	.	.	PUNCT
dpc-3412	247	1	br	br	PROPN
dpc-3412	247	2	j	j	PROPN
dpc-3412	247	3	dermatol	dermatol	NOUN
dpc-3412	247	4	.	.	PUNCT
dpc-3412	248	1	2003;149(6	2003;149(6	NUM
dpc-3412	248	2	):	):	PUNCT
dpc-3412	248	3	1305	1305	NUM
dpc-3412	248	4	-	-	SYM
dpc-3412	248	5	1306	1306	NUM
dpc-3412	248	6	.	.	PUNCT
dpc-3412	249	1	doi	doi	NOUN
dpc-3412	249	2	:	:	PUNCT
dpc-3412	249	3	10.1111	10.1111	NUM
dpc-3412	249	4	/	/	SYM
dpc-3412	249	5	j.1365	j.1365	NOUN
dpc-3412	249	6	-	-	PUNCT
dpc-3412	249	7	2133.2003.05675.x	2133.2003.05675.x	NUM
dpc-3412	249	8	.	.	PUNCT
dpc-3412	250	1	pmid	pmid	NOUN
dpc-3412	250	2	:	:	PUNCT
dpc-3412	250	3	14674922	14674922	NUM
dpc-3412	250	4	.	.	PUNCT
dpc-3412	251	1	33	33	NUM
dpc-3412	251	2	.	.	PUNCT
dpc-3412	251	3	saraswat	saraswat	VERB
dpc-3412	251	4	a	a	DET
dpc-3412	251	5	,	,	PUNCT
dpc-3412	251	6	saraswat	saraswat	ADJ
dpc-3412	251	7	m.	m.	NOUN
dpc-3412	251	8	pustular	pustular	ADJ
dpc-3412	251	9	exacerbation	exacerbation	NOUN
dpc-3412	251	10	of	of	ADP
dpc-3412	251	11	psoriasis	psoriasis	NOUN
dpc-3412	251	12	due	due	ADJ
dpc-3412	251	13	to	to	AUX
dpc-3412	251	14	fexofenadine	fexofenadine	VERB
dpc-3412	251	15	.	.	PUNCT
dpc-3412	252	1	clin	clin	PROPN
dpc-3412	252	2	exp	exp	NOUN
dpc-3412	252	3	dermatol	dermatol	NOUN
dpc-3412	252	4	.	.	PUNCT
dpc-3412	253	1	2006;31(3):477	2006;31(3):477	NUM
dpc-3412	253	2	-	-	PUNCT
dpc-3412	253	3	478	478	NUM
dpc-3412	253	4	.	.	PUNCT
dpc-3412	254	1	doi	doi	NOUN
dpc-3412	254	2	:	:	PUNCT
dpc-3412	254	3	10.1111	10.1111	NUM
dpc-3412	254	4	/	/	SYM
dpc-3412	254	5	j.1365	j.1365	NOUN
dpc-3412	254	6	-	-	PUNCT
dpc-3412	254	7	2230.2006.02104.x	2230.2006.02104.x	NUM
dpc-3412	254	8	.	.	PUNCT
dpc-3412	255	1	pmid	pmid	NOUN
dpc-3412	255	2	:	:	PUNCT
dpc-3412	255	3	16681618	16681618	NUM
dpc-3412	255	4	.	.	PUNCT
dpc-3412	256	1	34	34	NUM
dpc-3412	256	2	.	.	X
dpc-3412	256	3	navaratnam	navaratnam	PROPN
dpc-3412	256	4	ae	ae	PROPN
dpc-3412	256	5	,	,	PUNCT
dpc-3412	256	6	gebauer	gebauer	PROPN
dpc-3412	256	7	ka	ka	PROPN
dpc-3412	256	8	.	.	PROPN
dpc-3412	256	9	terfenadine	terfenadine	NOUN
dpc-3412	256	10	-	-	PUNCT
dpc-3412	256	11	induced	induce	VERB
dpc-3412	256	12	exacerbation	exacerbation	NOUN
dpc-3412	256	13	of	of	ADP
dpc-3412	256	14	psoriasis	psoriasis	NOUN
dpc-3412	256	15	.	.	PUNCT
dpc-3412	257	1	clin	clin	PROPN
dpc-3412	257	2	exp	exp	NOUN
dpc-3412	257	3	dermatol	dermatol	NOUN
dpc-3412	257	4	.	.	PUNCT
dpc-3412	258	1	1990;15(1):78	1990;15(1):78	X
dpc-3412	258	2	.	.	PUNCT
dpc-3412	258	3	doi	doi	NOUN
dpc-3412	258	4	:	:	PUNCT
dpc-3412	258	5	10.1111	10.1111	NUM
dpc-3412	258	6	/	/	SYM
dpc-3412	258	7	j.1365	j.1365	NOUN
dpc-3412	258	8	-	-	PUNCT
dpc-3412	258	9	2230.1990.tb02035.x	2230.1990.tb02035.x	NUM
dpc-3412	258	10	.	.	PUNCT
dpc-3412	259	1	pmid	pmid	NOUN
dpc-3412	259	2	:	:	PUNCT
dpc-3412	259	3	1968794	1968794	NUM
dpc-3412	259	4	.	.	PUNCT
dpc-3412	260	1	35	35	NUM
dpc-3412	260	2	.	.	PUNCT
dpc-3412	261	1	cira	cira	PROPN
dpc-3412	261	2	ci	ci	PROPN
dpc-3412	261	3	,	,	PUNCT
dpc-3412	261	4	carsote	carsote	VERB
dpc-3412	261	5	m	m	PROPN
dpc-3412	261	6	,	,	PUNCT
dpc-3412	261	7	nistor	nistor	NOUN
dpc-3412	261	8	c	c	PROPN
dpc-3412	261	9	,	,	PUNCT
dpc-3412	261	10	petca	petca	VERB
dpc-3412	261	11	a	a	DET
dpc-3412	261	12	,	,	PUNCT
dpc-3412	261	13	petca	petca	PROPN
dpc-3412	261	14	rc	rc	PROPN
dpc-3412	261	15	,	,	PUNCT
dpc-3412	261	16	sandru	sandru	NOUN
dpc-3412	261	17	f.	f.	PROPN
dpc-3412	261	18	conundrum	conundrum	PROPN
dpc-3412	261	19	for	for	ADP
dpc-3412	261	20	psoriasis	psoriasis	NOUN
dpc-3412	261	21	and	and	CCONJ
dpc-3412	261	22	thyroid	thyroid	NOUN
dpc-3412	261	23	involvement	involvement	NOUN
dpc-3412	261	24	.	.	PUNCT
dpc-3412	262	1	int	int	PROPN
dpc-3412	262	2	j	j	PROPN
dpc-3412	262	3	mol	mol	ADP
dpc-3412	262	4	sci	sci	PROPN
dpc-3412	262	5	.	.	PUNCT
dpc-3412	263	1	2023;24(5):4894	2023;24(5):4894	PROPN
dpc-3412	263	2	.	.	PUNCT
dpc-3412	263	3	doi	doi	PROPN
dpc-3412	263	4	:	:	PUNCT
dpc-3412	263	5	10.3390	10.3390	NUM
dpc-3412	263	6	/	/	SYM
dpc-3412	263	7	ijms24054894	ijms24054894	PROPN
dpc-3412	263	8	.	.	PUNCT
dpc-3412	264	1	pmid	pmid	NOUN
dpc-3412	264	2	:	:	PUNCT
dpc-3412	264	3	36902323	36902323	NUM
dpc-3412	264	4	.	.	PUNCT
dpc-3412	265	1	pmcid	pmcid	NOUN
dpc-3412	265	2	:	:	PUNCT
dpc-3412	265	3	pmc10003398	pmc10003398	PROPN
dpc-3412	265	4	.	.	PUNCT
dpc-3412	266	1	36	36	NUM
dpc-3412	266	2	.	.	PUNCT
dpc-3412	266	3	valduga	valduga	PROPN
dpc-3412	266	4	jag	jag	PROPN
dpc-3412	266	5	,	,	PUNCT
dpc-3412	266	6	rebeiko	rebeiko	NOUN
dpc-3412	266	7	lb	lb	NUM
dpc-3412	266	8	,	,	PUNCT
dpc-3412	266	9	skare	skare	NOUN
dpc-3412	266	10	tl	tl	PROPN
dpc-3412	266	11	.	.	PUNCT
dpc-3412	267	1	prevalence	prevalence	NOUN
dpc-3412	267	2	of	of	ADP
dpc-3412	267	3	hashimoto	hashimoto	NOUN
dpc-3412	267	4	’s	’s	PART
dpc-3412	267	5	thyroiditis	thyroiditis	NOUN
dpc-3412	267	6	in	in	ADP
dpc-3412	267	7	psoriasis	psoriasis	NOUN
dpc-3412	267	8	patients	patient	NOUN
dpc-3412	267	9	.	.	PUNCT
dpc-3412	268	1	rev	rev	PROPN
dpc-3412	268	2	assoc	assoc	PROPN
dpc-3412	268	3	med	med	PROPN
dpc-3412	268	4	bras	bras	NOUN
dpc-3412	268	5	(	(	PUNCT
dpc-3412	268	6	1992	1992	NUM
dpc-3412	268	7	)	)	PUNCT
dpc-3412	268	8	.	.	PUNCT
dpc-3412	269	1	2021;67(1):52	2021;67(1):52	PROPN
dpc-3412	269	2	-	-	SYM
dpc-3412	269	3	57	57	NUM
dpc-3412	269	4	.	.	PUNCT
dpc-3412	270	1	doi	doi	NOUN
dpc-3412	270	2	:	:	PUNCT
dpc-3412	270	3	10.1590/1806	10.1590/1806	NUM
dpc-3412	270	4	-	-	PUNCT
dpc-3412	270	5	9282.67.01.20200274	9282.67.01.20200274	NOUN
dpc-3412	270	6	.	.	PUNCT
dpc-3412	271	1	pmid	pmid	NOUN
dpc-3412	271	2	:	:	PUNCT
dpc-3412	271	3	34161490	34161490	NUM
dpc-3412	271	4	.	.	PUNCT
dpc-3412	272	1	37	37	NUM
dpc-3412	272	2	.	.	PUNCT
dpc-3412	273	1	alidrisi	alidrisi	PROPN
dpc-3412	273	2	ha	ha	INTJ
dpc-3412	273	3	,	,	PUNCT
dpc-3412	273	4	al	al	PROPN
dpc-3412	273	5	hamdi	hamdi	PROPN
dpc-3412	273	6	k	k	PROPN
dpc-3412	273	7	,	,	PUNCT
dpc-3412	273	8	mansour	mansour	PROPN
dpc-3412	273	9	aa	aa	PROPN
dpc-3412	273	10	.	.	PUNCT
dpc-3412	274	1	is	be	AUX
dpc-3412	274	2	there	there	PRON
dpc-3412	274	3	any	any	DET
dpc-3412	274	4	association	association	NOUN
dpc-3412	274	5	between	between	ADP
dpc-3412	274	6	psoriasis	psoriasis	NOUN
dpc-3412	274	7	and	and	CCONJ
dpc-3412	274	8	hashimoto	hashimoto	NOUN
dpc-3412	274	9	’s	’s	PART
dpc-3412	274	10	thyroiditis	thyroiditis	NOUN
dpc-3412	274	11	?	?	PUNCT
dpc-3412	275	1	cureus	cureus	NOUN
dpc-3412	275	2	.	.	PUNCT
dpc-3412	276	1	2019;11(3):e4269	2019;11(3):e4269	X
dpc-3412	276	2	.	.	PUNCT
dpc-3412	276	3	doi	doi	NOUN
dpc-3412	276	4	:	:	PUNCT
dpc-3412	276	5	10.7759	10.7759	NUM
dpc-3412	276	6	/	/	SYM
dpc-3412	276	7	cureus.4269	cureus.4269	PROPN
dpc-3412	276	8	.	.	PUNCT
dpc-3412	276	9	pmid	pmid	PROPN
dpc-3412	276	10	:	:	PUNCT
dpc-3412	276	11	31157131	31157131	NUM
dpc-3412	276	12	.	.	PUNCT
dpc-3412	277	1	pmcid	pmcid	NOUN
dpc-3412	277	2	:	:	PUNCT
dpc-3412	278	1	pmc6529052	pmc6529052	ADJ
dpc-3412	278	2	.	.	PUNCT
dpc-3412	279	1	38	38	NUM
dpc-3412	279	2	.	.	PUNCT
dpc-3412	280	1	kim	kim	PROPN
dpc-3412	280	2	hn	hn	PROPN
dpc-3412	280	3	,	,	PUNCT
dpc-3412	280	4	han	han	PROPN
dpc-3412	280	5	k	k	PROPN
dpc-3412	280	6	,	,	PUNCT
dpc-3412	280	7	song	song	PROPN
dpc-3412	280	8	sw	sw	PROPN
dpc-3412	280	9	,	,	PUNCT
dpc-3412	280	10	lee	lee	PROPN
dpc-3412	280	11	jh	jh	PROPN
dpc-3412	280	12	.	.	PUNCT
dpc-3412	281	1	hypertension	hypertension	NOUN
dpc-3412	281	2	and	and	CCONJ
dpc-3412	281	3	risk	risk	NOUN
dpc-3412	281	4	of	of	ADP
dpc-3412	281	5	psoriasis	psoriasis	NOUN
dpc-3412	281	6	incidence	incidence	NOUN
dpc-3412	281	7	:	:	PUNCT
dpc-3412	281	8	an	an	DET
dpc-3412	281	9	11	11	NUM
dpc-3412	281	10	-	-	PUNCT
dpc-3412	281	11	year	year	NOUN
dpc-3412	281	12	nationwide	nationwide	ADJ
dpc-3412	281	13	population	population	NOUN
dpc-3412	281	14	-	-	PUNCT
dpc-3412	281	15	based	base	VERB
dpc-3412	281	16	cohort	cohort	NOUN
dpc-3412	281	17	study	study	NOUN
dpc-3412	281	18	.	.	PUNCT
dpc-3412	282	1	plos	plos	PROPN
dpc-3412	282	2	one	one	NUM
dpc-3412	282	3	.	.	PUNCT
dpc-3412	283	1	2018;13(8):e0202854	2018;13(8):e0202854	NUM
dpc-3412	283	2	.	.	PUNCT
dpc-3412	284	1	doi	doi	NOUN
dpc-3412	284	2	:	:	PUNCT
dpc-3412	284	3	10.1371	10.1371	NUM
dpc-3412	284	4	/	/	SYM
dpc-3412	284	5	journal	journal	NOUN
dpc-3412	284	6	.	.	PUNCT
dpc-3412	285	1	pone.0202854	pone.0202854	X
dpc-3412	285	2	.	.	PUNCT
dpc-3412	286	1	pmid	pmid	NOUN
dpc-3412	286	2	:	:	PUNCT
dpc-3412	286	3	30142208	30142208	NUM
dpc-3412	286	4	.	.	PUNCT
dpc-3412	287	1	pmcid	pmcid	NOUN
dpc-3412	287	2	:	:	PUNCT
dpc-3412	287	3	pmc6108501	pmc6108501	ADJ
dpc-3412	287	4	.	.	PUNCT
dpc-3412	288	1	39	39	NUM
dpc-3412	288	2	.	.	PUNCT
dpc-3412	289	1	armstrong	armstrong	PROPN
dpc-3412	289	2	aw	aw	PROPN
dpc-3412	289	3	,	,	PUNCT
dpc-3412	289	4	lin	lin	PROPN
dpc-3412	289	5	sw	sw	PROPN
dpc-3412	289	6	,	,	PUNCT
dpc-3412	289	7	chambers	chambers	PROPN
dpc-3412	289	8	cj	cj	PROPN
dpc-3412	289	9	,	,	PUNCT
dpc-3412	289	10	sockolov	sockolov	VERB
dpc-3412	289	11	me	i	PRON
dpc-3412	289	12	,	,	PUNCT
dpc-3412	289	13	chin	chin	PROPN
dpc-3412	289	14	dl	dl	PROPN
dpc-3412	289	15	.	.	PROPN
dpc-3412	289	16	psoriasis	psoriasis	NOUN
dpc-3412	289	17	and	and	CCONJ
dpc-3412	289	18	hypertension	hypertension	NOUN
dpc-3412	289	19	severity	severity	NOUN
dpc-3412	289	20	:	:	PUNCT
dpc-3412	289	21	results	result	VERB
dpc-3412	289	22	from	from	ADP
dpc-3412	289	23	a	a	DET
dpc-3412	289	24	case	case	NOUN
dpc-3412	289	25	-	-	PUNCT
dpc-3412	289	26	control	control	NOUN
dpc-3412	289	27	study	study	NOUN
dpc-3412	289	28	.	.	PUNCT
dpc-3412	290	1	plos	plos	PROPN
dpc-3412	290	2	one	one	NUM
dpc-3412	290	3	.	.	PUNCT
dpc-3412	291	1	2011;6(3):e18227	2011;6(3):e18227	PROPN
dpc-3412	291	2	.	.	PUNCT
dpc-3412	292	1	doi	doi	NOUN
dpc-3412	292	2	:	:	PUNCT
dpc-3412	292	3	10.1371	10.1371	NUM
dpc-3412	292	4	/	/	SYM
dpc-3412	292	5	journal	journal	NOUN
dpc-3412	292	6	.	.	PUNCT
dpc-3412	293	1	pone.0018227	pone.0018227	PROPN
dpc-3412	293	2	.	.	PUNCT
dpc-3412	294	1	pmid	pmid	NOUN
dpc-3412	294	2	:	:	PUNCT
dpc-3412	294	3	21479272	21479272	NUM
dpc-3412	294	4	.	.	PUNCT
dpc-3412	295	1	pmcid	pmcid	NOUN
dpc-3412	295	2	:	:	PUNCT
dpc-3412	295	3	pmc3066207	pmc3066207	NOUN
dpc-3412	295	4	.	.	PUNCT
dpc-3412	296	1	40	40	NUM
dpc-3412	296	2	.	.	PUNCT
dpc-3412	296	3	brauchli	brauchli	PROPN
dpc-3412	296	4	yb	yb	PROPN
dpc-3412	296	5	,	,	PUNCT
dpc-3412	296	6	jick	jick	PROPN
dpc-3412	296	7	ss	ss	PROPN
dpc-3412	296	8	,	,	PUNCT
dpc-3412	296	9	curtin	curtin	PROPN
dpc-3412	296	10	f	f	PROPN
dpc-3412	296	11	,	,	PUNCT
dpc-3412	296	12	meier	meier	PROPN
dpc-3412	296	13	cr	cr	PROPN
dpc-3412	296	14	.	.	PROPN
dpc-3412	297	1	association	association	PROPN
dpc-3412	297	2	between	between	ADP
dpc-3412	297	3	beta	beta	NOUN
dpc-3412	297	4	-	-	PUNCT
dpc-3412	297	5	blockers	blocker	NOUN
dpc-3412	297	6	,	,	PUNCT
dpc-3412	297	7	other	other	ADJ
dpc-3412	297	8	antihypertensive	antihypertensive	ADJ
dpc-3412	297	9	drugs	drug	NOUN
dpc-3412	297	10	and	and	CCONJ
dpc-3412	297	11	psoriasis	psoriasis	NOUN
dpc-3412	297	12	:	:	PUNCT
dpc-3412	297	13	population	population	NOUN
dpc-3412	297	14	-	-	PUNCT
dpc-3412	297	15	based	base	VERB
dpc-3412	297	16	case	case	NOUN
dpc-3412	297	17	-	-	PUNCT
dpc-3412	297	18	control	control	NOUN
dpc-3412	297	19	study	study	NOUN
dpc-3412	297	20	.	.	PUNCT
dpc-3412	298	1	br	br	PROPN
dpc-3412	298	2	j	j	PROPN
dpc-3412	298	3	dermatol	dermatol	NOUN
dpc-3412	298	4	.	.	PUNCT
dpc-3412	299	1	2008;158(6):1299	2008;158(6):1299	NUM
dpc-3412	299	2	-	-	SYM
dpc-3412	299	3	1307	1307	NUM
dpc-3412	299	4	.	.	PUNCT
dpc-3412	300	1	doi	doi	NOUN
dpc-3412	300	2	:	:	PUNCT
dpc-3412	300	3	10.1111	10.1111	NUM
dpc-3412	300	4	/	/	SYM
dpc-3412	300	5	j.1365	j.1365	PROPN
dpc-3412	300	6	-	-	PUNCT
dpc-3412	300	7	2133.2008	2133.2008	NOUN
dpc-3412	300	8	.08563.x	.08563.x	X
dpc-3412	300	9	.	.	PUNCT
dpc-3412	301	1	pmid	pmid	NOUN
dpc-3412	301	2	:	:	PUNCT
dpc-3412	301	3	18410416	18410416	NUM
dpc-3412	301	4	.	.	PUNCT
dpc-3412	302	1	41	41	NUM
dpc-3412	302	2	.	.	PUNCT
dpc-3412	303	1	wilkin	wilkin	PROPN
dpc-3412	303	2	j.	j.	PROPN
dpc-3412	303	3	exacerbation	exacerbation	NOUN
dpc-3412	303	4	of	of	ADP
dpc-3412	303	5	psoriasis	psoriasis	NOUN
dpc-3412	303	6	during	during	ADP
dpc-3412	303	7	clonidine	clonidine	PROPN
dpc-3412	303	8	therapy	therapy	NOUN
dpc-3412	303	9	.	.	PUNCT
dpc-3412	304	1	arch	arch	ADJ
dpc-3412	304	2	dermatol	dermatol	NOUN
dpc-3412	304	3	.	.	PUNCT
dpc-3412	305	1	1981;117(1):4	1981;117(1):4	PROPN
dpc-3412	305	2	.	.	PUNCT
dpc-3412	306	1	pmid	pmid	NOUN
dpc-3412	306	2	:	:	PUNCT
dpc-3412	306	3	7458381	7458381	NUM
dpc-3412	306	4	.	.	PUNCT
dpc-3412	307	1	42	42	NUM
dpc-3412	307	2	.	.	PUNCT
dpc-3412	308	1	takehara	takehara	PROPN
dpc-3412	308	2	y	y	PROPN
dpc-3412	308	3	,	,	PUNCT
dpc-3412	308	4	igawa	igawa	PROPN
dpc-3412	308	5	k	k	PROPN
dpc-3412	308	6	,	,	PUNCT
dpc-3412	308	7	satoh	satoh	PROPN
dpc-3412	308	8	t	t	PROPN
dpc-3412	308	9	,	,	PUNCT
dpc-3412	308	10	yokozeki	yokozeki	PROPN
dpc-3412	308	11	h.	h.	PROPN
dpc-3412	308	12	psoriasiform	psoriasiform	PROPN
dpc-3412	308	13	eruption	eruption	NOUN
dpc-3412	308	14	induced	induce	VERB
dpc-3412	308	15	by	by	ADP
dpc-3412	308	16	alpha1	alpha1	NOUN
dpc-3412	308	17	-	-	PUNCT
dpc-3412	308	18	adrenergic	adrenergic	NOUN
dpc-3412	308	19	blocker	blocker	NOUN
dpc-3412	308	20	,	,	PUNCT
dpc-3412	308	21	urapidil	urapidil	NOUN
dpc-3412	308	22	.	.	PUNCT
dpc-3412	309	1	j	j	PROPN
dpc-3412	309	2	eur	eur	PROPN
dpc-3412	309	3	acad	acad	PROPN
dpc-3412	309	4	dermatol	dermatol	NOUN
dpc-3412	309	5	venereol	venereol	NOUN
dpc-3412	309	6	.	.	PUNCT
dpc-3412	310	1	2007;21(4):577	2007;21(4):577	NUM
dpc-3412	310	2	-	-	PUNCT
dpc-3412	310	3	578	578	NUM
dpc-3412	310	4	.	.	PUNCT
dpc-3412	311	1	doi	doi	NOUN
dpc-3412	311	2	:	:	PUNCT
dpc-3412	311	3	10.1111	10.1111	NUM
dpc-3412	311	4	/	/	SYM
dpc-3412	311	5	j.1468	j.1468	PROPN
dpc-3412	311	6	-3083.2006.01977.x	-3083.2006.01977.x	NOUN
dpc-3412	311	7	.	.	PUNCT
dpc-3412	312	1	pmid	pmid	NOUN
dpc-3412	312	2	:	:	PUNCT
dpc-3412	312	3	17374017	17374017	NUM
dpc-3412	312	4	.	.	PUNCT
dpc-3412	313	1	43	43	NUM
dpc-3412	313	2	.	.	PUNCT
dpc-3412	314	1	wu	wu	PROPN
dpc-3412	314	2	s	s	PROPN
dpc-3412	314	3	,	,	PUNCT
dpc-3412	314	4	han	han	PROPN
dpc-3412	314	5	j	j	PROPN
dpc-3412	314	6	,	,	PUNCT
dpc-3412	314	7	qureshi	qureshi	PROPN
dpc-3412	314	8	aa	aa	PROPN
dpc-3412	314	9	.	.	PUNCT
dpc-3412	315	1	use	use	NOUN
dpc-3412	315	2	of	of	ADP
dpc-3412	315	3	aspirin	aspirin	NOUN
dpc-3412	315	4	,	,	PUNCT
dpc-3412	315	5	non	non	ADJ
dpc-3412	315	6	-	-	ADJ
dpc-3412	315	7	steroidal	steroidal	ADJ
dpc-3412	315	8	anti	anti	ADJ
dpc-3412	315	9	-	-	ADJ
dpc-3412	315	10	inflammatory	inflammatory	ADJ
dpc-3412	315	11	drugs	drug	NOUN
dpc-3412	315	12	,	,	PUNCT
dpc-3412	315	13	and	and	CCONJ
dpc-3412	315	14	acetaminophen	acetaminophen	NOUN
dpc-3412	315	15	(	(	PUNCT
dpc-3412	315	16	paracetamol	paracetamol	NOUN
dpc-3412	315	17	)	)	PUNCT
dpc-3412	315	18	,	,	PUNCT
dpc-3412	315	19	and	and	CCONJ
dpc-3412	315	20	risk	risk	NOUN
dpc-3412	315	21	of	of	ADP
dpc-3412	315	22	psoriasis	psoriasis	NOUN
dpc-3412	315	23	and	and	CCONJ
dpc-3412	315	24	psoriatic	psoriatic	ADJ
dpc-3412	315	25	arthritis	arthritis	NOUN
dpc-3412	315	26	:	:	PUNCT
dpc-3412	315	27	a	a	DET
dpc-3412	315	28	cohort	cohort	NOUN
dpc-3412	315	29	study	study	NOUN
dpc-3412	315	30	.	.	PUNCT
dpc-3412	316	1	acta	acta	PROPN
dpc-3412	316	2	derm	derm	PROPN
dpc-3412	316	3	venereol	venereol	NOUN
dpc-3412	316	4	.	.	PUNCT
dpc-3412	317	1	2015;95(2):217	2015;95(2):217	NUM
dpc-3412	317	2	-	-	PUNCT
dpc-3412	317	3	223	223	NUM
dpc-3412	317	4	.	.	PUNCT
dpc-3412	318	1	doi	doi	NOUN
dpc-3412	318	2	:	:	PUNCT
dpc-3412	318	3	10.2340/00015555	10.2340/00015555	NUM
dpc-3412	318	4	-1855	-1855	NOUN
dpc-3412	318	5	.	.	PUNCT
dpc-3412	319	1	pmid	pmid	NOUN
dpc-3412	319	2	:	:	PUNCT
dpc-3412	319	3	24691893	24691893	NUM
dpc-3412	319	4	.	.	PUNCT
dpc-3412	320	1	pmcid	pmcid	NOUN
dpc-3412	320	2	:	:	PUNCT
dpc-3412	320	3	pmc4183729	pmc4183729	ADJ
dpc-3412	320	4	.	.	PUNCT
dpc-3412	321	1	13	13	NUM
dpc-3412	321	2	.	.	PUNCT
dpc-3412	322	1	karbach	karbach	PROPN
dpc-3412	322	2	s	s	PROPN
dpc-3412	322	3	,	,	PUNCT
dpc-3412	322	4	hobohm	hobohm	PROPN
dpc-3412	322	5	l	l	PROPN
dpc-3412	322	6	,	,	PUNCT
dpc-3412	322	7	wild	wild	PROPN
dpc-3412	322	8	j	j	PROPN
dpc-3412	322	9	,	,	PUNCT
dpc-3412	322	10	et	et	PROPN
dpc-3412	322	11	al	al	PROPN
dpc-3412	322	12	.	.	PROPN
dpc-3412	322	13	impact	impact	NOUN
dpc-3412	322	14	of	of	ADP
dpc-3412	322	15	psoriasis	psoriasis	NOUN
dpc-3412	322	16	on	on	ADP
dpc-3412	322	17	mortality	mortality	NOUN
dpc-3412	322	18	rate	rate	NOUN
dpc-3412	322	19	and	and	CCONJ
dpc-3412	322	20	outcome	outcome	NOUN
dpc-3412	322	21	in	in	ADP
dpc-3412	322	22	myocardial	myocardial	ADJ
dpc-3412	322	23	infarction	infarction	NOUN
dpc-3412	322	24	.	.	PUNCT
dpc-3412	323	1	j	j	PROPN
dpc-3412	323	2	am	be	AUX
dpc-3412	323	3	heart	heart	NOUN
dpc-3412	323	4	assoc	assoc	NOUN
dpc-3412	323	5	.	.	PUNCT
dpc-3412	324	1	2020;9(18):e016956	2020;9(18):e016956	NUM
dpc-3412	324	2	.	.	PUNCT
dpc-3412	324	3	doi	doi	NOUN
dpc-3412	324	4	:	:	PUNCT
dpc-3412	324	5	10.1161	10.1161	NUM
dpc-3412	324	6	/	/	SYM
dpc-3412	324	7	jaha.120.016956	jaha.120.016956	NOUN
dpc-3412	324	8	.	.	PUNCT
dpc-3412	325	1	pmid	pmid	NOUN
dpc-3412	325	2	:	:	PUNCT
dpc-3412	325	3	32914667	32914667	NUM
dpc-3412	325	4	.	.	PUNCT
dpc-3412	326	1	pmcid	pmcid	NOUN
dpc-3412	326	2	:	:	PUNCT
dpc-3412	326	3	pmc7726965	pmc7726965	NOUN
dpc-3412	326	4	.	.	PUNCT
dpc-3412	327	1	14	14	NUM
dpc-3412	327	2	.	.	PUNCT
dpc-3412	328	1	wang	wang	PROPN
dpc-3412	328	2	j	j	PROPN
dpc-3412	328	3	,	,	PUNCT
dpc-3412	328	4	ke	ke	PROPN
dpc-3412	328	5	r	r	PROPN
dpc-3412	328	6	,	,	PUNCT
dpc-3412	328	7	shi	shi	PROPN
dpc-3412	328	8	w	w	PROPN
dpc-3412	328	9	,	,	PUNCT
dpc-3412	328	10	yan	yan	PROPN
dpc-3412	328	11	x	x	X
dpc-3412	328	12	,	,	PUNCT
dpc-3412	328	13	et	et	PROPN
dpc-3412	328	14	al	al	PROPN
dpc-3412	328	15	.	.	PROPN
dpc-3412	328	16	association	association	NOUN
dpc-3412	328	17	between	between	ADP
dpc-3412	328	18	psoriasis	psoriasis	NOUN
dpc-3412	328	19	and	and	CCONJ
dpc-3412	328	20	asthma	asthma	NOUN
dpc-3412	328	21	risk	risk	NOUN
dpc-3412	328	22	:	:	PUNCT
dpc-3412	328	23	a	a	DET
dpc-3412	328	24	meta	meta	ADJ
dpc-3412	328	25	-	-	PUNCT
dpc-3412	328	26	analysis	analysis	NOUN
dpc-3412	328	27	.	.	PUNCT
dpc-3412	329	1	allergy	allergy	PROPN
dpc-3412	329	2	asthma	asthma	PROPN
dpc-3412	329	3	proc	proc	PROPN
dpc-3412	329	4	.	.	PUNCT
dpc-3412	330	1	2018;39(2):103	2018;39(2):103	NUM
dpc-3412	330	2	-	-	SYM
dpc-3412	330	3	109	109	NUM
dpc-3412	330	4	.	.	PUNCT
dpc-3412	331	1	doi	doi	NOUN
dpc-3412	331	2	:	:	PUNCT
dpc-3412	331	3	10.2500	10.2500	NUM
dpc-3412	331	4	/	/	SYM
dpc-3412	331	5	aap.2018.39.4109	aap.2018.39.4109	VERB
dpc-3412	331	6	.	.	PUNCT
dpc-3412	332	1	pmid	pmid	NOUN
dpc-3412	332	2	:	:	PUNCT
dpc-3412	332	3	29490768	29490768	NUM
dpc-3412	332	4	.	.	PUNCT
dpc-3412	333	1	pmcid	pmcid	NOUN
dpc-3412	333	2	:	:	PUNCT
dpc-3412	333	3	pmc5827153	pmc5827153	PROPN
dpc-3412	333	4	.	.	PUNCT
dpc-3412	334	1	15	15	NUM
dpc-3412	334	2	.	.	PUNCT
dpc-3412	334	3	fu	fu	PROPN
dpc-3412	334	4	y	y	PROPN
dpc-3412	334	5	,	,	PUNCT
dpc-3412	334	6	lee	lee	PROPN
dpc-3412	334	7	ch	ch	PROPN
dpc-3412	334	8	,	,	PUNCT
dpc-3412	334	9	chi	chi	PROPN
dpc-3412	334	10	cc	cc	PROPN
dpc-3412	334	11	.	.	PROPN
dpc-3412	334	12	association	association	NOUN
dpc-3412	334	13	of	of	ADP
dpc-3412	334	14	psoriasis	psoriasis	NOUN
dpc-3412	334	15	with	with	ADP
dpc-3412	334	16	inflammatory	inflammatory	ADJ
dpc-3412	334	17	bowel	bowel	NOUN
dpc-3412	334	18	disease	disease	NOUN
dpc-3412	334	19	:	:	PUNCT
dpc-3412	334	20	a	a	DET
dpc-3412	334	21	systematic	systematic	ADJ
dpc-3412	334	22	review	review	NOUN
dpc-3412	334	23	and	and	CCONJ
dpc-3412	334	24	meta	meta	ADJ
dpc-3412	334	25	-	-	PUNCT
dpc-3412	334	26	analysis	analysis	NOUN
dpc-3412	334	27	.	.	PUNCT
dpc-3412	335	1	jama	jama	PROPN
dpc-3412	335	2	dermatol	dermatol	NOUN
dpc-3412	335	3	.	.	PUNCT
dpc-3412	336	1	2018	2018	NUM
dpc-3412	336	2	dec	dec	PROPN
dpc-3412	336	3	1;154(12):1417	1;154(12):1417	PROPN
dpc-3412	336	4	-	-	SYM
dpc-3412	336	5	1423	1423	NUM
dpc-3412	336	6	.	.	PUNCT
dpc-3412	337	1	doi	doi	NOUN
dpc-3412	337	2	:	:	PUNCT
dpc-3412	337	3	10.1001	10.1001	NUM
dpc-3412	337	4	/	/	SYM
dpc-3412	337	5	jamadermatol.2018.3631	jamadermatol.2018.3631	PROPN
dpc-3412	337	6	.	.	PUNCT
dpc-3412	338	1	pmid	pmid	NOUN
dpc-3412	338	2	:	:	PUNCT
dpc-3412	338	3	30422277	30422277	NUM
dpc-3412	338	4	.	.	PUNCT
dpc-3412	339	1	pmcid	pmcid	NOUN
dpc-3412	339	2	:	:	PUNCT
dpc-3412	339	3	pmc6583370	pmc6583370	NOUN
dpc-3412	339	4	.	.	PUNCT
dpc-3412	340	1	16	16	NUM
dpc-3412	340	2	.	.	PUNCT
dpc-3412	341	1	ungprasert	ungprasert	PROPN
dpc-3412	341	2	p	p	NOUN
dpc-3412	341	3	,	,	PUNCT
dpc-3412	341	4	raksasuk	raksasuk	NOUN
dpc-3412	341	5	s.	s.	PROPN
dpc-3412	341	6	psoriasis	psoriasis	NOUN
dpc-3412	341	7	and	and	CCONJ
dpc-3412	341	8	risk	risk	NOUN
dpc-3412	341	9	of	of	ADP
dpc-3412	341	10	incident	incident	NOUN
dpc-3412	341	11	chronic	chronic	ADJ
dpc-3412	341	12	kidney	kidney	NOUN
dpc-3412	341	13	disease	disease	NOUN
dpc-3412	341	14	and	and	CCONJ
dpc-3412	341	15	end	end	NOUN
dpc-3412	341	16	-	-	PUNCT
dpc-3412	341	17	stage	stage	NOUN
dpc-3412	341	18	renal	renal	ADJ
dpc-3412	341	19	disease	disease	NOUN
dpc-3412	341	20	:	:	PUNCT
dpc-3412	341	21	a	a	DET
dpc-3412	341	22	systematic	systematic	ADJ
dpc-3412	341	23	review	review	NOUN
dpc-3412	341	24	and	and	CCONJ
dpc-3412	341	25	meta	meta	ADJ
dpc-3412	341	26	-	-	PUNCT
dpc-3412	341	27	analysis	analysis	NOUN
dpc-3412	341	28	.	.	PUNCT
dpc-3412	342	1	int	int	PROPN
dpc-3412	342	2	urol	urol	ADJ
dpc-3412	342	3	nephrol	nephrol	NOUN
dpc-3412	342	4	.	.	PUNCT
dpc-3412	343	1	2018;50(7):1277	2018;50(7):1277	NUM
dpc-3412	343	2	-	-	SYM
dpc-3412	343	3	1283	1283	NUM
dpc-3412	343	4	.	.	PUNCT
dpc-3412	344	1	doi	doi	NOUN
dpc-3412	344	2	:	:	PUNCT
dpc-3412	344	3	10.1007	10.1007	NUM
dpc-3412	344	4	/	/	SYM
dpc-3412	344	5	s11255	s11255	NOUN
dpc-3412	344	6	-	-	PUNCT
dpc-3412	344	7	018	018	NUM
dpc-3412	344	8	-	-	PUNCT
dpc-3412	344	9	1868	1868	NUM
dpc-3412	344	10	-	-	PUNCT
dpc-3412	344	11	z.	z.	PROPN
dpc-3412	344	12	pmid	pmid	PROPN
dpc-3412	344	13	:	:	PUNCT
dpc-3412	344	14	29644523	29644523	NUM
dpc-3412	344	15	.	.	PUNCT
dpc-3412	345	1	17	17	NUM
dpc-3412	345	2	.	.	X
dpc-3412	346	1	burgess	burgess	PROPN
dpc-3412	346	2	s	s	PROPN
dpc-3412	346	3	,	,	PUNCT
dpc-3412	346	4	small	small	ADJ
dpc-3412	346	5	ds	ds	NOUN
dpc-3412	346	6	,	,	PUNCT
dpc-3412	346	7	thompson	thompson	PROPN
dpc-3412	346	8	sg	sg	PROPN
dpc-3412	346	9	.	.	PUNCT
dpc-3412	347	1	a	a	DET
dpc-3412	347	2	review	review	NOUN
dpc-3412	347	3	of	of	ADP
dpc-3412	347	4	instrumental	instrumental	ADJ
dpc-3412	347	5	variable	variable	ADJ
dpc-3412	347	6	estimators	estimator	NOUN
dpc-3412	347	7	for	for	ADP
dpc-3412	347	8	mendelian	mendelian	ADJ
dpc-3412	347	9	randomization	randomization	NOUN
dpc-3412	347	10	.	.	PUNCT
dpc-3412	348	1	stat	stat	PROPN
dpc-3412	348	2	methods	method	NOUN
dpc-3412	348	3	med	me	VERB
dpc-3412	348	4	res	re	NOUN
dpc-3412	348	5	.	.	PUNCT
dpc-3412	349	1	2017;26(5):2333	2017;26(5):2333	NUM
dpc-3412	349	2	-	-	SYM
dpc-3412	349	3	2355	2355	NUM
dpc-3412	349	4	.	.	PUNCT
dpc-3412	350	1	doi	doi	NOUN
dpc-3412	350	2	:	:	PUNCT
dpc-3412	350	3	10.1177/0962280215597579	10.1177/0962280215597579	NUM
dpc-3412	350	4	.	.	PUNCT
dpc-3412	351	1	pmid	pmid	NOUN
dpc-3412	351	2	:	:	PUNCT
dpc-3412	351	3	26282889	26282889	NUM
dpc-3412	351	4	.	.	PUNCT
dpc-3412	352	1	pmcid	pmcid	NOUN
dpc-3412	352	2	:	:	PUNCT
dpc-3412	352	3	pmc5642006	pmc5642006	ADJ
dpc-3412	352	4	.	.	PUNCT
dpc-3412	353	1	18	18	NUM
dpc-3412	353	2	.	.	PUNCT
dpc-3412	353	3	wu	wu	PROPN
dpc-3412	353	4	y	y	PROPN
dpc-3412	353	5	,	,	PUNCT
dpc-3412	353	6	byrne	byrne	VERB
dpc-3412	353	7	em	em	PRON
dpc-3412	353	8	,	,	PUNCT
dpc-3412	353	9	zheng	zheng	PROPN
dpc-3412	353	10	z	z	PROPN
dpc-3412	353	11	,	,	PUNCT
dpc-3412	353	12	et	et	PROPN
dpc-3412	353	13	al	al	PROPN
dpc-3412	353	14	.	.	PUNCT
dpc-3412	353	15	genome	genome	NOUN
dpc-3412	353	16	-	-	PUNCT
dpc-3412	353	17	wide	wide	ADJ
dpc-3412	353	18	association	association	NOUN
dpc-3412	353	19	study	study	NOUN
dpc-3412	353	20	of	of	ADP
dpc-3412	353	21	medication	medication	NOUN
dpc-3412	353	22	-	-	PUNCT
dpc-3412	353	23	use	use	NOUN
dpc-3412	353	24	and	and	CCONJ
dpc-3412	353	25	associated	associated	ADJ
dpc-3412	353	26	disease	disease	NOUN
dpc-3412	353	27	in	in	ADP
dpc-3412	353	28	the	the	DET
dpc-3412	353	29	uk	uk	PROPN
dpc-3412	353	30	biobank	biobank	NOUN
dpc-3412	353	31	.	.	PUNCT
dpc-3412	354	1	nat	nat	PROPN
dpc-3412	354	2	commun	commun	PROPN
dpc-3412	354	3	.	.	PUNCT
dpc-3412	355	1	2019;10(1):1891	2019;10(1):1891	NUM
dpc-3412	355	2	.	.	PUNCT
dpc-3412	356	1	doi	doi	NOUN
dpc-3412	356	2	:	:	PUNCT
dpc-3412	356	3	10.1038	10.1038	NUM
dpc-3412	356	4	/	/	SYM
dpc-3412	356	5	s41467	s41467	NOUN
dpc-3412	356	6	-	-	PUNCT
dpc-3412	356	7	019	019	NUM
dpc-3412	356	8	-	-	PUNCT
dpc-3412	356	9	09572	09572	NUM
dpc-3412	356	10	-	-	SYM
dpc-3412	356	11	5	5	NUM
dpc-3412	356	12	.	.	PUNCT
dpc-3412	357	1	pmid	pmid	NOUN
dpc-3412	357	2	:	:	PUNCT
dpc-3412	357	3	31015401	31015401	NUM
dpc-3412	357	4	.	.	PUNCT
dpc-3412	358	1	pmcid	pmcid	NOUN
dpc-3412	358	2	:	:	PUNCT
dpc-3412	358	3	pmc6478889	pmc6478889	NOUN
dpc-3412	358	4	.	.	PUNCT
dpc-3412	359	1	19	19	NUM
dpc-3412	359	2	.	.	X
dpc-3412	359	3	burgess	burgess	PROPN
dpc-3412	359	4	s	s	PROPN
dpc-3412	359	5	,	,	PUNCT
dpc-3412	359	6	butterworth	butterworth	PROPN
dpc-3412	359	7	a	a	PRON
dpc-3412	359	8	,	,	PUNCT
dpc-3412	359	9	thompson	thompson	PROPN
dpc-3412	359	10	sg	sg	PROPN
dpc-3412	359	11	.	.	PUNCT
dpc-3412	360	1	mendelian	mendelian	ADJ
dpc-3412	360	2	randomization	randomization	NOUN
dpc-3412	360	3	analysis	analysis	NOUN
dpc-3412	360	4	with	with	ADP
dpc-3412	360	5	multiple	multiple	ADJ
dpc-3412	360	6	genetic	genetic	ADJ
dpc-3412	360	7	variants	variant	NOUN
dpc-3412	360	8	using	use	VERB
dpc-3412	360	9	summarized	summarize	VERB
dpc-3412	360	10	data	datum	NOUN
dpc-3412	360	11	.	.	PUNCT
dpc-3412	361	1	genet	genet	PROPN
dpc-3412	361	2	epidemiol	epidemiol	PROPN
dpc-3412	361	3	.	.	PUNCT
dpc-3412	362	1	2013;37(7):658	2013;37(7):658	NUM
dpc-3412	362	2	-	-	PUNCT
dpc-3412	362	3	665	665	NUM
dpc-3412	362	4	.	.	PUNCT
dpc-3412	363	1	doi	doi	NOUN
dpc-3412	363	2	:	:	PUNCT
dpc-3412	363	3	10.1002	10.1002	NUM
dpc-3412	363	4	/gepi.21758	/gepi.21758	X
dpc-3412	363	5	.	.	PUNCT
dpc-3412	364	1	pmid	pmid	NOUN
dpc-3412	364	2	:	:	PUNCT
dpc-3412	364	3	24114802	24114802	NUM
dpc-3412	364	4	.	.	PUNCT
dpc-3412	365	1	pmcid	pmcid	NOUN
dpc-3412	365	2	:	:	PUNCT
dpc-3412	365	3	pmc4377079	pmc4377079	NOUN
dpc-3412	365	4	.	.	PUNCT
dpc-3412	366	1	20	20	NUM
dpc-3412	366	2	.	.	PUNCT
dpc-3412	367	1	kurilshikov	kurilshikov	PROPN
dpc-3412	367	2	a	a	PROPN
dpc-3412	367	3	,	,	PUNCT
dpc-3412	367	4	medina	medina	PROPN
dpc-3412	367	5	-	-	PUNCT
dpc-3412	367	6	gomez	gomez	PROPN
dpc-3412	367	7	c	c	PROPN
dpc-3412	367	8	,	,	PUNCT
dpc-3412	367	9	bacigalupe	bacigalupe	ADJ
dpc-3412	367	10	r	r	NOUN
dpc-3412	367	11	,	,	PUNCT
dpc-3412	367	12	et	et	PROPN
dpc-3412	367	13	al	al	PROPN
dpc-3412	367	14	.	.	PUNCT
dpc-3412	368	1	large	large	ADJ
dpc-3412	368	2	scale	scale	NOUN
dpc-3412	368	3	association	association	NOUN
dpc-3412	368	4	analyses	analysis	NOUN
dpc-3412	368	5	identify	identify	VERB
dpc-3412	368	6	host	host	NOUN
dpc-3412	368	7	factors	factor	NOUN
dpc-3412	368	8	influencing	influence	VERB
dpc-3412	368	9	human	human	ADJ
dpc-3412	368	10	gut	gut	NOUN
dpc-3412	368	11	microbiome	microbiome	NOUN
dpc-3412	368	12	composition	composition	NOUN
dpc-3412	368	13	.	.	PUNCT
dpc-3412	369	1	nat	nat	PROPN
dpc-3412	369	2	genet	genet	PROPN
dpc-3412	369	3	.	.	PUNCT
dpc-3412	370	1	2021;53(2	2021;53(2	NUM
dpc-3412	370	2	):	):	PUNCT
dpc-3412	370	3	156	156	NUM
dpc-3412	370	4	-	-	SYM
dpc-3412	370	5	165	165	NUM
dpc-3412	370	6	.	.	PUNCT
dpc-3412	370	7	doi	doi	NOUN
dpc-3412	370	8	:	:	PUNCT
dpc-3412	370	9	10.1038	10.1038	NUM
dpc-3412	370	10	/	/	SYM
dpc-3412	370	11	s41588	s41588	VERB
dpc-3412	370	12	-	-	PUNCT
dpc-3412	370	13	020	020	NUM
dpc-3412	370	14	-	-	PUNCT
dpc-3412	370	15	00763	00763	NUM
dpc-3412	370	16	-	-	PUNCT
dpc-3412	370	17	1	1	NUM
dpc-3412	370	18	.	.	PUNCT
dpc-3412	371	1	pmid	pmid	NOUN
dpc-3412	371	2	:	:	PUNCT
dpc-3412	371	3	33462485	33462485	NUM
dpc-3412	371	4	.	.	PUNCT
dpc-3412	372	1	pmcid	pmcid	NOUN
dpc-3412	372	2	:	:	PUNCT
dpc-3412	372	3	pmc8515199	pmc8515199	NOUN
dpc-3412	372	4	.	.	PUNCT
dpc-3412	373	1	21	21	NUM
dpc-3412	373	2	.	.	PUNCT
dpc-3412	374	1	kurki	kurki	PROPN
dpc-3412	374	2	mi	mi	PROPN
dpc-3412	374	3	,	,	PUNCT
dpc-3412	374	4	karjalainen	karjalainen	PROPN
dpc-3412	374	5	j	j	PROPN
dpc-3412	374	6	,	,	PUNCT
dpc-3412	374	7	palta	palta	PROPN
dpc-3412	374	8	p	p	PROPN
dpc-3412	374	9	,	,	PUNCT
dpc-3412	374	10	et	et	PROPN
dpc-3412	374	11	al	al	PROPN
dpc-3412	374	12	.	.	PROPN
dpc-3412	374	13	finngen	finngen	PROPN
dpc-3412	374	14	provides	provide	VERB
dpc-3412	374	15	genetic	genetic	ADJ
dpc-3412	374	16	insights	insight	NOUN
dpc-3412	374	17	from	from	ADP
dpc-3412	374	18	a	a	DET
dpc-3412	374	19	well	well	ADV
dpc-3412	374	20	-	-	PUNCT
dpc-3412	374	21	phenotyped	phenotype	VERB
dpc-3412	374	22	isolated	isolated	ADJ
dpc-3412	374	23	population	population	NOUN
dpc-3412	374	24	.	.	PUNCT
dpc-3412	375	1	nature	nature	NOUN
dpc-3412	375	2	.	.	PUNCT
dpc-3412	376	1	2023;613(7944):508	2023;613(7944):508	NUM
dpc-3412	376	2	-	-	SYM
dpc-3412	376	3	518	518	NUM
dpc-3412	376	4	.	.	PUNCT
dpc-3412	376	5	doi	doi	NOUN
dpc-3412	376	6	:	:	PUNCT
dpc-3412	376	7	10.1038	10.1038	NUM
dpc-3412	376	8	/	/	SYM
dpc-3412	376	9	s41586	s41586	PROPN
dpc-3412	376	10	-	-	PUNCT
dpc-3412	376	11	022	022	NUM
dpc-3412	376	12	-	-	PUNCT
dpc-3412	376	13	05473	05473	NUM
dpc-3412	376	14	-	-	SYM
dpc-3412	376	15	8	8	NUM
dpc-3412	376	16	.	.	PUNCT
dpc-3412	377	1	pmid	pmid	NOUN
dpc-3412	377	2	:	:	PUNCT
dpc-3412	377	3	36653562	36653562	NUM
dpc-3412	377	4	.	.	PUNCT
dpc-3412	378	1	pmcid	pmcid	ADJ
dpc-3412	378	2	:	:	PUNCT
dpc-3412	378	3	pmc9849126	pmc9849126	NOUN
dpc-3412	378	4	.	.	PUNCT
dpc-3412	379	1	22	22	NUM
dpc-3412	379	2	.	.	PUNCT
dpc-3412	380	1	verbanck	verbanck	PROPN
dpc-3412	380	2	m	m	PROPN
dpc-3412	380	3	,	,	PUNCT
dpc-3412	380	4	chen	chen	PROPN
dpc-3412	380	5	cy	cy	PROPN
dpc-3412	380	6	,	,	PUNCT
dpc-3412	380	7	neale	neale	PROPN
dpc-3412	380	8	b	b	PROPN
dpc-3412	380	9	,	,	PUNCT
dpc-3412	380	10	do	do	VERB
dpc-3412	380	11	r.	r.	NOUN
dpc-3412	380	12	detection	detection	NOUN
dpc-3412	380	13	of	of	ADP
dpc-3412	380	14	widespread	widespread	ADJ
dpc-3412	380	15	horizontal	horizontal	ADJ
dpc-3412	380	16	pleiotropy	pleiotropy	NOUN
dpc-3412	380	17	in	in	ADP
dpc-3412	380	18	causal	causal	ADJ
dpc-3412	380	19	relationships	relationship	NOUN
dpc-3412	380	20	inferred	infer	VERB
dpc-3412	380	21	from	from	ADP
dpc-3412	380	22	mendelian	mendelian	ADJ
dpc-3412	380	23	randomization	randomization	NOUN
dpc-3412	380	24	between	between	ADP
dpc-3412	380	25	complex	complex	ADJ
dpc-3412	380	26	traits	trait	NOUN
dpc-3412	380	27	and	and	CCONJ
dpc-3412	380	28	diseases	disease	NOUN
dpc-3412	380	29	.	.	PUNCT
dpc-3412	381	1	nat	nat	PROPN
dpc-3412	381	2	genet	genet	PROPN
dpc-3412	381	3	.	.	PUNCT
dpc-3412	382	1	2018;50(5):693	2018;50(5):693	NUM
dpc-3412	382	2	-	-	SYM
dpc-3412	382	3	698	698	NUM
dpc-3412	382	4	.	.	PUNCT
dpc-3412	383	1	doi	doi	NOUN
dpc-3412	383	2	:	:	PUNCT
dpc-3412	383	3	10.1038	10.1038	NUM
dpc-3412	383	4	/	/	SYM
dpc-3412	383	5	s41588	s41588	VERB
dpc-3412	383	6	-	-	PUNCT
dpc-3412	383	7	018	018	NUM
dpc-3412	383	8	-	-	PUNCT
dpc-3412	383	9	0099	0099	NUM
dpc-3412	383	10	-	-	SYM
dpc-3412	383	11	7	7	NUM
dpc-3412	383	12	.	.	PUNCT
dpc-3412	384	1	pmid	pmid	NOUN
dpc-3412	384	2	:	:	PUNCT
dpc-3412	384	3	29686387	29686387	NUM
dpc-3412	384	4	.	.	PUNCT
dpc-3412	385	1	pmcid	pmcid	ADJ
dpc-3412	385	2	:	:	PUNCT
dpc-3412	385	3	pmc6083837	pmc6083837	NOUN
dpc-3412	385	4	.	.	PUNCT
dpc-3412	386	1	23	23	NUM
dpc-3412	386	2	.	.	X
dpc-3412	387	1	burgess	burgess	PROPN
dpc-3412	387	2	s	s	PROPN
dpc-3412	387	3	,	,	PUNCT
dpc-3412	387	4	davey	davey	PROPN
dpc-3412	387	5	smith	smith	PROPN
dpc-3412	387	6	g	g	PROPN
dpc-3412	387	7	,	,	PUNCT
dpc-3412	387	8	davies	davy	NOUN
dpc-3412	387	9	nm	nm	PROPN
dpc-3412	387	10	,	,	PUNCT
dpc-3412	387	11	et	et	PROPN
dpc-3412	387	12	al	al	PROPN
dpc-3412	387	13	.	.	PUNCT
dpc-3412	387	14	guidelines	guideline	NOUN
dpc-3412	387	15	for	for	ADP
dpc-3412	387	16	performing	perform	VERB
dpc-3412	387	17	mendelian	mendelian	ADJ
dpc-3412	387	18	randomization	randomization	NOUN
dpc-3412	387	19	investigations	investigation	NOUN
dpc-3412	387	20	:	:	PUNCT
dpc-3412	387	21	update	update	NOUN
dpc-3412	387	22	for	for	ADP
dpc-3412	387	23	summer	summer	NOUN
dpc-3412	387	24	2023	2023	NUM
dpc-3412	387	25	.	.	PUNCT
dpc-3412	388	1	wellcome	wellcome	PROPN
dpc-3412	388	2	open	open	ADJ
dpc-3412	388	3	res	re	NOUN
dpc-3412	388	4	.	.	PUNCT
dpc-3412	389	1	2023;4:186	2023;4:186	PROPN
dpc-3412	389	2	.	.	PUNCT
dpc-3412	390	1	doi	doi	NOUN
dpc-3412	390	2	:	:	PUNCT
dpc-3412	390	3	10.12688	10.12688	NUM
dpc-3412	390	4	/	/	SYM
dpc-3412	390	5	wellcomeopenres.15555.3	wellcomeopenres.15555.3	PROPN
dpc-3412	390	6	.	.	PUNCT
dpc-3412	391	1	pmid	pmid	PROPN
dpc-3412	391	2	:	:	PUNCT
dpc-3412	391	3	32760811	32760811	NUM
dpc-3412	391	4	.	.	PUNCT
dpc-3412	392	1	pmcid	pmcid	NOUN
dpc-3412	392	2	:	:	PUNCT
dpc-3412	392	3	pmc7384151	pmc7384151	NOUN
dpc-3412	392	4	.	.	PUNCT
dpc-3412	393	1	24	24	NUM
dpc-3412	393	2	.	.	X
dpc-3412	394	1	burgess	burgess	PROPN
dpc-3412	394	2	s	s	PROPN
dpc-3412	394	3	,	,	PUNCT
dpc-3412	394	4	thompson	thompson	PROPN
dpc-3412	394	5	sg	sg	PROPN
dpc-3412	394	6	.	.	PUNCT
dpc-3412	395	1	interpreting	interpret	VERB
dpc-3412	395	2	findings	finding	NOUN
dpc-3412	395	3	from	from	ADP
dpc-3412	395	4	mendelian	mendelian	ADJ
dpc-3412	395	5	randomization	randomization	NOUN
dpc-3412	395	6	using	use	VERB
dpc-3412	395	7	the	the	DET
dpc-3412	395	8	mr	mr	PROPN
dpc-3412	395	9	-	-	PUNCT
dpc-3412	395	10	egger	egger	NOUN
dpc-3412	395	11	method	method	NOUN
dpc-3412	395	12	.	.	PUNCT
dpc-3412	396	1	eur	eur	PROPN
dpc-3412	396	2	j	j	PROPN
dpc-3412	396	3	epidemiol	epidemiol	PROPN
dpc-3412	396	4	.	.	PUNCT
dpc-3412	397	1	2017;32(5):377	2017;32(5):377	NUM
dpc-3412	397	2	-	-	PUNCT
dpc-3412	397	3	389	389	NUM
dpc-3412	397	4	.	.	PUNCT
dpc-3412	398	1	doi	doi	NOUN
dpc-3412	398	2	:	:	PUNCT
dpc-3412	398	3	10.1007	10.1007	NUM
dpc-3412	398	4	/	/	SYM
dpc-3412	398	5	s10654	s10654	PROPN
dpc-3412	398	6	-	-	PUNCT
dpc-3412	398	7	017	017	NUM
dpc-3412	398	8	-	-	PUNCT
dpc-3412	398	9	0255	0255	NUM
dpc-3412	398	10	-	-	PUNCT
dpc-3412	398	11	x.	x.	NOUN
dpc-3412	398	12	pmid	pmid	PROPN
dpc-3412	398	13	:	:	PUNCT
dpc-3412	398	14	28527048	28527048	NUM
dpc-3412	398	15	.	.	PUNCT
dpc-3412	399	1	pmcid	pmcid	NOUN
dpc-3412	399	2	:	:	PUNCT
dpc-3412	399	3	pmc5506233	pmc5506233	NOUN
dpc-3412	399	4	.	.	PUNCT
dpc-3412	400	1	25	25	NUM
dpc-3412	400	2	.	.	PUNCT
dpc-3412	401	1	kim	kim	PROPN
dpc-3412	401	2	gk	gk	PROPN
dpc-3412	401	3	,	,	PUNCT
dpc-3412	401	4	del	del	PROPN
dpc-3412	401	5	rosso	rosso	PROPN
dpc-3412	401	6	jq	jq	PROPN
dpc-3412	401	7	.	.	PUNCT
dpc-3412	401	8	drug	drug	NOUN
dpc-3412	401	9	-	-	PUNCT
dpc-3412	401	10	provoked	provoke	VERB
dpc-3412	401	11	psoriasis	psoriasis	NOUN
dpc-3412	401	12	:	:	PUNCT
dpc-3412	401	13	is	be	AUX
dpc-3412	401	14	it	it	PRON
dpc-3412	401	15	drug	drug	NOUN
dpc-3412	401	16	induced	induced	ADJ
dpc-3412	401	17	or	or	CCONJ
dpc-3412	401	18	drug	drug	NOUN
dpc-3412	401	19	aggravated	aggravate	VERB
dpc-3412	401	20	?	?	PUNCT
dpc-3412	401	21	:	:	PUNCT
dpc-3412	401	22	understanding	understand	VERB
dpc-3412	401	23	pathophysiology	pathophysiology	NOUN
dpc-3412	401	24	and	and	CCONJ
dpc-3412	401	25	clinical	clinical	ADJ
dpc-3412	401	26	relevance	relevance	NOUN
dpc-3412	401	27	.	.	PUNCT
dpc-3412	402	1	j	j	PROPN
dpc-3412	402	2	clin	clin	PROPN
dpc-3412	402	3	aesthet	aesthet	PROPN
dpc-3412	402	4	dermatol	dermatol	PROPN
dpc-3412	402	5	.	.	PUNCT
dpc-3412	403	1	2010;3(1):32	2010;3(1):32	NUM
dpc-3412	403	2	-	-	SYM
dpc-3412	403	3	38	38	NUM
dpc-3412	403	4	.	.	PUNCT
dpc-3412	404	1	pmid	pmid	NOUN
dpc-3412	404	2	:	:	PUNCT
dpc-3412	404	3	20725536	20725536	NUM
dpc-3412	404	4	.	.	PUNCT
dpc-3412	405	1	pmcid	pmcid	NOUN
dpc-3412	405	2	:	:	PUNCT
dpc-3412	405	3	pmc2921739	pmc2921739	NOUN
dpc-3412	405	4	.	.	PUNCT
dpc-3412	406	1	26	26	NUM
dpc-3412	406	2	.	.	PUNCT
dpc-3412	406	3	balak	balak	PROPN
dpc-3412	406	4	dm	dm	PROPN
dpc-3412	406	5	,	,	PUNCT
dpc-3412	406	6	hajdarbegovic	hajdarbegovic	PROPN
dpc-3412	406	7	e.	e.	PROPN
dpc-3412	406	8	drug	drug	PROPN
dpc-3412	406	9	-	-	PUNCT
dpc-3412	406	10	induced	induce	VERB
dpc-3412	406	11	psoriasis	psoriasis	NOUN
dpc-3412	406	12	:	:	PUNCT
dpc-3412	406	13	clinical	clinical	ADJ
dpc-3412	406	14	perspectives	perspective	NOUN
dpc-3412	406	15	.	.	PUNCT
dpc-3412	407	1	psoriasis	psoriasis	NOUN
dpc-3412	407	2	(	(	PUNCT
dpc-3412	407	3	auckl	auckl	NOUN
dpc-3412	407	4	)	)	PUNCT
dpc-3412	407	5	.	.	PUNCT
dpc-3412	408	1	2017;7:87	2017;7:87	NUM
dpc-3412	408	2	-	-	SYM
dpc-3412	408	3	94	94	NUM
dpc-3412	408	4	.	.	PUNCT
dpc-3412	409	1	doi	doi	NOUN
dpc-3412	409	2	:	:	PUNCT
dpc-3412	409	3	10.2147	10.2147	NUM
dpc-3412	409	4	/ptt.s126727	/ptt.s126727	NOUN
dpc-3412	409	5	.	.	PUNCT
dpc-3412	410	1	pmid	pmid	NOUN
dpc-3412	410	2	:	:	PUNCT
dpc-3412	410	3	29387611	29387611	NUM
dpc-3412	410	4	.	.	PUNCT
dpc-3412	411	1	pmcid	pmcid	NOUN
dpc-3412	411	2	:	:	PUNCT
dpc-3412	411	3	pmc5774610	pmc5774610	NUM
dpc-3412	411	4	.	.	PUNCT
dpc-3412	412	1	27	27	NUM
dpc-3412	412	2	.	.	X
dpc-3412	412	3	shirinsky	shirinsky	NOUN
dpc-3412	412	4	iv	iv	NUM
dpc-3412	412	5	,	,	PUNCT
dpc-3412	412	6	shirinsky	shirinsky	NOUN
dpc-3412	412	7	vs.	vs.	ADP
dpc-3412	412	8	efficacy	efficacy	NOUN
dpc-3412	412	9	of	of	ADP
dpc-3412	412	10	simvastatin	simvastatin	NOUN
dpc-3412	412	11	in	in	ADP
dpc-3412	412	12	plaque	plaque	NOUN
dpc-3412	412	13	psoriasis	psoriasis	NOUN
dpc-3412	412	14	:	:	PUNCT
dpc-3412	412	15	a	a	DET
dpc-3412	412	16	pilot	pilot	NOUN
dpc-3412	412	17	study	study	NOUN
dpc-3412	412	18	.	.	PUNCT
dpc-3412	413	1	j	j	PROPN
dpc-3412	413	2	am	be	AUX
dpc-3412	413	3	acad	acad	ADJ
dpc-3412	413	4	dermatol	dermatol	NOUN
dpc-3412	413	5	.	.	PUNCT
dpc-3412	414	1	2007;57(3):529	2007;57(3):529	NUM
dpc-3412	414	2	-	-	PUNCT
dpc-3412	414	3	531	531	NUM
dpc-3412	414	4	.	.	PUNCT
dpc-3412	415	1	doi	doi	NOUN
dpc-3412	415	2	:	:	PUNCT
dpc-3412	415	3	10.1016	10.1016	NUM
dpc-3412	415	4	/	/	SYM
dpc-3412	415	5	j.jaad.2007.05.040	j.jaad.2007.05.040	PROPN
dpc-3412	415	6	.	.	PUNCT
dpc-3412	416	1	pmid	pmid	NOUN
dpc-3412	416	2	:	:	PUNCT
dpc-3412	416	3	17707157	17707157	NUM
dpc-3412	416	4	.	.	PUNCT